≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Speech and linguistic disorders

DOID Endpoint Browser

KRA_PSY_SPEELING

autism: A disorder characterized by marked impairments in social interaction and communication accompanied by a pattern of repetitive, stereotyped behaviors and activities. Developmental delays in social interaction and language surface prior to age 3 years.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F80, F81
  • Hospital discharge: ICD-9 — 315[0-3]|3159
  • Hospital discharge: ICD-8 — 31610
  • Cause of death: ICD-10 — F80, F81
  • Cause of death: ICD-9 — 315[0-3]|3159
  • Cause of death: ICD-8 — 31610

2 out of 7 registries used, show all original rules.

4387

4. Check minimum number of events

None

4387

5. Include endpoints

None

4387

6. Filter based on genotype QC (FinnGen only)

4080

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 4080 2071 2009
Unadjusted period prevalence (%) 0.83 0.74 0.92
Median age at first event (years) 12.55 15.68 9.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4310
Matched controls
41293
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F80.0
ICD-10 Finland
Specific speech articulation disorder
66.9
307.7
347
54
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
224.2
307.7
243
11
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
270.2
307.7
338
13
F81.0
ICD-10 Finland
Specific reading disorder
183.8
307.7
638
39
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
353.4
307.7
603
19
F80.1
ICD-10 Finland
Expressive language disorder
1104.8
307.7
1453
19
F83
ICD-10 Finland
Mixed specific developmental disorders
14.2
307.7
416
309
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
255.2
307.7
388
16
F82
ICD-10 Finland
Specific developmental disorder of motor function
16.5
307.7
288
178
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
135.7
307.7
490
39
XA800
NOMESCO Finland
Neuropsychological investigation
8.1
307.7
589
794
F80.2
ICD-10 Finland
Receptive language disorder
610.2
307.7
555
10
Z2445
NOMESCO Finland
Psychologist
5.1
292.6
705
1528
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
11.0
283.0
318
297
R62.0
ICD-10 Finland
Delayed milestone
10.1
256.4
306
311
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
231.8
224
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
212.2
1149
4317
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
17.2
211.9
181
105
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.4
190.5
814
2637
Z2446
NOMESCO Finland
Social worker
3.6
187.2
714
2148
F81.1
ICD-10 Finland
Specific spelling disorder
344.5
170.7
174
5
R4130
NOMESCO Finland
Speech therapy
7.3
168.2
260
362
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
159.1
505
1332
Z3226
NOMESCO Finland
Physiotherapist
2.8
154.0
986
3984
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.3
153.2
432
1043
AA1AD
NOMESCO Finland
CT of head and brain
2.7
150.3
1063
4512
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
146.4
142
*
N03AG01
ATC
valproic acid; systemic, rectal
3.9
143.1
465
1244
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
138.2
622
2055
Z50.5
ICD-10 Finland
Speech therapy
6.4
132.2
229
359
ZY010
NOMESCO Finland
Hospital outpatient
3.2
131.2
576
1872
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.5
129.2
491
1457
Z3231
NOMESCO Finland
Registered nurse
2.3
126.4
1411
7285
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.1
125.7
375
941
N05AH04
ATC
quetiapine; oral
2.4
125.4
1149
5448
N05AH03
ATC
olanzapine; systemic
3.2
118.0
534
1762
N05AX08
ATC
risperidone; systemic
3.1
116.9
538
1793
Z2221
NOMESCO Finland
Medical doctor
2.2
114.8
1276
6532
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.5
114.3
435
1289
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
111.6
1004
4692
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
111.2
108
*
P24
ICPC
Specific learning problem
5.8
111.1
211
362
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.2
111.0
489
1586
N06BA04
ATC
methylphenidate; oral
2.8
110.2
622
2320
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
12.4
109.9
112
89
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.5
108.0
278
622
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.8
107.5
601
2229
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.2
105.4
452
1441
R4120
NOMESCO Finland
Occupational therapy
3.5
104.5
390
1139
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.5
104.3
767
3261
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
101.1
461
1523
R47.0
ICD-10 Finland
Dysphasia and aphasia
13.9
100.0
95
67
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.4
99.1
264
606
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
99.1
410
1277
N05AX12
ATC
aripiprazole; systemic
3.1
95.4
448
1504
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
94.5
495
1766
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.1
92.3
265
644
N03AX14
ATC
levetiracetam; systemic
4.6
91.5
230
504
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
90.6
455
1585
N03AF02
ATC
oxcarbazepine; oral
4.1
90.2
262
642
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
89.6
508
1889
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
16.2
89.2
78
47
R1260
NOMESCO Finland
Evaluation of communicative skills
7.2
89.0
136
186
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.2
85.8
369
1174
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.3
83.3
342
1057
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
83.0
427
1505
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.0
80.6
242
607
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.9
80.3
428
1537
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
79.6
366
1210
N03AX09
ATC
lamotrigine; oral
2.9
79.5
399
1386
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
78.8
391
1349
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.1
78.1
227
556
R4110
NOMESCO Finland
Physiotherapy
2.0
78.0
1100
6025
A28
ICPC
Limited function/disability NOS
2.5
77.7
537
2198
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.1
77.0
347
1133
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.2
76.1
325
1028
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.9
76.0
403
1442
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
6.1
75.9
136
220
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
75.3
949
4984
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
75.2
330
1061
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
74.7
373
1291
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
4.8
74.4
173
355
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
74.3
1383
8291
IGV01
NOMESCO Finland
Psychiatric network contact
4.1
73.6
211
511
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.4
72.9
192
436
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
72.9
504
2060
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
71.3
1235
7218
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
7.5
71.2
104
135
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.7
71.0
239
649
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
70.1
598
2684
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
69.9
333
1121
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.2
68.7
293
925
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
67.8
513
2182
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
66.7
498
2105
N19
ICPC
Speech disorder
4.4
66.5
175
397
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.2
65.6
284
904
183
Kela drug reimbursment
Lamotrigin and topiramate
5.8
64.4
121
205
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
64.4
465
1935
N05BA01
ATC
diazepam; systemic, rectal
2.4
63.7
493
2116
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
18.7
63.7
52
27
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.8
62.8
197
509
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.6
62.8
213
581
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
62.7
613
2904
N06AX16
ATC
venlafaxine; oral
2.1
62.3
700
3499
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.4
61.8
105
161
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
61.5
1528
9870
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.1
61.2
265
843
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
60.2
798
4231
N06AB04
ATC
citalopram; systemic
2.1
59.0
674
3385
F84.5
ICD-10 Finland
Asperger syndrome
4.3
58.8
155
352
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
8.7
58.8
76
85
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.4
58.7
118
213
R47.1
ICD-10 Finland
Dysarthria and anarthria
9.9
57.8
68
67
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.0
57.2
171
427
ZXE00
NOMESCO Finland
One hour or less
1.7
57.1
1528
10025
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.6
56.3
136
288
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
4.8
55.8
130
267
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.9
55.8
287
1006
IGP01
NOMESCO Finland
Psychiatric family contact
3.5
55.5
201
572
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
55.2
1036
6129
RT150, ,
NOMESCO Finland
6.8
54.0
86
123
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
6.0
53.7
97
158
PA6AD
NOMESCO Finland
CT of neck arteries
3.9
53.2
163
414
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
53.2
606
3032
P22
ICPC
Child behaviour symptom/complaint
3.6
53.0
182
500
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
52.8
375
1544
P29
ICPC
Psychological sympt/compl other
2.0
52.7
681
3565
P99
ICPC
Psychological disorders other
2.9
52.0
266
929
F81.2
ICD-10 Finland
Specific disorder of arithmetical skills
110.7
51.9
57
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
51.2
804
4487
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.3
51.1
206
627
R5599
NOMESCO Finland
Other rehabilitation service
3.6
51.0
176
485
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.5
50.7
128
281
N05AH02
ATC
clozapine; systemic
3.8
50.2
158
409
F88
ICD-10 Finland
Other disorders of psychological development
7.6
50.0
72
92
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.5
49.6
180
513
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.5
49.5
340
1377
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
49.4
610
3137
RL140, ,
NOMESCO Finland
8.1
49.2
67
80
N05AA02
ATC
levomepromazine; systemic
3.4
49.2
183
530
N06AX11
ATC
mirtazapine; oral
1.7
49.1
1256
8073
R1250
NOMESCO Finland
Evaluation of functional capability
4.2
48.8
133
310
WX882
NOMESCO Finland
High dependency care
2.9
48.7
240
821
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
48.2
784
4416
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.2
48.2
198
610
N06AB03
ATC
fluoxetine; oral
2.1
47.7
531
2628
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
47.4
418
1888
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.2
47.3
130
305
RL130, ,
NOMESCO Finland
7.6
47.1
68
87
3150A
ICD-9 Finland
Specific delays in development, Specific reading disorder
+∞
46.2
45
*
N05BA09
ATC
clobazam; oral
5.0
46.0
102
201
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
45.9
282
1082
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
6.7
45.6
74
108
R51.80
ICD-10 Finland
Headache
1.8
45.6
875
5174
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
45.4
282
1088
N06AX21
ATC
duloxetine; oral
2.1
45.4
454
2156
N05BA04
ATC
oxazepam; oral
1.7
45.3
951
5770
N05CD08
ATC
midazolam; nasal, systemic
3.8
45.1
143
372
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.5
44.6
306
1237
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
44.5
669
3668
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
44.5
346
1481
A29
ICPC
General symptom/complaint other
2.0
44.2
553
2850
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.2
44.1
119
275
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
11.7
43.9
46
38
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
13.5
43.7
42
30
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.2
43.4
178
548
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.9
42.8
213
732
F84.8
ICD-10 Finland
Other pervasive developmental disorders
6.7
42.8
69
100
N06AB06
ATC
sertraline; oral
1.9
42.7
640
3503
RS220, ,
NOMESCO Finland
4.2
42.6
115
266
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.8
42.5
97
196
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
42.4
747
4296
K03.66
ICD-10 Finland
Tooth plaque
2.0
41.8
511
2609
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.4
41.3
155
451
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.7
41.0
134
356
DFF20
NOMESCO Finland
Audiometry for children
6.1
40.7
72
115
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.3
40.7
160
480
IEV99
NOMESCO Finland
Other psychiatric network intervention
3.8
40.2
128
334
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.5
40.2
277
1122
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
4.7
40.1
95
198
F84.0
ICD-10 Finland
Childhood autism
9.3
40.0
49
51
R55
ICD-10 Finland
Syncope and collapse
2.1
39.9
397
1878
S18
ICPC
Laceration/cut
1.6
39.8
1647
11760
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
39.7
219
795
L12
ICPC
Hand/finger symptom/complaint
1.7
39.3
891
5495
OAA68, ,
SPAT
3.9
39.2
117
292
L17
ICPC
Foot/toe symptom/complaint
1.6
38.8
1256
8465
N03AX18
ATC
lacosamide; systemic
5.4
38.8
78
141
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
3.7
38.6
127
339
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
7.8
38.4
54
67
F61.0
ICD-10 Finland
Mixed personality disorders
3.9
38.2
116
293
N06AB10
ATC
escitalopram; oral
1.6
38.2
1045
6759
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.7
38.1
125
333
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
2.8
38.1
195
681
B01AC04
ATC
clopidogrel; oral
2.3
37.9
317
1397
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
37.8
3248
27061
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
3.9
37.6
113
283
A97
ICPC
No disease
1.6
37.6
1042
6756
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.6
37.6
237
920
Z02.7
ICD-10 Finland
Issue of medical certificate
2.1
37.5
367
1724
SPAT1395
SPAT
Health check-up of persons outside student and working life
3.7
37.4
120
315
OAB43, ,
SPAT
0.6
37.2
1031
13877
SPAT1307
SPAT
Psychosocial counselling and guidance
1.8
37.2
587
3256
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.1
36.8
159
505
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
36.8
174
582
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.6
36.6
124
338
G40.10
ICD-10 Finland
Simple partial seizures
6.0
35.9
64
103
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
35.8
1082
7152
IEY01
NOMESCO Finland
Psychoeducation, individual
3.9
35.8
109
276
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
35.7
391
1915
L28
ICPC
Limited function/disability (L)
1.9
35.5
503
2693
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
34.7
798
4922
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.4
34.2
69
125
RS222, ,
NOMESCO Finland
4.4
33.8
86
190
ZXA10
NOMESCO Finland
Bilateral
1.8
33.8
622
3605
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
33.8
823
5148
F80
ICD-10 Finland
Specific developmental disorders of speech and language
49.5
33.8
41
8
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.9
33.3
75
150
WX892
NOMESCO Finland
Monitored bed care
2.2
33.1
293
1321
XX4AW, ,
NOMESCO Finland
5.0
33.0
72
140
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.0
32.9
154
512
3152A
ICD-9 Finland
Specific delays in development, Other specific learning difficulties
+∞
32.8
32
*
P76
ICPC
Depressive disorder
1.9
32.6
452
2399
IEP99
NOMESCO Finland
Other psychiatric family intervention
3.7
32.5
103
268
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.8
32.4
99
251
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.5
32.4
115
323
RD210, ,
NOMESCO Finland
2.8
32.1
167
588
N06BA09
ATC
atomoxetine; oral
4.2
32.1
86
198
RT420, ,
NOMESCO Finland
8.0
32.1
44
53
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
32.1
475
2576
D01
ICPC
Abdominal pain/cramps general
1.7
32.0
755
4676
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
32.0
330
1579
N17
ICPC
Vertigo/dizziness
1.8
32.0
493
2707
Z71.8
ICD-10 Finland
Other specified counselling
1.5
32.0
1589
11647
IGY02, ,
SPAT
3.1
31.7
136
430
ICB06, ,
NOMESCO Finland
3.4
31.7
119
347
N05AD01
ATC
haloperidol; systemic
3.4
31.6
114
324
WX002
NOMESCO Finland
Sedation and analgesia
1.8
31.5
541
3069
IEP03
NOMESCO Finland
Focused parental counselling
3.8
31.4
97
248
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
4.9
31.4
70
139
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
31.1
1570
11526
R42
ICD-10 Finland
Dizziness and giddiness
1.7
30.7
708
4357
N06AX12
ATC
bupropion; oral
1.9
30.6
460
2504
N03AE01
ATC
clonazepam; systemic
2.6
30.5
185
705
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.6
30.4
189
729
N88
ICPC
Epilepsy
4.8
30.3
70
143
P03
ICPC
Feeling depressed
1.6
30.3
782
4949
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
30.0
340
1684
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.3
29.6
114
338
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
29.5
757
4781
H01
ICPC
Ear pain/earache
1.6
29.5
774
4916
SPAT1389
SPAT
Visit based on need for special support
2.0
29.4
357
1810
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
29.4
246
1083
R4190
NOMESCO Finland
Nutritional therapy
2.1
29.4
302
1442
RS211, ,
NOMESCO Finland
5.0
29.2
64
125
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
4.5
29.1
71
152
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.2
28.9
248
1104
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
4.7
28.8
67
138
R02
ICPC
Shortness of breath/dyspnoea
1.8
28.8
506
2887
H01AC01
ATC
somatropin; parenteral
3.8
28.7
90
233
Z07
ICPC
Education problem
2.9
28.7
137
461
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
28.6
1951
15093
RS221, ,
NOMESCO Finland
3.5
28.6
102
288
P74
ICPC
Anxiety disorder/anxiety state
1.9
28.5
377
1968
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
3.1
28.2
123
393
P85
ICPC
Mental retardation
4.4
28.2
71
156
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.7
28.2
152
546
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
28.1
160
591
N01
ICPC
Headache
1.5
28.1
964
6507
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.1
27.9
273
1279
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
27.9
301
1464
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
27.9
229
1001
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
5.1
27.8
59
112
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
27.7
160
595
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
27.5
623
3807
K02.1
ICD-10 Finland
Caries of dentine
1.4
27.4
2784
23064
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
27.2
229
1011
FM2CE, ,
NOMESCO Finland
2.8
27.1
137
475
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
27.1
536
3157
WX402
NOMESCO Finland
General anaesthesia
1.6
27.1
861
5707
F40.1
ICD-10 Finland
Social phobias
2.1
27.1
256
1184
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
27.1
789
5127
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.7
27.0
151
552
A04
ICPC
Weakness/tiredness general
1.6
26.8
812
5324
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
7.6
26.6
38
48
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.5
26.6
93
259
K08.3
ICD-10 Finland
Retained dental root
2.2
26.6
221
970
SPAT1234
SPAT
Support of social functional capacity
2.5
26.6
177
705
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
5.1
26.5
56
106
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
26.5
796
5206
N05AB03
ATC
perphenazine; systemic, rectal
2.8
26.5
136
476
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
26.4
706
4491
ZXA00
NOMESCO Finland
Right side
1.6
26.4
645
4014
F34.1
ICD-10 Finland
Dysthymia
2.3
26.4
199
838
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.3
26.3
99
289
Z31.5
ICD-10 Finland
Genetic counselling
2.0
26.3
302
1502
D12
ICPC
Constipation
2.6
26.3
157
594
SPAT1240
SPAT
Therapeutic discussion
1.6
26.2
652
4075
N05AF03
ATC
chlorprothixene; systemic
3.1
26.2
113
359
F81
ICD-10 Finland
Specific developmental disorders of scholastic skills
26.7
26.1
36
13
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
4.6
26.0
63
134
U07
ICPC
Urine symptom/complaint other
2.0
25.9
290
1428
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
44.1
25.9
32
7
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
44.1
25.9
32
7
TAB00
NOMESCO Finland
Lumbar puncture
2.3
25.7
200
854
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.2
25.7
105
323
R41.0
ICD-10 Finland
Disorientation, unspecified
3.4
25.7
94
270
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.7
25.6
83
220
ZXA05
NOMESCO Finland
Left side
1.6
25.5
603
3719
R11
ICD-10 Finland
Nausea and vomiting
1.7
25.4
463
2663
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
25.4
739
4792
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
3.9
25.4
74
182
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
25.3
1650
12571
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.6
25.3
364
5893
A06AD11
ATC
lactulose; oral
1.8
25.2
370
1997
G47.3
ICD-10 Finland
Sleep apnoea
1.6
25.1
584
3588
N03AX16
ATC
[U] pregabalin
1.7
25.0
550
3331
SPAT1216
SPAT
Assessment of functional ability
1.8
24.9
405
2253
N04AA02
ATC
biperiden; systemic
3.7
24.9
81
215
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
4.3
24.9
65
147
ZX199
NOMESCO Finland
Other rote
6.8
24.8
39
55
N06AX22
ATC
agomelatine; oral
2.6
24.8
147
554
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
10.4
24.7
28
26
N18
ICPC
Paralysis/weakness
4.3
24.7
65
148
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.5
24.5
87
245
RT160, ,
NOMESCO Finland
5.1
24.5
52
99
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.2
24.5
97
293
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
24.5
767
5056
N03AX11
ATC
topiramate; oral
2.7
24.4
135
491
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.9
24.3
330
1735
SPAT1243
SPAT
Psychiatric/psychological examination
2.1
24.3
235
1096
ZXD20
NOMESCO Finland
Day surgery
1.8
24.2
403
2257
P01
ICPC
Feeling anxious/nervous/tense
1.5
24.2
1068
7556
N06AX05
ATC
trazodone; oral
3.0
24.2
108
350
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.8
24.1
372
2037
M79.6
ICD-10 Finland
Pain in limb
1.4
23.9
1516
11465
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
3.2
23.8
94
283
A02BC02
ATC
pantoprazole; systemic
1.4
23.8
1945
15354
N06AX26
ATC
vortioxetine; oral
1.7
23.7
436
2513
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
3.7
23.7
76
200
ZXY02
NOMESCO Finland
Neuropsychologist
5.7
23.7
44
74
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.6
23.4
77
206
N05AN01
ATC
lithium; oral
2.7
23.4
129
469
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
23.3
172
718
Z06
ICPC
Unemployment problem
3.9
23.3
70
176
A03
ICPC
Fever
1.5
23.2
1113
7991
S29
ICPC
Skin symptom/complaint other
1.5
23.1
813
5486
C07AB07
ATC
bisoprolol; oral
1.5
23.1
974
6820
SPAT1301
SPAT
No procedures
1.4
23.1
1209
8822
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.5
23.1
151
597
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
23.1
455
2674
T82
ICPC
Obesity
2.2
23.0
196
869
C08CA01
ATC
amlodipine; oral
1.6
23.0
673
4361
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.9
23.0
297
1536
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
23.0
2008
15989
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.0
22.7
103
337
P07.2
ICD-10 Finland
Extreme immaturity
9.6
22.6
27
27
N03AX23
ATC
brivaracetam; systemic
6.0
22.6
40
64
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.5
22.6
150
597
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.8
22.6
112
385
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
22.6
2082
16706
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
6.7
22.4
36
52
R05
ICPC
Cough
1.4
22.4
1083
7780
Z08
ICPC
Social welfare problem
3.6
22.3
73
195
602
Kela drug reimbursment
Children's severe malnutrition
3.2
22.3
91
280
R4140
NOMESCO Finland
Psychotherapy
3.9
22.3
65
160
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
28.9
22.3
30
10
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
22.2
397
2270
H02AB09
ATC
hydrocortisone; systemic
2.5
22.2
146
579
ZXD05
NOMESCO Finland
Urgent procedure
1.5
22.2
1008
7156
K90
ICPC
Stroke/cerebrovascular accident
3.8
22.2
69
178
F05.9
ICD-10 Finland
Delirium, unspecified
3.9
22.1
66
165
OAA43, ,
SPAT
2.1
22.1
215
1005
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
22.1
3239
28009
P06
ICPC
Sleep disturbance
1.6
22.0
594
3776
H81
ICPC
Excessive ear wax
1.7
22.0
479
2889
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
22.0
863
5953
N07BB01
ATC
disulfiram; oral
2.4
21.9
151
612
A99
ICPC
Disease/condition unspecnature/site
1.7
21.8
400
2304
N28
ICPC
Limited function/disability (N)
3.9
21.7
65
163
K04.08
ICD-10 Finland
Other specified pulpit
1.7
21.6
409
2374
D11
ICPC
Diarrhoea
1.6
21.6
656
4282
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.8
21.6
110
384
C07AB02
ATC
metoprolol; systemic
1.7
21.6
380
2163
C03CA01
ATC
furosemide; systemic
1.6
21.5
513
3163
RS140, ,
NOMESCO Finland
4.7
21.5
50
103
D10
ICPC
Vomiting
1.6
21.4
483
2937
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
4.2
21.4
57
131
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.2
21.3
83
248
P72
ICPC
Schizophrenia
2.9
21.3
102
344
N03AX12
ATC
[U] gabapentin; oral
1.7
21.3
389
2236
EBA00
NOMESCO Finland
Extraction of tooth
1.4
21.2
1804
14241
RK320, ,
NOMESCO Finland
5.8
21.2
39
65
ZY000
NOMESCO Finland
Hospital inpatient
2.7
21.1
115
416
OAA46, ,
SPAT
3.2
21.0
85
260
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
21.0
260
1326
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.7
21.0
419
2468
R25.1
ICD-10 Finland
Tremor, unspecified
2.9
20.9
101
343
N05CF01
ATC
zopiclone; oral
1.5
20.7
747
5057
H52.2
ICD-10 Finland
Astigmatism
2.5
20.7
137
545
D09
ICPC
Nausea
1.7
20.7
391
2269
H29
ICPC
Ear symptom/complaint other
1.7
20.6
450
2714
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.2
20.6
80
239
C07AA05
ATC
propranolol; systemic
1.5
20.6
776
5301
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.5
20.5
71
197
E66.9
ICD-10 Finland
Obesity, unspecified
2.3
20.5
163
703
N06BA12
ATC
lisdexamfetamine; oral
2.4
20.4
149
619
S06.0
ICD-10 Finland
Concussion
1.6
20.4
539
3405
IEY03
NOMESCO Finland
Vocational rehabilitation
4.6
20.4
48
100
A05
ICPC
Feeling ill
1.6
20.3
564
3605
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.2
20.3
80
241
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
20.3
685
4571
RS122, ,
NOMESCO Finland
6.0
20.2
36
58
IER01
NOMESCO Finland
Psychoeducation, group
3.0
20.2
92
302
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
20.2
733
4968
SFA30
NOMESCO Finland
Three-surface restoration
1.4
20.1
1230
9181
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.2
20.1
30
40
R53
ICD-10 Finland
Malaise and fatigue
1.4
19.9
991
7133
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.4
19.9
143
591
H50.31
ICD-10 Finland
Intermittent exotropia
2.9
19.9
92
305
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
3.5
19.8
67
183
D06
ICPC
Abdominal pain localized other
1.7
19.8
418
2497
N29
ICPC
Neurological sympt/complt other
3.2
19.8
79
240
XA820, ,
NOMESCO Finland
5.6
19.8
38
66
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
2.8
19.8
100
348
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.4
19.8
71
202
SFA20
NOMESCO Finland
Two-surface restoration
1.3
19.7
2331
19271
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.8
19.7
101
354
R13
ICD-10 Finland
Dysphagia
2.1
19.7
191
893
E66.8
ICD-10 Finland
Other obesity
2.1
19.7
201
958
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
6.6
19.7
32
47
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.1
19.6
82
256
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
19.6
1818
14483
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.8
19.6
102
360
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.1
19.5
84
267
F80.3
ICD-10 Finland
Acquired aphasia with epilepsy [Landau-Kleffner]
+∞
19.5
19
*
F89
ICD-10 Finland
Unspecified disorder of psychological development
4.9
19.4
43
85
P15
ICPC
Chronic alcohol abuse
2.4
19.4
137
561
SCA02
NOMESCO Finland
Preventive oral health care
1.5
19.4
859
6047
K89
ICPC
Transient cerebral ischaemia
6.1
19.4
34
54
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
19.4
322
1801
SFA10
NOMESCO Finland
One-surface restoration
1.3
19.4
2446
20396
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
4.0
19.4
55
133
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
19.3
187
873
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
19.3
258
1349
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
70.7
19.3
22
*
WX704
NOMESCO Finland
Intubation
1.9
19.2
261
1373
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
19.1
487
3050
R50.9
ICD-10 Finland
Fever, unspecified
1.5
19.0
695
4710
EB1WA, ,
NOMESCO Finland
4.9
19.0
42
83
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
3.8
19.0
58
148
C10AA05
ATC
atorvastatin; oral
1.5
19.0
693
4697
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
18.9
190
900
XF404
NOMESCO Finland
Ambulatory ECG
1.9
18.9
236
1208
SPAT1283
SPAT
Restricted health certificate
1.4
18.8
1150
8564
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
18.8
233
1188
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
4.2
18.8
50
115
N03AX22
ATC
perampanel; oral
5.9
18.7
34
56
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.9
18.7
90
305
WX872
NOMESCO Finland
Intensive care
2.5
18.7
121
477
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.4
18.6
67
191
P28
ICPC
Limited function/disability (P)
3.7
18.6
60
159
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.6
18.5
104
382
N06AA04
ATC
clomipramine; systemic
3.7
18.5
59
155
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
3.3
18.4
68
197
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.4
18.4
122
486
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
4.6
18.4
44
93
WX110, ,
SPAT
1.8
18.3
279
1520
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
18.3
856
6081
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.1
18.3
76
237
N05BE01
ATC
buspirone; oral
2.5
18.2
115
448
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.2
18.2
157
701
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.1
18.1
78
248
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
4.4
18.1
45
98
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.5
18.1
674
4580
R33
ICD-10 Finland
Retention of urine
2.2
18.1
161
727
P20
ICPC
Memory disturbance
1.9
18.1
232
1197
RS314, ,
NOMESCO Finland
6.9
18.0
28
39
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
18.0
379
2261
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
18.0
491
3121
RS210, ,
NOMESCO Finland
4.7
18.0
42
87
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.8
18.0
54
136
F60.8
ICD-10 Finland
Other specific personality disorders
4.1
18.0
50
119
127
Kela drug reimbursment
Transplant complication
2.9
18.0
83
275
RK220, ,
NOMESCO Finland
5.0
17.9
39
76
A01
ICPC
Pain general/multiple sites
1.7
17.9
345
2011
Z25
ICPC
Assault/harmful event problem
3.0
17.8
77
246
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
17.7
485
3085
A11
ICPC
Chest pain NOS
1.9
17.7
248
1317
WX730
NOMESCO Finland
Conventional respirator
3.6
17.7
59
160
F98.5
ICD-10 Finland
Stuttering [stammering]
7.0
17.7
27
37
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
7.0
17.7
27
37
AA5PD
NOMESCO Finland
CT examination of brain pefusion
5.4
17.6
35
63
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
17.6
497
3186
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
17.5
430
2666
R06.0
ICD-10 Finland
Dyspnoea
1.4
17.5
761
5330
SAA04
NOMESCO Finland
Special examination of mouth
1.7
17.5
336
1958
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
17.4
264
1437
R41.3
ICD-10 Finland
Other amnesia
3.1
17.4
73
229
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.7
17.4
55
144
P27
ICPC
Fear of mental disorder
2.5
17.3
112
441
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
17.3
258
1396
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
4.3
17.3
44
98
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
91.5
17.2
19
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.9
17.2
50
123
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.5
17.2
59
163
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
3.4
17.2
62
177
OAA62, ,
SPAT
0.6
17.0
253
4095
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.7
17.0
329
1920
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
3.8
17.0
52
133
N06AB05
ATC
paroxetine; oral
2.0
16.9
180
871
N03AD01
ATC
ethosuximide; oral
7.3
16.9
25
33
R52.9
ICD-10 Finland
Pain, unspecified
1.6
16.8
374
2262
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
16.8
943
6906
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
16.8
627
4262
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.0
16.7
48
117
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.5
16.7
102
391
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
16.7
313
1810
SPAT1254
SPAT
Administration of medicine
1.5
16.7
700
4864
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.0
16.7
181
882
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.1
16.6
69
215
G40.89
ICD-10 Finland
Other epilepsy
4.5
16.6
40
85
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
16.6
265
1465
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.3
16.6
125
528
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
16.6
177
858
XX4BW, ,
NOMESCO Finland
5.5
16.6
32
56
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
7.1
16.5
25
34
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
4.2
16.4
44
102
F90.8
ICD-10 Finland
Other hyperkinetic disorders
5.3
16.4
33
60
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.9
16.4
78
263
H13
ICPC
Plugged feeling ear
1.5
16.4
560
3736
IEP02
NOMESCO Finland
Child-centred family therapy
2.9
16.3
76
253
ZXY60
NOMESCO Finland
2-person team, nurses
3.2
16.3
64
193
N03AF01
ATC
carbamazepine; oral, rectal
2.4
16.3
114
466
R74
ICPC
Upper respiratory infection acute
1.3
16.3
1860
15137
F92.0
ICD-10 Finland
Depressive conduct disorder
3.4
16.2
57
160
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.1
16.2
45
107
N99
ICPC
Neurological disease other
4.1
16.2
45
107
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
3.4
16.2
58
165
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.4
16.2
40
87
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.5
16.2
100
386
Q38.1
ICD-10 Finland
Ankyloglossia
3.0
16.1
71
229
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
3.6
16.1
52
138
S21
ICPC
Skin texture symptom/complaint
1.5
16.1
563
3773
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.4
16.0
977
7242
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.0
16.0
72
235
OAA67, ,
SPAT
0.6
15.8
376
5428
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
15.8
326
1933
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.6
15.8
94
356
J01DB01
ATC
cefalexin; oral
1.4
15.8
3224
28367
F91.9
ICD-10 Finland
Conduct disorder, unspecified
4.2
15.7
42
97
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.4
15.7
39
85
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.3
15.7
40
89
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
4.0
15.6
44
106
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
15.6
268
1513
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.4
15.6
55
155
RT490, ,
NOMESCO Finland
5.7
15.6
29
49
301
Kela drug reimbursment
Growth hormone
4.2
15.5
41
94
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
15.5
267
1508
XA400
NOMESCO Finland
EEG
4.4
15.5
39
86
XKD00
NOMESCO Finland
Uroflowmetry
1.7
15.5
280
1604
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
15.4
256
1431
N05AX15
ATC
cariprazine; oral
3.7
15.4
49
129
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
15.4
157
749
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
15.4
331
1986
T90
ICPC
Diabetes non-insulin dependent
1.6
15.4
414
2622
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.2
15.3
132
590
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
15.3
397
2493
R4110, ,
SPAT
1.6
15.3
334
2012
R27.0
ICD-10 Finland
Ataxia, unspecified
6.5
15.3
25
37
F94.0
ICD-10 Finland
Elective mutism
7.1
15.3
23
31
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.9
15.2
189
965
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
15.2
112
469
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
4.6
15.1
36
76
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
15.1
139
638
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
5.9
15.0
27
44
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
15.0
132
595
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
14.9
3298
29197
RK110, ,
NOMESCO Finland
4.1
14.9
40
93
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
14.9
1011
7614
H52.0
ICD-10 Finland
Hypermetropia
2.2
14.8
132
598
J20
ICD-10 Finland
Acute bronchitis
1.6
14.8
342
2088
F41.8
ICD-10 Finland
Other specified anxiety disorders
1.8
14.8
227
1240
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
14.8
1461
11612
WX290
NOMESCO Finland
Other blockage of nerve
1.3
14.8
2283
19241
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
19.3
14.7
22
11
U04
ICPC
Incontinence urine
2.1
14.7
139
644
A11CC03
ATC
alfacalcidol; systemic
2.7
14.7
80
290
F29
ICPC
Eye symptom/complaint other
1.5
14.7
432
2790
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
3.0
14.7
66
216
SPAT1229
SPAT
Assessment of need for aid
2.0
14.6
156
756
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
5.4
14.6
29
52
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
14.6
350
2157
N05BA12
ATC
alprazolam; oral
1.8
14.6
239
1332
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
3.6
14.5
47
125
EMB30
NOMESCO Finland
Adenotomy
1.5
14.5
413
2648
H50.1
ICD-10 Finland
Divergent concomitant strabismus
3.3
14.5
54
158
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
14.4
227
1249
RS123, ,
NOMESCO Finland
6.7
14.4
23
33
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
14.4
237
1321
RT130, ,
NOMESCO Finland
5.0
14.4
31
60
K59.0
ICD-10 Finland
Constipation
1.8
14.4
200
1060
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.7
14.4
74
261
Z01.2
ICD-10 Finland
Dental examination
1.3
14.3
2197
18468
U02
ICPC
Urinary frequency/urgency
1.5
14.2
495
3310
N05AE03
ATC
sertindole; oral
5.1
14.2
30
57
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
14.2
275
1604
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
2.6
14.2
83
312
RT120, ,
NOMESCO Finland
5.4
14.2
28
50
K04.09
ICD-10 Finland
Pulpit UNS
1.8
14.2
213
1157
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.0
14.1
152
739
A92
ICPC
Allergy/allergic reaction NOS
1.8
14.1
227
1257
ICB03, ,
SPAT
3.9
14.1
41
101
Z94.0
ICD-10 Finland
Kidney transplant status
3.1
14.1
59
185
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
14.1
760
5507
UJF32
NOMESCO Finland
Coloscopy
1.5
14.1
563
3867
OAA40, ,
SPAT
1.6
14.0
349
2168
KMAK, ,
NOMESCO Finland
1.3
14.0
1777
14563
N05AE05
ATC
lurasidone; oral
3.8
14.0
42
106
L04AD02
ATC
tacrolimus; systemic
2.9
14.0
65
217
G44.2
ICD-10 Finland
Tension-type headache
1.5
14.0
497
3339
ZX120
NOMESCO Finland
Intravenous
1.7
13.9
271
1583
R03AC02
ATC
salbutamol; inhalant
1.3
13.9
2113
17709
K04.0
ICD-10 Finland
Pulpitis
1.5
13.9
392
2506
SPA47
NOMESCO Finland
Precision impression for denture
3.1
13.9
59
187
RK520, ,
NOMESCO Finland
5.9
13.8
25
41
UKC02
NOMESCO Finland
Cystoscopy
1.6
13.8
302
1820
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
3.2
13.8
55
168
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.5
13.7
85
329
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
3.9
13.7
40
99
R4120, ,
SPAT
3.3
13.7
51
149
R5110, ,
SPAT
1.9
13.6
180
940
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.3
13.6
51
150
RS230, ,
NOMESCO Finland
4.4
13.5
34
75
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.1
13.5
127
588
H03AA01
ATC
levothyroxine sodium; systemic
1.4
13.5
559
3865
L16
ICPC
Ankle symptom/complaint
1.4
13.5
567
3931
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.4
13.5
49
141
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
3.5
13.5
46
127
EB1VA, ,
NOMESCO Finland
1.4
13.5
588
4105
H47.2
ICD-10 Finland
Optic atrophy
5.3
13.5
27
49
XCK00
NOMESCO Finland
Perimetry
2.1
13.5
134
634
N30.0
ICD-10 Finland
Acute cystitis
1.4
13.4
597
4181
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
3.4
13.4
47
132
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
19.2
13.4
20
10
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
13.4
400
2589
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
5.9
13.4
24
39
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.6
13.4
365
2316
N05AX16
ATC
brexpiprazole; oral
4.1
13.4
37
88
R60.0
ICD-10 Finland
Localized oedema
1.7
13.4
280
1668
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
13.4
574
3996
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
3.3
13.3
50
147
L29
ICPC
Musculoskeletal sympt/complt other
1.6
13.3
299
1813
N06AG02
ATC
moclobemide; oral
2.3
13.2
101
430
OAB95, ,
SPAT
0.6
13.2
188
3087
KAY40, ,
NOMESCO Finland
0.5
13.2
117
2219
KAY20, ,
NOMESCO Finland
0.4
13.2
51
1348
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
1.8
13.1
203
1112
F28
ICD-10 Finland
Other nonorganic psychotic disorders
4.5
13.1
32
69
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.9
13.1
159
807
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
15.5
13.1
21
13
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.3
13.1
49
144
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
3.6
13.1
43
116
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.7
13.1
67
236
IBA03
NOMESCO Finland
Psychotherapy evaluation
2.5
13.1
81
314
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.9
13.0
176
925
IEZ99, ,
SPAT
5.3
13.0
26
47
G81.1
ICD-10 Finland
Spastic hemiplegia
12.3
13.0
23
18
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.9
13.0
159
809
E34.35
ICD-10 Finland
Abnormal growth retardation
2.6
13.0
74
275
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.7
13.0
253
1479
SPAT1260
SPAT
Consultation of another employee
1.4
13.0
600
4232
R5120
NOMESCO Finland
Preparation of an aid
2.7
12.9
71
259
RS120, ,
NOMESCO Finland
4.1
12.9
35
82
K06.18
ICD-10 Finland
Another gingival hyperplasia
4.1
12.9
35
82
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.2
12.9
110
490
B03XA01
ATC
erythropoietin; parenteral
4.2
12.9
34
78
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
11.0
12.9
24
21
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
12.9
219
1233
F40.2
ICD-10 Finland
Specific (isolated) phobias
2.8
12.9
62
211
T83
ICPC
Overweight
2.2
12.9
107
472
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
12.9
769
5661
N06AX03
ATC
mianserin; oral
2.2
12.8
112
504
R32
ICD-10 Finland
Unspecified urinary incontinence
2.5
12.8
80
311
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
12.8
222
1257
R96
ICPC
Asthma
1.6
12.8
322
2006
ZX121
NOMESCO Finland
Central venous catheter
4.0
12.8
36
87
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2.8
12.8
61
207
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
3.8
12.8
39
100
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
4.1
12.7
35
83
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
2.0
12.7
138
674
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
12.7
72
267
T74.1
ICD-10 Finland
Physical abuse
2.0
12.7
129
615
SPAT1262
SPAT
Handing over of treatment supplies
1.5
12.7
392
2556
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
27.2
12.7
17
6
G40
ICD-10 Finland
Epilepsy
3.2
12.7
49
147
F21
ICD-10 Finland
Schizotypal disorder
3.9
12.6
37
92
L15
ICPC
Knee symptom/complaint
1.3
12.6
868
6526
SPAT1360
SPAT
Extensive global examination
1.8
12.6
202
1119
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
3.7
12.6
39
101
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
2.8
12.6
62
214
S80.0
ICD-10 Finland
Contusion of knee
1.6
12.6
331
2084
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
3.6
12.6
41
110
H50.0
ICD-10 Finland
Convergent concomitant strabismus
2.6
12.6
69
252
G04BD12
ATC
mirabegron; oral
1.8
12.5
206
1149
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
3.0
12.5
55
178
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
3.8
12.5
38
97
RS214, ,
NOMESCO Finland
4.1
12.5
34
80
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.4
12.5
45
129
IER02, ,
SPAT
6.3
12.5
21
32
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
4.5
12.5
30
64
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
5.1
12.5
26
49
F33.8
ICD-10 Finland
Other recurrent depressive disorders
2.9
12.5
58
194
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
12.4
157
808
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.9
12.4
56
184
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.1
12.4
52
164
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.0
12.4
133
648
Z50.1
ICD-10 Finland
Other physical therapy
2.0
12.3
124
589
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.7
12.3
676
8390
Z29
ICPC
Social problem NOS
2.0
12.3
127
609
SCE00
NOMESCO Finland
Fissure sealant
1.6
12.3
338
2148
M79.7
ICD-10 Finland
Fibromyalgia
2.2
12.3
104
462
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.5
12.3
457
3093
F41.00
ICD-10 Finland
Moderate panic disorder
2.2
12.3
97
419
Q21.10
ICD-10 Finland
Persistent ostium secundum
2.8
12.3
60
206
L01
ICPC
Neck symptom/complaint
1.4
12.3
598
4254
R03BA02
ATC
budesonide; inhalant
1.4
12.3
636
4572
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.2
12.3
49
150
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
3.5
12.2
41
112
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
12.2
194
1072
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
12.2
164
861
S10
ICPC
Boil/carbuncle
1.7
12.2
223
1282
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
12.1
617
4420
P98
ICPC
Psychosis NOS/other
3.0
12.1
52
166
K29
ICPC
Cardiovascular sympt/complt other
2.3
12.1
87
361
H61.2
ICD-10 Finland
Impacted cerumen
1.7
12.1
218
1248
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
12.1
212
1205
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.8
12.1
60
208
N02BF02
ATC
pregabalin; oral
1.8
12.1
191
1054
SGA01
NOMESCO Finland
Emergency treatment
1.4
12.1
620
4449
UDC00
NOMESCO Finland
Ear microscopy
1.6
12.1
286
1757
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
12.0
190
1048
ZXY61
NOMESCO Finland
2-person team, special workers
4.2
12.0
32
74
K85
ICPC
Elevated blood pressure
1.6
12.0
298
1850
SDA03
NOMESCO Finland
Periodontal treatment
1.3
12.0
1532
12496
RK230, ,
NOMESCO Finland
5.1
12.0
25
47
IEV99, ,
SPAT
4.4
12.0
30
66
C09CA01
ATC
losartan; oral
1.5
12.0
415
2769
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
3.0
12.0
52
167
P81
ICPC
Hyperkinetic disorder
2.1
12.0
117
550
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.8
12.0
196
1092
L03
ICPC
Low back symptom/complaint
1.3
12.0
1069
8331
SPAT1303
SPAT
Counselling and guidance related to growth and development
1.8
12.0
193
1071
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
12.0
335
2139
F70
ICD-10 Finland
Mild mental retardation
13.7
11.9
20
14
P77
ICPC
Suicide/suicide attempt
5.7
11.9
22
37
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
11.9
131
644
F20
ICD-10 Finland
Schizophrenia
3.6
11.8
38
101
EB1AA, ,
SPAT
1.7
11.8
234
1375
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
11.8
190
1055
L02
ICPC
Back symptom/complaint
1.4
11.7
465
3187
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
5.4
11.7
23
41
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
11.7
1227
9763
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
3.3
11.7
44
130
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
4.8
11.7
26
52
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
11.7
636
4608
H04
ICPC
Ear discharge
2.1
11.6
112
524
SPAT1281
SPAT
Other administrative function
1.6
11.6
307
1934
RT250, ,
NOMESCO Finland
4.6
11.6
27
56
E34.31
ICD-10 Finland
Short stature, prenatal disorder
4.6
11.6
27
56
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
4.1
11.6
31
72
XF402
NOMESCO Finland
ECG with work load test
1.7
11.6
196
1103
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
11.6
214
1234
RS313, ,
NOMESCO Finland
5.1
11.6
24
45
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.5
11.5
393
2614
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.2
11.5
94
412
N05AL01
ATC
sulpiride; systemic
3.6
11.5
38
103
K07.24
ICD-10 Finland
Open bite
2.1
11.5
106
488
W19
ICD-10 Finland
Unspecified fall
1.5
11.5
382
2529
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.6
11.5
295
1848
R07.3
ICD-10 Finland
Other chest pain
1.6
11.4
290
1812
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
3.4
11.4
40
113
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
11.4
279
1728
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
3.8
11.4
34
86
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
11.3
160
854
XF602
NOMESCO Finland
Bloodpressure monitoring
3.0
11.3
50
163
N05AF05
ATC
zuclopenthixol; systemic
3.7
11.3
35
91
X84
ICD-10 Finland
Intentional self-harm by unspecified means
3.7
11.3
35
91
IHZ07, ,
SPAT
3.1
11.2
46
143
L04AA01
ATC
[U] ciclosporin
3.4
11.2
40
114
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
11.2
1234
9870
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
3.3
11.2
42
124
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
11.2
153
809
SPAT1285
SPAT
Provision of consultation response
1.8
11.1
180
1000
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.4
11.1
76
309
XKC03
NOMESCO Finland
Water cystometry
2.5
11.1
70
274
ZXY03
NOMESCO Finland
Occupational therapist
3.5
11.1
37
101
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
3.7
11.1
35
92
J01FF01
ATC
clindamycin; systemic
1.3
11.1
725
5401
SBB10
NOMESCO Finland
Dental impressions
1.4
11.1
557
3980
A10BA02
ATC
metformin; oral
1.4
11.1
514
3623
3140B
ICD-9 Finland
Hyperkinetic syndrome of childhood, Attention deficit disorder
33.6
11.0
14
*
N02AX02
ATC
tramadol; systemic, rectal
1.3
11.0
996
7763
D21
ICPC
Swallowing problem
3.0
11.0
49
160
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
11.0
488
3411
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
11.0
277
1726
G24.9
ICD-10 Finland
Dystonia, unspecified
5.8
11.0
20
33
EJC20
NOMESCO Finland
Operation on frenulum of tongue
2.8
11.0
53
181
OAA50, ,
SPAT
1.8
11.0
157
841
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
4.1
11.0
30
71
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.3
11.0
78
323
SPAT1139
SPAT
Nutrition survey
2.1
10.9
103
479
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
3.4
10.9
38
107
M54.5
ICD-10 Finland
Low back pain
1.3
10.8
1204
9630
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
10.8
546
6884
E23.00
ICD-10 Finland
Panhypopituitarism
5.5
10.8
21
37
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
3.9
10.8
31
76
Z00.8
ICD-10 Finland
Other general examinations
1.5
10.8
341
2233
XF600, ,
SPAT
2.2
10.8
91
405
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.5
10.8
331
2156
E0000UV, ,
ATC
1.2
10.7
1667
13860
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
10.7
334
2181
Z94.4
ICD-10 Finland
Liver transplant status
4.6
10.7
25
52
N03AG04
ATC
vigabatrin; oral
4.5
10.7
26
56
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
41.6
10.7
13
*
SPE02
NOMESCO Finland
Metal-framed partial denture
3.5
10.7
36
99
A27
ICPC
Fear of other disease NOS
1.8
10.7
163
891
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
10.7
215
1269
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
8.8
10.6
22
24
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.3
10.6
1417
11576
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
10.6
521
3705
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.1
10.6
93
420
IHZ04, ,
SPAT
2.0
10.6
116
569
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
3.6
10.6
35
95
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
4.9
10.6
23
45
Z61.8
ICD-10 Finland
Other negative life events in childhood
3.4
10.6
38
109
R05
ICD-10 Finland
Cough
1.3
10.6
748
5634
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
10.5
252
1552
IAB03
NOMESCO Finland
Neuropsychiatric consultation
5.3
10.5
21
38
F50.9
ICD-10 Finland
Eating disorder, unspecified
2.1
10.5
96
441
4122
FHL
Tympanostomy (tympanic tube)
1.8
10.5
151
811
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
3.8
10.4
31
78
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
3.8
10.4
31
78
OAA52, ,
SPAT
7.9
10.4
23
28
H50.2
ICD-10 Finland
Vertical strabismus
3.5
10.4
35
96
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
10.4
283
1795
L04
ICPC
Chest symptom/complaint
1.6
10.4
241
1473
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
10.4
424
2919
H53.2
ICD-10 Finland
Diplopia
2.2
10.4
90
405
D07AA02
ATC
hydrocortisone; topical
1.3
10.3
696
5202
Z91.5
ICD-10 Finland
Personal history of self-harm
3.7
10.3
32
83
ICB01, ,
SPAT
2.5
10.3
63
243
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.0
10.3
29
70
H53.4
ICD-10 Finland
Visual field defects
2.8
10.3
52
182
N03AX15
ATC
zonisamide; oral
4.1
10.3
28
66
P16
ICPC
Acute alcohol abuse
2.3
10.3
77
326
U05
ICPC
Urination problems other
1.9
10.3
127
650
Z00.1
ICD-10 Finland
Routine child health examination
1.3
10.3
715
5370
H66
ICD-10 Finland
Suppurative and unspecified otitis media
1.7
10.3
193
1119
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.7
10.3
55
199
R4130, ,
SPAT
4.5
10.3
25
54
P73
ICPC
Affective psychosis
4.5
10.3
25
54
B01AA03
ATC
warfarin; systemic
1.6
10.2
273
1724
N05AE04
ATC
ziprasidone; systemic
3.0
10.2
43
136
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
3.4
10.2
36
102
A91
ICPC
Abnormal result investigation NOS
1.7
10.2
170
953
R35
ICD-10 Finland
Polyuria
1.8
10.2
161
890
BC00A, ,
NOMESCO Finland
8.8
10.2
21
23
G12.2
ICD-10 Finland
Motor neuron disease
8.8
10.2
21
23
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
3.9
10.1
29
71
SPAT1284
SPAT
Extensive health certificate
1.9
10.1
135
708
XG413
NOMESCO Finland
Spirometry with oscillometry
3.0
10.1
45
147
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
4.0
10.1
28
67
W78
ICPC
Pregnancy
0.7
10.1
539
6742
RS312, ,
NOMESCO Finland
4.7
10.1
23
47
N05AL05
ATC
amisulpride; oral
5.3
10.1
20
36
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.7
10.1
181
1037
R40.2
ICD-10 Finland
Coma, unspecified
4.2
10.0
26
59
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
4.2
10.0
26
59
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
10.0
406
2791
H92.0
ICD-10 Finland
Otalgia
1.5
10.0
315
2061
ZYD01
NOMESCO Finland
Emergency clinic
3.8
10.0
30
76
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
3.5
10.0
34
94
SGC10
NOMESCO Finland
Pulp capping
1.4
10.0
421
2914
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
18.0
10.0
15
8
U08
ICPC
Urinary retention
3.0
10.0
43
138
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.1
10.0
40
123
C09AA05
ATC
ramipril; oral
1.5
10.0
366
2470
4451
FHL
Guitar cutting
1.6
10.0
250
1557
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
10.0
1047
8303
RK310, ,
NOMESCO Finland
5.0
10.0
21
40
A13
ICPC
Concern/fear medical treatment
2.4
10.0
66
265
N06AA12
ATC
doxepin; systemic
2.1
10.0
95
444
G43.8
ICD-10 Finland
Other migraine
2.2
9.9
82
362
D19
ICPC
Teeth/gum symptom/complaint
1.3
9.9
1348
11018
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.5
9.9
60
231
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.0
9.9
101
484
RK120, ,
NOMESCO Finland
4.8
9.9
22
44
IFA01, ,
SPAT
3.4
9.9
34
95
WVA20, ,
SPAT
1.9
9.9
127
659
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
9.9
230
1409
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
9.8
292
1888
A08
ICPC
Swelling
1.9
9.8
125
646
RS311, ,
NOMESCO Finland
4.6
9.8
23
48
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.1
9.8
90
414
A46
ICD-10 Finland
Erysipelas
1.5
9.8
295
1912
L14
ICPC
Leg/thigh symptom/complaint
1.5
9.8
280
1795
C03DA01
ATC
spironolactone; oral
1.6
9.8
233
1433
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
2.8
9.8
49
171
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
9.8
305
1992
K86
ICPC
Hypertension uncomplicated
1.7
9.8
192
1126
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.6
9.8
55
204
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
5.2
9.8
20
37
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
9.8
354
2383
SPAT1369
SPAT
Meeting with student welfare group of educational institution
2.6
9.7
54
199
S51.8
ICD-10 Finland
Open wound of other parts of forearm
2.6
9.7
54
199
L60.0
ICD-10 Finland
Ingrowing nail
1.6
9.7
216
1307
R44.0
ICD-10 Finland
Auditory hallucinations
3.4
9.7
34
96
A02BC01
ATC
omeprazole; systemic
1.3
9.7
683
5134
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
9.7
110
547
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
9.7
219
1331
ZYB05
NOMESCO Finland
Outreach service at patient’s workplace, school or occupational/school health care
4.9
9.7
21
41
SPAT1016
SPAT
Examination of vision
1.4
9.7
368
2500
S01
ICPC
Pain/tenderness of skin
1.7
9.7
164
925
L04AD01
ATC
ciclosporin; systemic
2.2
9.7
75
323
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.3
9.6
36
106
P23
ICPC
Adolescent behaviour sympt/compl
2.3
9.6
73
311
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
9.6
106
522
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
9.6
140
755
WYA30, ,
SPAT
3.0
9.6
41
131
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
9.6
387
2658
F20.8
ICD-10 Finland
Other schizophrenia
4.2
9.6
25
57
SPAT1172
SPAT
Guidance concerning hydration
2.8
9.6
46
157
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.5
9.6
327
2176
EBA00, ,
SPAT
1.9
9.6
124
645
RS121, ,
NOMESCO Finland
2.9
9.6
45
152
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
3.4
9.6
34
97
IFA99, ,
SPAT
3.3
9.5
35
102
N02BF01
ATC
gabapentin; oral
1.6
9.5
239
1489
SPF10
NOMESCO Finland
Demanding reparation of dental prosthesis
3.7
9.5
30
79
N05AX13
ATC
paliperidone; systemic
3.0
9.5
41
132
SCA01
NOMESCO Finland
Preventive oral health care, short
1.2
9.5
1869
15875
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
3.1
9.5
38
117
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.8
9.5
152
844
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
3.4
9.5
33
93
W01
ICPC
Question of pregnancy
2.2
9.5
75
326
C09CA06
ATC
candesartan; oral
1.4
9.5
506
3649
Z00.0
ICD-10 Finland
General medical examination
1.3
9.4
757
5794
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
9.4
2198
18987
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.0
9.4
98
473
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
3.7
9.4
29
75
K92.0
ICD-10 Finland
Haematemesis
2.3
9.4
67
278
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
4.1
9.4
25
58
R45.1
ICD-10 Finland
Restlessness and agitation
4.6
9.4
22
46
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.8
9.4
149
825
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.0
9.4
98
474
R49.08
ICD-10 Finland
Other specified dysphonia
2.6
9.4
54
203
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
3.0
9.4
40
128
Y34
ICD-10 Finland
Unspecified event, undetermined intent
3.2
9.4
37
113
ZXY49
NOMESCO Finland
Other health care provider
2.8
9.4
45
154
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
9.3
553
4052
A02BC05
ATC
esomeprazole; systemic
1.3
9.3
948
7480
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
9.3
27
67
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
9.3
924
7270
7803A
ICD-9 Finland
General symptoms, Convulsions
2.3
9.3
66
274
J46
ICD-10 Finland
Status asthmaticus
2.1
9.2
82
373
WX290, ,
SPAT
1.7
9.2
169
974
78151
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Aphasia
+∞
9.2
9
*
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.8
9.2
130
695
A10BJ06
ATC
semaglutide; parenteral
2.0
9.2
97
471
5AB14, ,
NOMESCO Finland
4.7
9.2
21
43
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
9.2
694
5267
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
3.6
9.2
30
81
181
Kela drug reimbursment
Retigabine and vigabatrin
4.5
9.2
22
47
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
20.8
9.1
13
6
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.1
9.1
82
375
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
2.2
9.1
78
350
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
9.1
301
1991
K05.18
ICD-10 Finland
Chronic gingivitis
1.5
9.1
321
2151
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
9.1
100
493
L86
ICPC
Back syndrome with radiating pain
1.7
9.1
153
862
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
5.1
9.1
19
36
SFA00
NOMESCO Finland
Small restoration
1.4
9.1
441
3131
V03AG01
ATC
sodium cellulose phosphate; systemic
3.9
9.1
26
64
P01AB01
ATC
metronidazole; oral, rectal
1.3
9.0
1071
8600
S02
ICPC
Pruritus
1.7
9.0
180
1061
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
9.0
314
4224
H02
ICPC
Hearing complaint
1.5
9.0
296
1955
IEP01
NOMESCO Finland
Psychoeducation, family
2.9
9.0
40
131
R49.2
ICD-10 Finland
Hypernasality and hyponasality
10.2
9.0
17
16
ZXY54
NOMESCO Finland
2-person team, doctor-occupational therapist
10.2
9.0
17
16
EB1SA, ,
SPAT
1.6
9.0
231
1448
F06.7
ICD-10 Finland
Mild cognitive disorder
2.6
9.0
50
185
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
9.1
9.0
18
19
IGV01, ,
SPAT
4.1
9.0
24
56
N89
ICPC
Migraine
1.5
9.0
245
1557
IHZ29, ,
SPAT
4.4
8.9
22
48
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
4.4
8.9
22
48
R2210
NOMESCO Finland
Guidance to educational rehabilitation
13.1
8.9
15
11
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
8.9
265
1715
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
8.9
140
774
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
8.9
155
882
XQ800
NOMESCO Finland
Prick test
1.5
8.9
328
2217
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
8.9
175
1029
G04BD08
ATC
solifenacin; oral
1.9
8.8
103
518
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
8.8
200
1217
SPAT1211
SPAT
Application of soft bandage
1.4
8.8
355
2438
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
7.4
8.8
20
26
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
7.4
8.8
20
26
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
3.9
8.8
25
61
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
3.9
8.8
25
61
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.4
8.8
56
221
N06AA09
ATC
amitriptyline; systemic
1.7
8.8
148
834
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
3.3
8.8
32
93
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
1.8
8.8
131
713
WYA20
NOMESCO Finland
Home visit
2.6
8.8
51
193
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.8
8.8
43
149
F32
ICD-10 Finland
Depressive episode
1.5
8.7
257
1660
F10.24
ICD-10 Finland
Alcohol depence active use
2.6
8.7
50
188
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
6.7
8.7
21
30
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.4
8.7
60
246
N05AA01
ATC
chlorpromazine; systemic, rectal
3.4
8.7
31
89
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
2.9
8.7
40
134
W02
ICPC
Fear of pregnancy
2.7
8.6
45
161
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.3
8.6
65
277
I95.1
ICD-10 Finland
Orthostatic hypotension
2.2
8.6
71
314
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
2.7
8.6
46
167
S76
ICPC
Skin infection other
1.7
8.6
159
920
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
3.4
8.6
30
85
N03AB02
ATC
phenytoin; systemic
3.4
8.6
30
85
3459X
ICD-9 Finland
Epilepsy, unspecified
7.6
8.6
19
24
K02.9
ICD-10 Finland
Dental caries, unspecified
2.1
8.5
77
353
G04BD11
ATC
fesoterodine; oral
2.7
8.5
45
162
Z03
ICPC
Housing/neighbourhood problem
3.3
8.5
31
90
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
3.5
8.5
28
76
R04.0
ICD-10 Finland
Epistaxis
1.6
8.5
187
1130
RT190, ,
NOMESCO Finland
4.6
8.5
20
42
T74.2
ICD-10 Finland
Sexual abuse
4.2
8.5
22
50
SPA50
NOMESCO Finland
Determination of bite and dental arch location
3.2
8.5
32
95
WX725
NOMESCO Finland
Noninvasive ventilation
1.7
8.5
151
864
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.9
8.5
107
553
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
8.5
207
1283
R29
ICPC
Respiratory symptom/complaint other
1.5
8.5
243
1561
SPAT1043
SPAT
Audiometry
1.5
8.5
258
1679
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
3.4
8.5
29
81
R06AE07
ATC
cetirizine; oral
1.2
8.5
1688
14304
D03
ICPC
Heartburn
1.7
8.5
150
858
H02AB06
ATC
prednisolone; systemic
1.2
8.5
1301
10739
N05CD07
ATC
temazepam; oral
1.7
8.4
159
925
S01.0
ICD-10 Finland
Open wound of scalp
1.6
8.4
215
1347
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
8.4
121
652
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
8.4
160
933
N06AA10
ATC
nortriptyline; systemic
2.5
8.4
49
186
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.8
8.4
41
142
-, ,
ICD-10 Finland
2.4
8.4
53
209
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.0
8.4
36
116
ZX108
NOMESCO Finland
Inhalation
3.0
8.3
35
111
WZB00, ,
SPAT
0.7
8.3
464
5783
F31
ICD-10 Finland
Bipolar affective disorder
2.3
8.3
61
257
Z01.7
ICD-10 Finland
Laboratory examination
1.3
8.3
547
4068
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
8.3
454
5674
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.6
8.3
199
1228
31
HP
Congenital heart failure surgery
4.1
8.3
22
51
DFE00
NOMESCO Finland
Insertion of cochlear implant
7.9
8.3
18
22
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
8.3
300
2021
SPAT1101
SPAT
Orthostatic test
2.2
8.3
69
307
3431A
ICD-9 Finland
Infantile cerebral palsy, Hemiplegic
19.2
8.3
12
6
Q93.8
ICD-10 Finland
Other deletions from the autosomes
9.6
8.3
16
16
N06AX18
ATC
reboxetine; oral
3.6
8.3
27
73
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.9
8.3
100
510
SPAT1370
SPAT
Other health check-up
1.7
8.3
135
755
T91
ICPC
Vitamin/nutritional deficiency
3.2
8.2
31
92
SPAT1380
SPAT
Postpartum check-up
0.7
8.2
269
3663
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.9
8.2
99
504
WYA20, ,
SPAT
3.8
8.2
24
60
G41.9
ICD-10 Finland
Status epilepticus, unspecified
3.6
8.2
26
69
Z56.7
ICD-10 Finland
Other and unspecified problems related to employment
3.4
8.2
29
83
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
2.6
8.2
45
166
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.8
8.2
110
581
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.3
8.2
619
4697
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
8.1
200
1242
-1, ,
NOMESCO Finland
1.2
8.1
1650
13989
J01CA04
ATC
amoxicillin; systemic
1.3
8.1
3683
33821
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
8.1
86
419
F50.1
ICD-10 Finland
Atypical anorexia nervosa
2.5
8.1
49
189
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
4.8
8.1
18
36
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
4.1
8.1
22
52
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
7.5
8.1
18
23
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.5
8.1
245
1593
SPAT1384
SPAT
Extensive health check-up on first grade
1.5
8.1
224
1429
X57
ICD-10 Finland
Unspecified privation
2.1
8.1
77
361
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
4.2
8.1
21
48
Z94.1
ICD-10 Finland
Heart transplant status
4.2
8.1
21
48
R51.81
ICD-10 Finland
Facial pain NOS
2.1
8.0
73
336
P19
ICPC
Drug abuse
2.0
8.0
83
401
SPAT1197
SPAT
Extensive health check-up of expecting family
0.7
8.0
394
5006
L04AA06
ATC
mycophenolic acid; systemic
2.1
8.0
69
311
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
8.0
494
3640
B01AF02
ATC
apixaban; oral
1.6
8.0
192
1186
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
2.8
8.0
39
135
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.5
8.0
245
1597
X21
ICPC
Breast sympt/compl female other
2.1
8.0
77
363
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.8
8.0
38
130
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
7.9
461
3366
A85
ICPC
Adverse effect medical agent
2.7
7.9
40
141
OAB72, ,
SPAT
2.1
7.9
75
351
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
32.0
7.9
10
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
2.1
7.9
72
332
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
2.9
7.9
36
120
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
2.0
7.9
78
371
A98
ICPC
Health maint/preventive medicine
1.8
7.9
4205
39539
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.7
7.9
41
147
L05
ICPC
Flank/axilla symptom/complaint
1.6
7.9
194
1206
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
4.1
7.9
21
49
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.3
7.9
777
6097
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.2
7.9
30
90
F32.8
ICD-10 Finland
Other depressive episodes
2.0
7.9
84
411
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.7
7.8
24
62
G91.0
ICD-10 Finland
Communicating hydrocephalus
4.3
7.8
20
45
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.3
7.8
20
45
Q82.50
ICD-10 Finland
Naevus flammeus
4.5
7.8
19
41
R06.4
ICD-10 Finland
Hyperventilation
2.2
7.8
60
258
R03AC03
ATC
terbutaline; inhalant
1.4
7.8
408
2930
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.8
73
340
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
2.1
7.8
73
340
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
7.8
173
1049
A10BJ05
ATC
dulaglutide; parenteral
2.7
7.8
39
137
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.0
7.8
78
373
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
6.5
7.8
19
28
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
3.6
7.8
25
67
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
3.6
7.8
25
67
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
2.9
7.8
35
116
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
7.8
520
3877
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.1
7.7
73
341
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
7.7
138
791
Q55.20
ICD-10 Finland
Retractile testis
3.0
7.7
33
106
Z30.8
ICD-10 Finland
Other contraceptive management
1.5
7.7
201
1265
SXC05
NOMESCO Finland
Other oral or dental procedure
1.3
7.7
452
3304
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.6
7.7
180
1105
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.0
7.7
82
401
SPAT1167
SPAT
Insertion of urinary catheter
2.4
7.7
51
206
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.3
7.7
57
242
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
7.7
57
242
7707A
ICD-9 Finland
Other respiratory conditions of foetus and newborn, Chronic respiratory disease arising in the perinatal period[DYSPLASIA BRONCHOPULMONALIS NEONATALIS]
12.5
7.7
13
10
A10BK01
ATC
dapagliflozin; oral
1.7
7.7
127
714
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
7.7
62
273
R21
ICPC
Throat symptom/complaint
1.2
7.6
1353
11303
R03BA05
ATC
fluticasone; inhalant
1.3
7.6
705
5484
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.3
7.6
28
82
SJD40
NOMESCO Finland
Placement of prefabricated palatal or lingual arch
1.5
7.6
274
1844
N02AA05
ATC
oxycodone; systemic
1.4
7.6
294
2005
F34.0
ICD-10 Finland
Cyclothymia
3.5
7.6
25
68
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.7
7.6
23
59
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.7
7.6
413
5167
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
7.6
330
2300
N05AC01
ATC
periciazine; systemic
8.1
7.6
16
19
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.4
7.6
48
190
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.3
7.6
627
4812
W90
ICPC
Uncompl labour/delivery livebirth
0.6
7.6
128
2007
Y04.2
ICD-10 Finland
Assault by bodily force by friend
3.4
7.5
26
73
DFF15
NOMESCO Finland
Speech audiometry
2.0
7.5
82
404
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
2.7
7.5
40
145
K08.80
ICD-10 Finland
Toothache NOS
1.4
7.5
330
2302
R2110
NOMESCO Finland
Giving the first information
1.6
7.5
177
1089
L50.9
ICD-10 Finland
Urticaria, unspecified
1.6
7.5
176
1082
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.6
7.5
150
887
F95.9
ICD-10 Finland
Tic disorder, unspecified
3.2
7.5
28
83
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.7
7.5
341
4385
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
2.0
7.5
77
372
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
7.5
194
1221
D02AX
ATC
Other emollients and protectives
1.6
7.5
172
1053
P80
ICPC
Personality disorder
3.1
7.5
30
93
H02AB04
ATC
methylprednisolone; systemic
1.4
7.5
299
2053
N02BE01
ATC
paracetamol; systemic, rectal
1.2
7.4
3097
27969
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
7.4
148
874
ZXC95
NOMESCO Finland
Use of surgical navigator
2.8
7.4
35
119
H65.2
ICD-10 Finland
Chronic serous otitis media
2.0
7.4
73
347
3A566, ,
NOMESCO Finland
24.0
7.4
10
*
RK290, ,
NOMESCO Finland
4.4
7.4
18
39
F50.3
ICD-10 Finland
Atypical bulimia nervosa
2.9
7.4
33
109
F20.0
ICD-10 Finland
Paranoid schizophrenia
3.3
7.4
27
79
S20.2
ICD-10 Finland
Contusion of thorax
1.6
7.4
150
891
G40.80
ICD-10 Finland
Epilepsy with continuous EEG spike-waves during slow wave sleep
11.4
7.4
13
11
F44.5
ICD-10 Finland
Dissociative convulsions
11.4
7.4
13
11
Z04.6
ICD-10 Finland
General psychiatric examination, requested by authority
3.6
7.4
24
65
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
7.3
132
759
E86
ICD-10 Finland
Volume depletion
2.2
7.3
58
253
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.1
7.3
70
329
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
2.0
7.3
79
388
WX105, ,
SPAT
2.5
7.3
43
164
A12AA04
ATC
calcium carbonate; oral
2.5
7.3
43
164
R06.2
ICD-10 Finland
Wheezing
1.5
7.3
189
1188
SPAT1385
SPAT
Extensive health check-up on fifth grade
1.5
7.3
251
1674
Z61.1
ICD-10 Finland
Removal from home in childhood
9.6
7.3
14
14
R1270
NOMESCO Finland
Evaluation of the need for educational rehabilitation
8.5
7.3
15
17
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
2.8
7.3
34
115
G91.1
ICD-10 Finland
Obstructive hydrocephalus
3.9
7.3
21
52
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
3.9
7.3
21
52
K05.1
ICD-10 Finland
Chronic gingivitis
1.4
7.3
265
1788
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.7
7.3
201
2826
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.9
7.3
83
416
L18
ICPC
Muscle pain
1.6
7.3
163
992
G83.4
ICD-10 Finland
Cauda equina syndrome
5.9
7.3
19
31
P17
ICPC
Tobacco abuse
2.2
7.3
56
242
K07.60
ICD-10 Finland
Snapping jaw
1.5
7.2
204
1307
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
1.5
7.2
238
1575
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
6.8
7.2
17
24
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
6.8
7.2
17
24
SPAT1244
SPAT
Occupational therapy
3.1
7.2
29
90
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
3.1
7.2
29
90
P50
ICPC
Psychological, Medication/prescr/renewal
3.5
7.2
24
66
EB1MA
NOMESCO Finland
Cephalometry with X-ray
1.5
7.2
248
1656
K05.30
ICD-10 Finland
Periodontitis complex
1.4
7.2
306
2124
J01MA12
ATC
levofloxacin; systemic
1.4
7.2
344
2436
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
7.2
150
897
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.2
7.2
55
237
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
7.2
7
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
4.3
7.2
18
40
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
4.3
7.2
18
40
JN4AD
NOMESCO Finland
Body CT examination
1.5
7.2
190
1202
IAZ99
NOMESCO Finland
Other psychiatric consultation
2.7
7.1
38
138
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
7.1
263
1779
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.1
317
2218
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
3.0
7.1
31
101
EBA30
NOMESCO Finland
Extraction of root of tooth
1.7
7.1
121
686
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.6
7.1
39
144
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
3.2
7.1
27
81
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
7.1
196
1251
SPAT1081
SPAT
Cardiorespiratory global assessment
1.8
7.1
94
495
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
10.4
7.1
13
12
-1, ,
ICPC
1.8
7.1
99
530
N04BC05
ATC
pramipexole; oral
1.7
7.1
129
745
F41.01
ICD-10 Finland
Severe panic disorder
2.5
7.1
43
167
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.6
7.1
176
1098
AA400
NOMESCO Finland
Electroconvulsive therapy
2.7
7.1
36
128
RF120, ,
NOMESCO Finland
2.7
7.1
36
128
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
15.1
7.0
11
7
RS110, ,
NOMESCO Finland
3.4
7.0
24
67
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
7.0
48
197
S04
ICPC
Lump/swelling localized
1.3
7.0
443
3275
C10AX09
ATC
ezetimibe; oral
1.5
7.0
236
1569
R52.2
ICD-10 Finland
Other chronic pain
1.8
7.0
103
560
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
7.0
547
4164
RK222, ,
NOMESCO Finland
28.8
7.0
9
*
30610
ICD-8 Finland
Special symptoms not elsewhere classified, Specific learning disturbance
28.8
7.0
9
*
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
7.0
122
697
K30
ICD-10 Finland
Functional dyspepsia
1.4
7.0
318
2234
K29.1
ICD-10 Finland
Other acute gastritis
2.8
7.0
34
118
XX8XW, ,
NOMESCO Finland
6.0
7.0
18
29
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
6.0
7.0
18
29
Z99.2
ICD-10 Finland
Dependence on renal dialysis
4.2
7.0
18
41
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
4.2
7.0
18
41
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
4.2
7.0
18
41
OAA12, ,
SPAT
0.6
7.0
157
2302
F22.0
ICD-10 Finland
Delusional disorder
2.6
7.0
38
140
C02AC02
ATC
guanfacine; oral
7.0
6.9
16
22
79388
ICD-8 Finland
Observation, without need for further medical care, Morbi alii definiti
7.0
6.9
16
22
IAA02, ,
SPAT
2.8
6.9
33
113
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
3.7
6.9
21
54
K99
ICPC
Cardiovascular disease other
2.5
6.9
42
163
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
2.6
6.9
39
146
207
Kela drug reimbursment
Chronic arrhythmias
1.5
6.9
207
1344
137
Kela drug reimbursment
Uraemia requiring dialysis
2.9
6.9
32
108
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
6.9
220
1447
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
6.9
183
1158
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
3.4
6.9
24
68
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.6
6.9
175
1097
SJB00
NOMESCO Finland
Fitting of removable appliance incl. patient instructions
1.4
6.9
281
1937
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2.8
6.9
34
119
Z72.2
ICD-10 Finland
Drug use
2.3
6.9
47
193
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
2.0
6.9
67
318
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
3.8
6.9
20
50
N05CF02
ATC
zolpidem; oral
1.3
6.9
387
2813
RF220, ,
NOMESCO Finland
2.7
6.9
36
130
WX722
NOMESCO Finland
PEEP
1.8
6.8
97
523
K11.2
ICD-10 Finland
Sialoadenitis
1.8
6.8
94
502
KAY60, ,
NOMESCO Finland
0.5
6.8
52
1030
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
6.8
191
1225
R12
ICD-10 Finland
Heartburn
1.4
6.8
268
1837
WX212
NOMESCO Finland
Femoral plexus blockade
2.2
6.8
54
237
SPAT1379
SPAT
Health check-up of pregnant person
0.7
6.8
363
4554
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.0
6.8
65
307
L11
ICPC
Wrist symptom/complaint
1.3
6.7
418
3081
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
2.5
6.7
39
148
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
6.7
204
1328
RK312, ,
NOMESCO Finland
4.3
6.7
17
38
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.6
6.7
143
860
SPAT1336
SPAT
Request for examination
1.8
6.7
99
539
WVA20
NOMESCO Finland
Medicine administration
1.8
6.7
92
490
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
3.2
6.7
26
79
H60.3
ICD-10 Finland
Other infective otitis externa
1.9
6.7
78
394
U01
ICPC
Dysuria/painful urination
1.4
6.7
298
2085
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.8
6.7
104
575
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
3.8
6.7
20
51
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
3.8
6.7
20
51
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
2.7
6.7
34
121
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.4
6.7
44
178
H51.1
ICD-10 Finland
Convergence insufficiency and excess
3.4
6.6
23
65
R06.5
ICD-10 Finland
Mouth breathing
1.4
6.6
269
1852
A10BK03
ATC
empagliflozin; oral
1.6
6.6
154
946
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
6.6
1059
8738
61
HP
Catheterization and pressure measurement of the left side of the heart
2.7
6.6
33
116
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
2.7
6.6
33
116
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
38.3
6.6
8
*
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
38.3
6.6
8
*
TKC22
NOMESCO Finland
Catheterisation instruction
2.5
6.6
41
161
L08.0
ICD-10 Finland
Pyoderma
2.5
6.6
41
161
M25.5
ICD-10 Finland
Pain in joint
1.2
6.6
982
8044
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
7.9
6.6
14
17
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
2.9
6.6
29
95
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
10.5
6.6
12
11
Y28
ICPC
Limited function/disability (Y)
3.6
6.6
21
56
R44.3
ICD-10 Finland
Hallucinations, unspecified
3.2
6.6
25
75
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
8.9
6.6
13
14
MA3AE
NOMESCO Finland
Combined first trimester screening
0.7
6.6
199
2748
4302
FHL
Tooth patching under general anesthesia
6.4
6.6
16
24
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
6.4
6.6
16
24
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.0
6.6
64
304
R1420, ,
SPAT
3.5
6.5
22
61
S00.8
ICD-10 Finland
Superficial injury of other parts of head
1.9
6.5
73
364
IDY18
NOMESCO Finland
Systematic individual therapy, music therapy
21.6
6.5
9
*
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
4.2
6.5
17
39
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
2.6
6.5
35
128
Z61.9
ICD-10 Finland
Negative life event in childhood, unspecified
5.8
6.5
17
28
F43.00
ICD-10 Finland
Acute stress reaction mild
1.8
6.5
97
530
N03
ICPC
Pain face
2.5
6.5
38
145
A02BC03
ATC
lansoprazole; oral
1.3
6.5
488
3695
ZYC03
NOMESCO Finland
Remote contact, text-based
3.4
6.5
23
66
H60.8
ICD-10 Finland
Other otitis externa
1.7
6.5
107
602
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
2.8
6.5
32
112
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
6.5
65
312
ZX114
NOMESCO Finland
Intramuscular
2.2
6.5
52
229
H35.1
ICD-10 Finland
Retinopathy of prematurity
6.9
6.5
15
21
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.3
6.5
24
71
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
3.2
6.5
25
76
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
3.1
6.4
26
81
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
3.8
6.4
19
48
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.4
6.4
42
169
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.3
6.4
45
187
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
6.4
291
2043
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.5
6.4
213
1413
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.4
6.4
336
2415
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
6.4
120
699
A07AA02
ATC
nystatin; oral
1.7
6.4
110
626
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
6.4
326
2333
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
6.2
6.4
16
25
WYA10
NOMESCO Finland
Emergency care or similar visit
1.4
6.4
288
2020
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
3.4
6.4
22
62
E66
ICD-10 Finland
Obesity
1.5
6.4
177
1132
SPAT1310
SPAT
Counselling related to known health issue
1.2
6.4
1202
10069
B01AB05
ATC
enoxaparin; parenteral
1.3
6.4
606
4728
S82.0
ICD-10 Finland
Fracture of patella
2.3
6.3
45
188
G80.8
ICD-10 Finland
Other cerebral palsy
8.3
6.3
13
15
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.1
6.3
58
269
Z61.7
ICD-10 Finland
Personal frightening experience in childhood
3.6
6.3
20
53
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.7
6.3
117
679
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
9.6
6.3
12
12
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
9.6
6.3
12
12
B05DA
ATC
Isotonic solutions
3.0
6.3
27
87
SGA03
NOMESCO Finland
Opening and preparing the root canals, complicated
1.4
6.3
301
2130
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
3.1
6.3
26
82
N80
ICPC
Head injury other
1.7
6.3
108
614
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
4.1
6.3
17
40
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
4.1
6.3
17
40
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
6.3
198
1299
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.1
6.3
59
276
K73
ICPC
Congenital anomaly cardiovascular
67.0
6.3
7
*
V202A
ICD-9 Finland
Health supervision of infant or child, Routine infant or child health check
67.0
6.3
7
*
K07
ICPC
Swollen ankles/oedema
1.8
6.3
84
444
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.5
6.3
36
136
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
6.6
6.3
15
22
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
3.5
6.3
21
58
H65.0
ICD-10 Finland
Acute serous otitis media
1.7
6.3
102
572
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.4
6.3
258
1782
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
6.3
373
2734
RS142, ,
NOMESCO Finland
3.7
6.3
19
49
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.0
6.2
66
323
S19
ICPC
Skin injury other
1.6
6.2
146
899
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
2.9
6.2
28
93
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.9
6.2
28
93
SPAT1241
SPAT
Extensive assessment of psychosocial situation
1.8
6.2
80
418
DM1QA, ,
SPAT
0.5
6.2
62
1125
F20.5
ICD-10 Finland
Residual schizophrenia
5.9
6.2
16
26
7505
FHL
Funicular lysis and orchidopexy
3.0
6.2
27
88
SPAT1312
SPAT
General health counselling
1.2
6.2
1441
12288
A10BH01
ATC
sitagliptin; oral
1.6
6.2
126
750
G40.30
ICD-10 Finland
Benign myoclonic eplilepsy in infancy
5.1
6.2
18
34
RS130, ,
NOMESCO Finland
7.1
6.2
14
19
E30.09
ICD-10 Finland
Delayed puberty NOS
3.1
6.2
25
78
Z13.88
ICD-10 Finland
Special screening examination for other specified diseases and disorders
1.5
6.2
204
1352
W10
ICD-10 Finland
Fall on and from stairs and steps
1.6
6.2
141
863
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
1.7
6.2
115
669
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
3.6
6.2
20
54
J06.80
ICD-10 Finland
Continuously repeating infections of a child
2.7
6.2
32
115
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.6
6.2
142
871
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.4
6.2
260
1803
O80.8
ICD-10 Finland
Other single spontaneous delivery
0.6
6.2
86
1415
A10AE04
ATC
insulin glargine; parenteral
1.5
6.2
213
1425
3151A
ICD-9 Finland
Specific delays in development, Specific arithmetical disorder
+∞
6.1
6
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
6.1
167
1064
E22.1
ICD-10 Finland
Hyperprolactinaemia
2.6
6.1
33
121
W0A10
NOMESCO Finland
Mapping of psychosocial situation
3.4
6.1
21
59
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
6.1
280
1969
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
17.3
6.1
9
5
3092E
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
8.9
6.1
12
13
C05AA08
ATC
fluocortolone; rectal, topical
1.5
6.1
211
1412
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
3.7
6.1
19
50
R49.03
ICD-10 Finland
Atrophic dysphonia
3.7
6.1
19
50
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
6.1
163
1035
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.7
6.1
32
116
P11
ICPC
Eating problem in child
3.0
6.1
26
84
M79.1
ICD-10 Finland
Myalgia
1.3
6.1
493
3770
F43.01
ICD-10 Finland
Acute stress reaction moderate
1.9
6.1
67
333
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.3
6.1
362
2654
SPAT1104
SPAT
Monitoring of emergency patient
1.5
6.1
156
982
4304
FHL
Tooth or tooth extraction under general anesthesia
5.7
6.1
16
27
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
2.8
6.1
29
100
3A019, ,
NOMESCO Finland
5.3
6.0
17
31
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
6.0
170
1091
SPAT1050
SPAT
Extensive neurological examination
2.0
6.0
61
294
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.6
6.0
141
2050
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.6
6.0
121
718
SPAT1210
SPAT
Application of cast or individual aid
1.6
6.0
123
733
ZXD35
NOMESCO Finland
Usual procedure
1.9
6.0
76
395
G93.0
ICD-10 Finland
Cerebral cysts
3.5
6.0
20
55
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
6.0
82
437
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
3.8
6.0
18
46
L08
ICPC
Shoulder symptom/complaint
1.3
6.0
572
4461
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.4
6.0
38
151

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Disturbance of activity and attention
F90.0 [45542870]
1.7e+00
1.9e+00
2.1e+00
6.2e+00
2.7e+00
2.4e+00
1.8e+00
cases:3.89%
controls:0.77%
cases:4.75%
controls:0.72%
cases:2.00%
controls:0.24%
cases:6.66%
controls:0.01%
cases:3.55%
controls:0.25%
cases:8.10%
controls:0.83%
cases:10.95%
controls:1.95%
135
256
3336
32981
166
241
3331
33214
70
80
3427
33375
233
5
3264
33450
124
85
3366
33318
273
271
3096
32240
318
552
2585
27688
Neurology
13 [38004458]
8.2e-01
1.5e+00
2.2e+00
7.2e+00
2.7e+00
1.9e+00
1.0e+00
cases:11.61%
controls:5.47%
cases:10.01%
controls:2.48%
cases:4.32%
controls:0.50%
cases:16.44%
controls:0.01%
cases:8.34%
controls:0.60%
cases:14.43%
controls:2.48%
cases:14.36%
controls:5.60%
403
1819
3068
31418
350
830
3147
32625
151
167
3346
33288
575
5
2922
33450
291
199
3199
33204
486
806
2883
31705
417
1582
2486
26658
Psychiatry
26 [38004469]
1.3e+00
2.0e+00
2.3e+00
5.2e+00
2.4e+00
2.1e+00
1.5e+00
cases:12.91%
controls:3.77%
cases:12.98%
controls:1.98%
cases:7.41%
controls:0.77%
cases:11.50%
controls:0.07%
cases:8.42%
controls:0.80%
cases:14.01%
controls:2.01%
cases:17.19%
controls:4.34%
448
1252
3023
31985
454
664
3043
32791
259
259
3238
33196
402
23
3095
33432
294
267
3196
33136
472
654
2897
31857
499
1225
2404
27015
Specific developmental disorder of motor function
F82 [45605516]
2.0e+00
2.6e+00
2.6e+00
—
3.8e+00
3.2e+00
2.6e+00
cases:1.90%
controls:0.25%
cases:1.17%
controls:0.09%
cases:0.31%
controls:0.02%
—
—
cases:0.83%
controls:0.02%
cases:1.99%
controls:0.08%
cases:3.27%
controls:0.24%
66
83
3405
33154
41
29
3456
33426
11
8
3486
33447
—
29
6
3461
33397
67
27
3302
32484
95
68
2808
28172
Paediatric neurology
421 [44777781]
9.5e-01
1.3e+00
2.1e+00
5.9e+00
2.8e+00
1.9e+00
1.7e+00
cases:11.93%
controls:4.96%
cases:10.12%
controls:3.01%
cases:4.46%
controls:0.59%
cases:17.41%
controls:0.06%
cases:8.74%
controls:0.57%
cases:15.61%
controls:2.65%
cases:19.46%
controls:4.29%
414
1650
3057
31587
354
1007
3143
32448
156
196
3341
33259
609
20
2888
33435
305
192
3185
33211
526
863
2843
31648
565
1211
2338
27029
Neuropsychological investigation
XA800 [2001300412]
1.5e+00
2.6e+00
4.2e+00
1.0e+50
3.3e+00
2.5e+00
2.3e+00
cases:2.94%
controls:0.70%
cases:2.72%
controls:0.21%
cases:1.37%
controls:0.02%
cases:1.12%
controls:0.00%
cases:0.72%
controls:0.03%
cases:2.85%
controls:0.23%
cases:5.24%
controls:0.53%
102
232
3369
33005
95
71
3402
33384
48
7
3449
33448
39
0
3458
33455
25
9
3465
33394
96
76
3273
32435
152
151
2751
28089
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.3e+00
2.1e+00
1.6e+00
3.9e+00
2.3e+00
2.1e+00
1.7e+00
cases:1.79%
controls:0.49%
cases:1.40%
controls:0.17%
cases:0.43%
controls:0.08%
cases:0.89%
controls:0.02%
cases:0.80%
controls:0.08%
cases:1.84%
controls:0.23%
cases:3.03%
controls:0.57%
62
163
3409
33074
49
57
3448
33398
15
28
3482
33427
31
6
3466
33449
28
26
3462
33377
62
74
3307
32437
88
160
2815
28080
Psychologist
Z2445 [2001311558]
1.3e+00
2.0e+00
3.0e+00
1.0e+50
3.3e+00
2.3e+00
2.6e+00
cases:3.92%
controls:1.15%
cases:2.55%
controls:0.34%
cases:1.37%
controls:0.07%
cases:1.37%
controls:0.00%
cases:1.15%
controls:0.04%
cases:3.06%
controls:0.30%
cases:5.17%
controls:0.41%
136
383
3335
32854
89
115
3408
33340
48
24
3449
33431
48
0
3449
33455
40
14
3450
33389
103
98
3266
32413
150
116
2753
28124
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
F98.8 [45605524]
1.9e+00
2.0e+00
2.1e+00
1.0e+50
2.7e+00
2.7e+00
2.4e+00
cases:0.58%
controls:0.09%
cases:0.40%
controls:0.06%
cases:0.17%
controls:0.02%
cases:0.54%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.92%
controls:0.06%
cases:1.38%
controls:0.13%
20
29
3451
33208
14
19
3483
33436
6
7
3491
33448
19
0
3478
33455
12
8
3478
33395
31
20
3338
32491
40
36
2863
28204
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
1.9e+00
2.5e+00
2.6e+00
—
3.0e+00
2.0e+00
1.6e+00
cases:0.66%
controls:0.10%
cases:0.69%
controls:0.06%
cases:0.31%
controls:0.02%
—
—
cases:0.43%
controls:0.02%
cases:0.56%
controls:0.07%
cases:0.76%
controls:0.15%
23
33
3448
33204
24
19
3473
33436
11
8
3486
33447
—
15
7
3475
33396
19
24
3350
32487
22
43
2881
28197
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
9.0e-01
1.4e+00
1.7e+00
4.7e+00
1.9e+00
1.7e+00
1.3e+00
cases:7.87%
controls:3.35%
cases:7.89%
controls:2.04%
cases:4.29%
controls:0.79%
cases:5.60%
controls:0.05%
cases:5.21%
controls:0.82%
cases:10.51%
controls:2.13%
cases:14.92%
controls:4.67%
273
1114
3198
32123
276
681
3221
32774
150
265
3347
33190
196
18
3301
33437
182
274
3308
33129
354
692
3015
31819
433
1319
2470
26921
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
1.9e+00
2.1e+00
2.1e+00
—
2.7e+00
2.4e+00
2.3e+00
cases:0.78%
controls:0.11%
cases:0.63%
controls:0.08%
cases:0.26%
controls:0.03%
—
—
cases:0.32%
controls:0.02%
cases:0.77%
controls:0.07%
cases:1.31%
controls:0.13%
27
38
3444
33199
22
26
3475
33429
9
11
3488
33444
—
11
7
3479
33396
26
22
3343
32489
38
38
2865
28202
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
1.3e+00
2.0e+00
3.2e+00
1.0e+50
3.6e+00
2.2e+00
9.9e-01
cases:1.64%
controls:0.45%
cases:1.06%
controls:0.15%
cases:0.51%
controls:0.02%
cases:2.26%
controls:0.00%
cases:0.97%
controls:0.03%
cases:1.42%
controls:0.16%
cases:1.17%
controls:0.44%
57
151
3414
33086
37
49
3460
33406
18
7
3479
33448
79
0
3418
33455
34
9
3456
33394
48
52
3321
32459
34
124
2869
28116
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.2e+00
1.4e+00
1.7e+00
4.3e+00
1.6e+00
1.6e+00
1.3e+00
cases:2.62%
controls:0.81%
cases:1.83%
controls:0.44%
cases:0.94%
controls:0.17%
cases:1.12%
controls:0.01%
cases:0.92%
controls:0.18%
cases:2.34%
controls:0.48%
cases:3.82%
controls:1.10%
91
270
3380
32967
64
146
3433
33309
33
56
3464
33399
39
5
3458
33450
32
61
3458
33342
79
155
3290
32356
111
312
2792
27928
Speech therapy
Z50.5 [45547321]
1.3e+00
2.1e+00
2.8e+00
1.0e+50
3.4e+00
2.2e+00
1.3e+00
cases:1.64%
controls:0.46%
cases:1.34%
controls:0.17%
cases:0.49%
controls:0.03%
cases:0.17%
controls:0.00%
cases:0.43%
controls:0.01%
cases:1.13%
controls:0.13%
cases:1.07%
controls:0.28%
57
154
3414
33083
47
57
3450
33398
17
10
3480
33445
6
0
3491
33455
15
5
3475
33398
38
42
3331
32469
31
79
2872
28161
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.5e+00
2.4e+00
2.4e+00
—
2.7e+00
2.1e+00
1.7e+00
cases:1.93%
controls:0.42%
cases:1.74%
controls:0.16%
cases:0.80%
controls:0.07%
—
—
cases:0.89%
controls:0.06%
cases:1.69%
controls:0.21%
cases:2.62%
controls:0.50%
67
141
3404
33096
61
53
3436
33402
28
24
3469
33431
—
31
20
3459
33383
57
67
3312
32444
76
142
2827
28098
Mixed personality disorders
F61.0 [2000502024]
2.3e+00
2.3e+00
1.9e+00
1.0e+50
2.7e+00
3.0e+00
2.5e+00
cases:0.78%
controls:0.08%
cases:0.46%
controls:0.04%
cases:0.17%
controls:0.03%
cases:0.66%
controls:0.00%
cases:0.37%
controls:0.02%
cases:0.71%
controls:0.04%
cases:0.90%
controls:0.07%
27
27
3444
33210
16
15
3481
33440
6
9
3491
33446
23
0
3474
33455
13
8
3477
33395
24
12
3345
32499
26
21
2877
28219
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
1.2e+00
2.2e+00
3.0e+00
—
2.6e+00
2.1e+00
1.5e+00
cases:0.61%
controls:0.19%
cases:0.69%
controls:0.08%
cases:0.29%
controls:0.01%
—
—
cases:0.32%
controls:0.02%
cases:0.68%
controls:0.09%
cases:1.00%
controls:0.22%
21
62
3450
33175
24
26
3473
33429
10
5
3487
33450
—
11
8
3479
33395
23
28
3346
32483
29
62
2874
28178
Post-traumatic stress disorder
F43.1 [45595909]
1.7e+00
2.0e+00
2.1e+00
—
2.7e+00
2.3e+00
1.7e+00
cases:0.98%
controls:0.19%
cases:1.00%
controls:0.14%
cases:0.51%
controls:0.06%
—
—
cases:0.60%
controls:0.04%
cases:1.37%
controls:0.14%
cases:1.79%
controls:0.33%
34
63
3437
33174
35
48
3462
33407
18
21
3479
33434
—
21
13
3469
33390
46
46
3323
32465
52
94
2851
28146
Other and unspecified speech disturbances
R47.8 [45592422]
2.3e+00
3.4e+00
—
1.0e+50
—
3.6e+00
3.1e+00
cases:0.43%
controls:0.04%
cases:0.46%
controls:0.01%
—
—
cases:0.49%
controls:0.00%
—
—
cases:0.53%
controls:0.02%
cases:0.86%
controls:0.04%
15
14
3456
33223
16
5
3481
33450
—
17
0
3480
33455
—
18
5
3351
32506
25
11
2878
28229
Cerebral infarction, unspecified
I63.9 [45596216]
1.0e+00
2.0e+00
2.7e+00
1.0e+50
3.5e+00
1.8e+00
1.1e+00
cases:1.82%
controls:0.65%
cases:1.26%
controls:0.18%
cases:0.46%
controls:0.03%
cases:1.74%
controls:0.00%
cases:1.17%
controls:0.04%
cases:1.42%
controls:0.23%
cases:1.58%
controls:0.55%
63
216
3408
33021
44
60
3453
33395
16
10
3481
33445
61
0
3436
33455
41
12
3449
33391
48
75
3321
32436
46
155
2857
28085
Delayed milestone
R62.0 [45597195]
1.2e+00
2.0e+00
2.8e+00
1.0e+50
2.5e+00
1.9e+00
1.7e+00
cases:2.77%
controls:0.89%
cases:2.23%
controls:0.29%
cases:0.80%
controls:0.05%
cases:0.40%
controls:0.00%
cases:0.43%
controls:0.04%
cases:0.86%
controls:0.13%
cases:0.86%
controls:0.17%
96
296
3375
32941
78
98
3419
33357
28
16
3469
33439
14
0
3483
33455
15
12
3475
33391
29
41
3340
32470
25
47
2878
28193
Social phobias
F40.1 [45595907]
1.8e+00
1.9e+00
2.0e+00
—
2.4e+00
2.4e+00
1.6e+00
cases:1.24%
controls:0.21%
cases:1.06%
controls:0.16%
cases:0.46%
controls:0.06%
—
—
cases:0.60%
controls:0.05%
cases:1.69%
controls:0.16%
cases:1.93%
controls:0.40%
43
71
3428
33166
37
53
3460
33402
16
20
3481
33435
—
21
18
3469
33385
57
53
3312
32458
56
113
2847
28127
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
1.5e+00
2.5e+00
2.1e+00
—
3.0e+00
1.6e+00
1.3e+00
cases:1.82%
controls:0.41%
cases:2.14%
controls:0.18%
cases:0.17%
controls:0.02%
—
—
cases:0.49%
controls:0.02%
cases:0.77%
controls:0.16%
cases:1.96%
controls:0.55%
63
137
3408
33100
75
59
3422
33396
6
7
3491
33448
—
17
8
3473
33395
26
51
3343
32460
57
155
2846
28085
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.6e+00
1.9e+00
2.3e+00
1.0e+50
2.4e+00
2.1e+00
1.7e+00
cases:1.53%
controls:0.31%
cases:1.12%
controls:0.16%
cases:0.49%
controls:0.05%
cases:0.80%
controls:0.00%
cases:0.60%
controls:0.05%
cases:1.19%
controls:0.14%
cases:1.96%
controls:0.37%
53
104
3418
33133
39
55
3458
33400
17
17
3480
33438
28
0
3469
33455
21
18
3469
33385
40
46
3329
32465
57
105
2846
28135
lisdexamfetamine; oral
N06BA12 [40252237]
1.6e+00
1.9e+00
2.0e+00
—
2.7e+00
2.0e+00
1.8e+00
cases:0.58%
controls:0.12%
cases:0.77%
controls:0.12%
cases:0.37%
controls:0.05%
—
—
cases:0.54%
controls:0.04%
cases:1.04%
controls:0.14%
cases:2.03%
controls:0.33%
20
39
3451
33198
27
39
3470
33416
13
17
3484
33438
—
19
12
3471
33391
35
47
3334
32464
59
94
2844
28146
Social worker
Z2446 [2001311559]
9.1e-01
1.6e+00
2.1e+00
1.0e+50
3.0e+00
2.2e+00
2.1e+00
cases:4.52%
controls:1.88%
cases:1.86%
controls:0.39%
cases:0.40%
controls:0.05%
cases:0.40%
controls:0.00%
cases:0.49%
controls:0.02%
cases:1.99%
controls:0.23%
cases:3.75%
controls:0.46%
157
625
3314
32612
65
130
3432
33325
14
17
3483
33438
14
0
3483
33455
17
8
3473
33395
67
76
3302
32435
109
129
2794
28111
Hyperkinetic disorder, unspecified
F90.9 [45533124]
1.3e+00
2.1e+00
2.3e+00
1.0e+50
2.7e+00
2.1e+00
1.4e+00
cases:0.43%
controls:0.12%
cases:0.69%
controls:0.08%
cases:0.20%
controls:0.02%
cases:0.37%
controls:0.00%
cases:0.40%
controls:0.03%
cases:0.80%
controls:0.10%
cases:1.07%
controls:0.27%
15
41
3456
33196
24
28
3473
33427
7
7
3490
33448
13
0
3484
33455
14
9
3476
33394
27
31
3342
32480
31
76
2872
28164
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
1.4e+00
2.4e+00
2.6e+00
—
2.2e+00
2.0e+00
1.3e+00
cases:1.09%
controls:0.28%
cases:1.74%
controls:0.16%
cases:0.54%
controls:0.04%
—
—
cases:0.40%
controls:0.04%
cases:1.45%
controls:0.20%
cases:2.24%
controls:0.62%
38
93
3433
33144
61
54
3436
33401
19
14
3478
33441
—
14
15
3476
33388
49
65
3320
32446
65
175
2838
28065
Emergency Room and Inpatient Visit
ERIP [262]
3.8e-01
7.9e-01
1.5e+00
5.8e+00
2.1e+00
7.7e-01
3.6e-01
cases:7.12%
controls:4.97%
cases:5.89%
controls:2.77%
cases:1.63%
controls:0.36%
cases:5.86%
controls:0.02%
cases:2.98%
controls:0.36%
cases:6.03%
controls:2.87%
cases:9.96%
controls:7.19%
247
1651
3224
31586
206
926
3291
32529
57
120
3440
33335
205
6
3292
33449
104
120
3386
33283
203
933
3166
31578
289
2031
2614
26209
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
9.7e-01
1.7e+00
2.7e+00
1.0e+50
3.1e+00
2.1e+00
1.1e+00
cases:2.05%
controls:0.78%
cases:1.03%
controls:0.18%
cases:0.34%
controls:0.02%
cases:0.34%
controls:0.00%
cases:0.40%
controls:0.02%
cases:1.22%
controls:0.15%
cases:1.45%
controls:0.49%
71
260
3400
32977
36
61
3461
33394
12
8
3485
33447
12
0
3485
33455
14
6
3476
33397
41
50
3328
32461
42
138
2861
28102
Recurrent depressive disorder, unspecified
F33.9 [45581458]
1.6e+00
1.9e+00
2.2e+00
1.0e+50
2.8e+00
1.8e+00
1.4e+00
cases:1.53%
controls:0.31%
cases:0.97%
controls:0.15%
cases:0.40%
controls:0.04%
cases:0.54%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.80%
controls:0.14%
cases:1.48%
controls:0.38%
53
102
3418
33135
34
50
3463
33405
14
15
3483
33440
19
0
3478
33455
12
7
3478
33396
27
45
3342
32466
43
106
2860
28134
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
3.3e-01
7.2e-01
1.2e+00
5.4e+00
2.4e+00
8.8e-01
5.6e-01
cases:8.30%
controls:6.08%
cases:5.60%
controls:2.80%
cases:1.52%
controls:0.45%
cases:3.32%
controls:0.01%
cases:3.72%
controls:0.36%
cases:5.08%
controls:2.16%
cases:7.79%
controls:4.61%
288
2021
3183
31216
196
937
3301
32518
53
150
3444
33305
116
5
3381
33450
130
120
3360
33283
171
703
3198
31808
226
1302
2677
26938
Speech therapy
R4130 [2001310235]
1.5e+00
1.6e+00
—
1.0e+50
3.8e+00
2.4e+00
2.1e+00
cases:1.09%
controls:0.25%
cases:0.92%
controls:0.18%
—
—
cases:0.80%
controls:0.00%
cases:0.69%
controls:0.01%
cases:1.90%
controls:0.17%
cases:3.00%
controls:0.38%
38
84
3433
33153
32
60
3465
33395
—
28
0
3469
33455
24
5
3466
33398
64
56
3305
32455
87
107
2816
28133
Other bipolar affective disorders
F31.8 [45586237]
1.5e+00
1.8e+00
2.1e+00
—
2.3e+00
2.0e+00
1.7e+00
cases:0.61%
controls:0.13%
cases:0.46%
controls:0.07%
cases:0.26%
controls:0.03%
—
—
cases:0.34%
controls:0.04%
cases:0.56%
controls:0.07%
cases:0.76%
controls:0.14%
21
43
3450
33194
16
25
3481
33430
9
11
3488
33444
—
12
12
3478
33391
19
24
3350
32487
22
39
2881
28201
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.6e-01
7.5e-01
1.5e+00
5.7e+00
2.3e+00
6.7e-01
1.9e-01
cases:8.41%
controls:5.46%
cases:4.80%
controls:2.33%
cases:1.37%
controls:0.32%
cases:5.75%
controls:0.02%
cases:3.12%
controls:0.33%
cases:4.60%
controls:2.41%
cases:6.72%
controls:5.60%
292
1816
3179
31421
168
778
3329
32677
48
106
3449
33349
201
7
3296
33448
109
110
3381
33293
155
783
3214
31728
195
1581
2708
26659
Stroke/cerebrovascular accident
K90 [2002000617]
4.0e-01
1.8e+00
2.5e+00
—
2.7e+00
2.4e+00
1.6e+00
cases:0.26%
controls:0.17%
cases:0.34%
controls:0.06%
cases:0.23%
controls:0.02%
—
—
cases:0.23%
controls:0.01%
cases:0.62%
controls:0.06%
cases:0.83%
controls:0.17%
9
58
3462
33179
12
19
3485
33436
8
6
3489
33449
—
8
5
3482
33398
21
19
3348
32492
24
48
2879
28192
Chronic alcohol abuse
P15 [2002000811]
1.4e+00
1.6e+00
2.4e+00
—
2.3e+00
1.6e+00
1.7e+00
cases:0.63%
controls:0.16%
cases:0.37%
controls:0.07%
cases:0.20%
controls:0.02%
—
—
cases:0.17%
controls:0.02%
cases:0.36%
controls:0.07%
cases:0.83%
controls:0.15%
22
52
3449
33185
13
25
3484
33430
7
6
3490
33449
—
6
6
3484
33397
12
24
3357
32487
24
42
2879
28198
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.19 [2000502138]
1.2e+00
1.6e+00
2.3e+00
—
2.4e+00
2.2e+00
1.3e+00
cases:0.58%
controls:0.18%
cases:0.37%
controls:0.07%
cases:0.23%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.56%
controls:0.06%
cases:0.69%
controls:0.18%
20
60
3451
33177
13
25
3484
33430
8
8
3489
33447
—
9
8
3481
33395
19
20
3350
32491
20
51
2883
28189
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.3e+00
2.3e+00
1.9e+00
—
3.2e+00
1.5e+00
7.3e-01
cases:0.98%
controls:0.27%
cases:1.52%
controls:0.15%
cases:0.26%
controls:0.04%
—
—
cases:0.52%
controls:0.02%
cases:0.89%
controls:0.19%
cases:1.72%
controls:0.84%
34
91
3437
33146
53
51
3444
33404
9
13
3488
33442
—
18
7
3472
33396
30
62
3339
32449
50
237
2853
28003
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.9e-01
6.8e-01
1.3e+00
5.5e+00
1.9e+00
7.2e-01
3.6e-01
cases:18.12%
controls:13.04%
cases:11.18%
controls:6.02%
cases:3.09%
controls:0.86%
cases:9.47%
controls:0.04%
cases:5.53%
controls:0.87%
cases:10.30%
controls:5.28%
cases:16.57%
controls:12.18%
629
4334
2842
28903
391
2013
3106
31442
108
287
3389
33168
331
15
3166
33440
193
289
3297
33114
347
1716
3022
30795
481
3441
2422
24799
Depressive episode, unspecified
F32.9 [45571760]
1.2e+00
1.8e+00
2.6e+00
—
2.5e+00
1.5e+00
1.2e+00
cases:4.29%
controls:1.28%
cases:2.86%
controls:0.50%
cases:1.14%
controls:0.08%
—
—
cases:1.03%
controls:0.09%
cases:2.29%
controls:0.52%
cases:5.06%
controls:1.63%
149
424
3322
32813
100
166
3397
33289
40
28
3457
33427
—
36
30
3454
33373
77
169
3292
32342
147
459
2756
27781
Occupational therapy
R4120 [2001310234]
1.0e+00
1.4e+00
2.4e+00
1.0e+50
2.9e+00
1.7e+00
1.4e+00
cases:2.05%
controls:0.74%
cases:1.32%
controls:0.31%
cases:0.57%
controls:0.05%
cases:0.74%
controls:0.00%
cases:0.52%
controls:0.03%
cases:1.57%
controls:0.30%
cases:3.20%
controls:0.79%
71
247
3400
32990
46
105
3451
33350
20
18
3477
33437
26
0
3471
33455
18
10
3472
33393
53
99
3316
32412
93
224
2810
28016
Dysthymia
F34.1 [45586238]
1.2e+00
1.8e+00
1.7e+00
1.0e+50
2.5e+00
2.1e+00
1.3e+00
cases:0.81%
controls:0.24%
cases:0.83%
controls:0.14%
cases:0.26%
controls:0.04%
cases:0.74%
controls:0.00%
cases:0.54%
controls:0.04%
cases:1.25%
controls:0.15%
cases:1.24%
controls:0.34%
28
79
3443
33158
29
46
3468
33409
9
15
3488
33440
26
0
3471
33455
19
15
3471
33388
42
48
3327
32463
36
97
2867
28143
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
1.5e+00
2.1e+00
—
1.0e+50
3.1e+00
2.0e+00
2.1e+00
cases:1.07%
controls:0.23%
cases:1.14%
controls:0.15%
—
—
cases:0.57%
controls:0.00%
cases:0.32%
controls:0.01%
cases:1.45%
controls:0.21%
cases:3.58%
controls:0.45%
37
77
3434
33160
40
49
3457
33406
—
20
0
3477
33455
11
5
3479
33398
49
68
3320
32443
104
127
2799
28113
Asperger syndrome
F84.5 [45576562]
1.8e+00
1.9e+00
1.8e+00
—
3.0e+00
2.1e+00
2.0e+00
cases:0.43%
controls:0.08%
cases:0.49%
controls:0.07%
cases:0.14%
controls:0.02%
—
—
cases:0.29%
controls:0.01%
cases:0.59%
controls:0.07%
cases:1.31%
controls:0.18%
15
25
3456
33212
17
25
3480
33430
5
8
3492
33447
—
10
5
3480
33398
20
24
3349
32487
38
50
2865
28190
Other childhood emotional disorders
F93.89 [2000502046]
9.8e-01
1.9e+00
1.6e+00
1.0e+50
2.3e+00
2.1e+00
1.6e+00
cases:0.69%
controls:0.26%
cases:0.77%
controls:0.11%
cases:0.31%
controls:0.06%
cases:0.51%
controls:0.00%
cases:0.54%
controls:0.05%
cases:1.10%
controls:0.13%
cases:1.86%
controls:0.38%
24
87
3447
33150
27
38
3470
33417
11
21
3486
33434
18
0
3479
33455
19
18
3471
33385
37
43
3332
32468
54
108
2849
28132
General Practice
1 [38004446]
4.4e-01
7.1e-01
1.1e+00
4.8e+00
2.1e+00
8.2e-01
4.5e-01
cases:16.51%
controls:11.33%
cases:7.75%
controls:3.98%
cases:1.77%
controls:0.60%
cases:3.32%
controls:0.03%
cases:4.01%
controls:0.51%
cases:8.46%
controls:3.92%
cases:15.16%
controls:10.25%
573
3767
2898
29470
271
1331
3226
32124
62
200
3435
33255
116
9
3381
33446
140
172
3350
33231
285
1275
3084
31236
440
2896
2463
25344
Evaluation concerning developmental neuropsychiatry
IBZ06 [2001304080]
2.0e+00
3.4e+00
1.0e+50
1.0e+50
1.0e+50
3.4e+00
1.6e+00
cases:0.46%
controls:0.06%
cases:0.83%
controls:0.03%
cases:0.31%
controls:0.00%
cases:0.60%
controls:0.00%
cases:0.26%
controls:0.00%
cases:0.80%
controls:0.03%
cases:0.69%
controls:0.14%
16
21
3455
33216
29
9
3468
33446
11
0
3486
33455
21
0
3476
33455
9
0
3481
33403
27
9
3342
32502
20
40
2883
28200
Emergency Room Visit
ER [9203]
2.8e-01
6.2e-01
1.3e+00
5.7e+00
1.4e+00
6.1e-01
4.6e-01
cases:39.15%
controls:32.80%
cases:18.04%
controls:10.61%
cases:4.23%
controls:1.24%
cases:10.18%
controls:0.04%
cases:4.96%
controls:1.21%
cases:15.94%
controls:9.32%
cases:34.65%
controls:25.04%
1359
10901
2112
22336
631
3550
2866
29905
148
415
3349
33040
356
13
3141
33442
173
405
3317
32998
537
3031
2832
29480
1006
7070
1897
21170
Emergency Medicine
93 [38004510]
2.3e-01
6.3e-01
1.4e+00
6.0e+00
1.2e+00
5.8e-01
2.4e-01
cases:16.48%
controls:13.55%
cases:12.87%
controls:7.31%
cases:3.83%
controls:0.97%
cases:12.24%
controls:0.03%
cases:3.47%
controls:1.07%
cases:12.79%
controls:7.63%
cases:22.25%
controls:18.32%
572
4503
2899
28734
450
2444
3047
31011
134
324
3363
33131
428
11
3069
33444
121
359
3369
33044
431
2479
2938
30032
646
5173
2257
23067
quetiapine; oral
N05AH04 [21604544]
1.1e+00
1.2e+00
1.3e+00
2.7e+00
1.4e+00
1.3e+00
1.3e+00
cases:7.14%
controls:2.38%
cases:5.12%
controls:1.54%
cases:2.03%
controls:0.54%
cases:0.26%
controls:0.02%
cases:2.01%
controls:0.50%
cases:5.55%
controls:1.65%
cases:9.06%
controls:2.73%
248
792
3223
32445
179
516
3318
32939
71
182
3426
33273
9
6
3488
33449
70
168
3420
33235
187
535
3182
31976
263
772
2640
27468
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
7.0e-01
1.8e+00
1.9e+00
1.0e+50
2.8e+00
1.8e+00
1.4e+00
cases:2.51%
controls:1.25%
cases:1.54%
controls:0.26%
cases:0.23%
controls:0.04%
cases:1.94%
controls:0.00%
cases:0.60%
controls:0.04%
cases:1.31%
controls:0.22%
cases:2.51%
controls:0.66%
87
417
3384
32820
54
88
3443
33367
8
12
3489
33443
68
0
3429
33455
21
12
3469
33391
44
73
3325
32438
73
186
2830
28054
Otolaryngology
4 [38004449]
3.3e-01
4.9e-01
1.0e+00
5.2e+00
1.7e+00
9.6e-01
6.0e-01
cases:18.44%
controls:13.98%
cases:7.72%
controls:4.88%
cases:1.83%
controls:0.66%
cases:3.03%
controls:0.02%
cases:3.67%
controls:0.71%
cases:10.33%
controls:4.24%
cases:17.50%
controls:10.41%
640
4645
2831
28592
270
1634
3227
31821
64
221
3433
33234
106
6
3391
33449
128
237
3362
33166
348
1378
3021
31133
508
2941
2395
25299
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.3e+00
1.5e+00
2.3e+00
—
2.4e+00
1.5e+00
1.2e+00
cases:3.05%
controls:0.85%
cases:1.54%
controls:0.34%
cases:0.57%
controls:0.06%
—
—
cases:0.66%
controls:0.06%
cases:1.75%
controls:0.38%
cases:2.93%
controls:0.90%
106
281
3365
32956
54
115
3443
33340
20
19
3477
33436
—
23
21
3467
33382
59
123
3310
32388
85
255
2818
27985
Sequelae of cerebral infarction
I69.3 [45533476]
1.3e+00
1.6e+00
1.7e+00
—
2.5e+00
1.8e+00
1.3e+00
cases:1.58%
controls:0.42%
cases:1.23%
controls:0.26%
cases:0.34%
controls:0.06%
—
—
cases:1.06%
controls:0.09%
cases:1.96%
controls:0.34%
cases:2.41%
controls:0.69%
55
141
3416
33096
43
87
3454
33368
12
21
3485
33434
—
37
30
3453
33373
66
109
3303
32402
70
194
2833
28046
methylphenidate; oral
N06BA04 [21604757]
1.3e+00
1.5e+00
1.7e+00
—
1.9e+00
1.9e+00
1.6e+00
cases:2.91%
controls:0.78%
cases:3.00%
controls:0.68%
cases:1.52%
controls:0.27%
—
—
cases:2.21%
controls:0.32%
cases:5.40%
controls:0.81%
cases:7.96%
controls:1.71%
101
258
3370
32979
105
227
3392
33228
53
91
3444
33364
—
77
108
3413
33295
182
263
3187
32248
231
482
2672
27758
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
1.2e+00
2.1e+00
2.1e+00
—
2.5e+00
1.4e+00
7.8e-01
cases:2.05%
controls:0.64%
cases:2.29%
controls:0.30%
cases:0.17%
controls:0.02%
—
—
cases:0.49%
controls:0.04%
cases:1.04%
controls:0.27%
cases:2.17%
controls:1.00%
71
213
3400
33024
80
100
3417
33355
6
7
3491
33448
—
17
13
3473
33390
35
88
3334
32423
63
283
2840
27957
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
1.3e+00
2.4e+00
2.1e+00
—
—
2.1e+00
2.1e+00
cases:0.61%
controls:0.17%
cases:0.46%
controls:0.04%
cases:0.17%
controls:0.02%
—
—
—
—
cases:0.42%
controls:0.05%
cases:1.14%
controls:0.14%
21
55
3450
33182
16
14
3481
33441
6
7
3491
33448
—
—
14
17
3355
32494
33
40
2870
28200
Generalized anxiety disorder
F41.1 [45571764]
1.3e+00
1.7e+00
2.1e+00
—
2.2e+00
1.6e+00
1.0e+00
cases:1.56%
controls:0.42%
cases:1.32%
controls:0.24%
cases:0.77%
controls:0.10%
—
—
cases:0.92%
controls:0.10%
cases:1.72%
controls:0.35%
cases:2.24%
controls:0.84%
54
138
3417
33099
46
81
3451
33374
27
32
3470
33423
—
32
34
3458
33369
58
115
3311
32396
65
236
2838
28004
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.3e+00
2.0e+00
2.3e+00
—
1.7e+00
1.5e+00
1.2e+00
cases:5.85%
controls:1.73%
cases:5.55%
controls:0.82%
cases:1.92%
controls:0.20%
—
—
cases:1.06%
controls:0.19%
cases:3.27%
controls:0.75%
cases:7.51%
controls:2.49%
203
575
3268
32662
194
273
3303
33182
67
67
3430
33388
—
37
65
3453
33338
110
245
3259
32266
218
703
2685
27537
Hospital outpatient
ZY010 [2001311599]
9.6e-01
1.5e+00
1.9e+00
—
2.0e+00
1.8e+00
1.7e+00
cases:2.97%
controls:1.16%
cases:1.97%
controls:0.47%
cases:0.92%
controls:0.13%
—
—
cases:1.03%
controls:0.15%
cases:2.23%
controls:0.38%
cases:3.31%
controls:0.60%
103
386
3368
32851
69
157
3428
33298
32
45
3465
33410
—
36
49
3454
33354
75
125
3294
32386
96
169
2807
28071
Physiotherapist
Z3226 [2001311560]
7.8e-01
1.2e+00
2.1e+00
—
2.2e+00
2.0e+00
1.6e+00
cases:6.77%
controls:3.21%
cases:2.69%
controls:0.86%
cases:0.94%
controls:0.12%
—
—
cases:1.06%
controls:0.12%
cases:3.80%
controls:0.55%
cases:5.27%
controls:1.07%
235
1066
3236
32171
94
288
3403
33167
33
40
3464
33415
—
37
41
3453
33362
128
178
3241
32333
153
301
2750
27939
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
8.6e-01
1.5e+00
2.0e+00
—
2.7e+00
1.7e+00
8.5e-01
cases:1.79%
controls:0.76%
cases:1.32%
controls:0.29%
cases:0.54%
controls:0.07%
—
—
cases:0.52%
controls:0.04%
cases:1.54%
controls:0.29%
cases:1.93%
controls:0.83%
62
254
3409
32983
46
96
3451
33359
19
24
3478
33431
—
18
12
3472
33391
52
95
3317
32416
56
235
2847
28005
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.4e+00
2.1e+00
1.8e+00
—
2.2e+00
1.2e+00
1.0e+00
cases:2.10%
controls:0.55%
cases:2.06%
controls:0.26%
cases:0.20%
controls:0.03%
—
—
cases:0.37%
controls:0.04%
cases:1.01%
controls:0.32%
cases:2.51%
controls:0.93%
73
183
3398
33054
72
88
3425
33367
7
11
3490
33444
—
13
14
3477
33389
34
103
3335
32408
73
263
2830
27977
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
1.2e+00
1.7e+00
2.0e+00
1.0e+50
2.7e+00
2.2e+00
1.8e+00
cases:0.49%
controls:0.15%
cases:0.29%
controls:0.05%
cases:0.17%
controls:0.02%
cases:0.20%
controls:0.00%
cases:0.23%
controls:0.01%
cases:0.53%
controls:0.06%
cases:0.69%
controls:0.12%
17
50
3454
33187
10
17
3487
33438
6
8
3491
33447
7
0
3490
33455
8
5
3482
33398
18
20
3351
32491
20
34
2883
28206
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
1.5e+00
1.9e+00
—
1.0e+50
2.4e+00
1.7e+00
2.0e+00
cases:0.35%
controls:0.08%
cases:0.23%
controls:0.04%
—
—
cases:0.17%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.24%
controls:0.04%
cases:0.52%
controls:0.07%
12
27
3459
33210
8
12
3489
33443
—
6
0
3491
33455
6
5
3484
33398
8
14
3361
32497
15
19
2888
28221
Clinic/Center
261Q00000X [38004207]
1.0e+00
1.3e+00
2.2e+00
—
2.1e+00
1.5e+00
1.3e+00
cases:1.58%
controls:0.57%
cases:0.60%
controls:0.16%
cases:0.34%
controls:0.04%
—
—
cases:0.29%
controls:0.04%
cases:0.50%
controls:0.11%
cases:0.69%
controls:0.19%
55
190
3416
33047
21
54
3476
33401
12
13
3485
33442
—
10
12
3480
33391
17
36
3352
32475
20
53
2883
28187
Depressive conduct disorder
F92.0 [45581477]
2.1e+00
2.3e+00
—
1.0e+50
—
2.5e+00
2.3e+00
cases:0.23%
controls:0.03%
cases:0.17%
controls:0.02%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.27%
controls:0.02%
cases:0.48%
controls:0.05%
8
9
3463
33228
6
6
3491
33449
—
10
0
3487
33455
—
9
7
3360
32504
14
14
2889
28226
INR in Blood by Coagulation assay
34714-6 [3032080]
4.3e-01
6.6e-01
9.0e-01
4.7e+00
1.3e+00
7.4e-01
4.7e-01
cases:12.45%
controls:8.44%
cases:8.04%
controls:4.32%
cases:3.20%
controls:1.33%
cases:8.69%
controls:0.08%
cases:4.41%
controls:1.29%
cases:7.78%
controls:3.85%
cases:10.82%
controls:7.06%
432
2805
3039
30432
281
1445
3216
32010
112
446
3385
33009
304
28
3193
33427
154
431
3336
32972
262
1252
3107
31259
314
1993
2589
26247
Specific learning problem
P24 [2002000819]
1.8e+00
2.2e+00
2.1e+00
—
2.2e+00
8.8e-01
1.0e+00
cases:1.70%
controls:0.30%
cases:1.49%
controls:0.17%
cases:0.34%
controls:0.04%
—
—
cases:0.26%
controls:0.03%
cases:0.42%
controls:0.17%
cases:1.55%
controls:0.58%
59
99
3412
33138
52
57
3445
33398
12
14
3485
33441
—
9
10
3481
33393
14
56
3355
32455
45
163
2858
28077
Functional capacity evaluation
443351003 [40481051]
7.0e-01
1.0e+00
1.4e+00
2.6e+00
1.8e+00
1.0e+00
5.9e-01
cases:4.06%
controls:2.06%
cases:2.26%
controls:0.82%
cases:0.66%
controls:0.16%
cases:0.46%
controls:0.03%
cases:0.97%
controls:0.17%
cases:2.17%
controls:0.81%
cases:3.07%
controls:1.72%
141
686
3330
32551
79
273
3418
33182
23
53
3474
33402
16
11
3481
33444
34
57
3456
33346
73
263
3296
32248
89
485
2814
27755
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
1.5e+00
1.9e+00
1.7e+00
—
2.3e+00
1.7e+00
1.7e+00
cases:0.58%
controls:0.13%
cases:0.46%
controls:0.07%
cases:0.17%
controls:0.03%
—
—
cases:0.23%
controls:0.02%
cases:0.39%
controls:0.07%
cases:0.72%
controls:0.13%
20
44
3451
33193
16
22
3481
33433
6
10
3491
33445
—
8
8
3482
33395
13
23
3356
32488
21
38
2882
28202
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.2e+00
1.4e+00
1.8e+00
—
2.0e+00
1.4e+00
1.3e+00
cases:1.84%
controls:0.58%
cases:1.46%
controls:0.37%
cases:0.31%
controls:0.05%
—
—
cases:0.32%
controls:0.04%
cases:1.66%
controls:0.40%
cases:2.93%
controls:0.84%
64
194
3407
33043
51
124
3446
33331
11
17
3486
33438
—
11
15
3479
33388
56
130
3313
32381
85
238
2818
28002
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.9e-01
6.9e-01
1.0e+00
4.0e+00
1.7e+00
5.9e-01
4.2e-01
cases:3.28%
controls:1.84%
cases:1.83%
controls:0.93%
cases:0.43%
controls:0.15%
cases:0.80%
controls:0.01%
cases:0.74%
controls:0.14%
cases:1.48%
controls:0.83%
cases:3.82%
controls:2.55%
114
612
3357
32625
64
310
3433
33145
15
51
3482
33404
28
5
3469
33450
26
47
3464
33356
50
269
3319
32242
111
721
2792
27519
Audiology
64 [38004489]
5.0e-01
7.4e-01
1.3e+00
—
2.9e+00
1.9e+00
1.4e+00
cases:4.44%
controls:2.75%
cases:2.69%
controls:1.30%
cases:0.89%
controls:0.23%
—
—
cases:3.98%
controls:0.22%
cases:8.04%
controls:1.24%
cases:9.47%
controls:2.62%
154
913
3317
32324
94
436
3403
33019
31
78
3466
33377
—
139
74
3351
33329
271
404
3098
32107
275
739
2628
27501
Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19568-5 [3002148]
1.8e+00
3.5e+00
—
—
—
1.9e+00
1.5e+00
cases:0.49%
controls:0.08%
cases:1.00%
controls:0.03%
—
—
—
—
—
—
cases:0.30%
controls:0.04%
cases:0.90%
controls:0.21%
17
26
3454
33211
35
10
3462
33445
—
—
—
10
14
3359
32497
26
59
2877
28181
Atrial fibrillation and flutter
I48 [45596206]
3.0e-01
5.0e-01
8.8e-01
4.4e+00
1.6e+00
6.4e-01
4.6e-01
cases:4.38%
controls:3.29%
cases:2.75%
controls:1.68%
cases:0.83%
controls:0.35%
cases:1.14%
controls:0.01%
cases:1.38%
controls:0.28%
cases:2.73%
controls:1.46%
cases:3.79%
controls:2.42%
152
1092
3319
32145
96
563
3401
32892
29
116
3468
33339
40
5
3457
33450
48
95
3442
33308
92
476
3277
32035
110
684
2793
27556
Severe psychotic and other severe mental disorders
112 [2001600112]
1.5e+00
2.4e+00
—
—
—
2.8e+00
2.0e+00
cases:1.56%
controls:0.34%
cases:0.63%
controls:0.06%
—
—
—
—
—
—
cases:0.62%
controls:0.04%
cases:1.89%
controls:0.25%
54
114
3417
33123
22
19
3475
33436
—
—
—
21
13
3348
32498
55
72
2848
28168
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
3.5e-01
4.1e-01
1.1e+00
4.5e+00
1.3e+00
5.1e-01
4.9e-01
cases:5.21%
controls:3.75%
cases:2.95%
controls:1.98%
cases:0.89%
controls:0.28%
cases:1.29%
controls:0.01%
cases:1.00%
controls:0.27%
cases:2.49%
controls:1.51%
cases:5.10%
controls:3.18%
181
1245
3290
31992
103
661
3394
32794
31
95
3466
33360
45
5
3452
33450
35
90
3455
33313
84
491
3285
32020
148
899
2755
27341
Poisoning by systemic antibiotics
T36 [45756588]
1.3e+00
1.5e+00
2.4e+00
—
—
2.0e+00
1.5e+00
cases:1.27%
controls:0.35%
cases:0.40%
controls:0.09%
cases:0.17%
controls:0.01%
—
—
—
—
cases:0.56%
controls:0.08%
cases:1.34%
controls:0.30%
44
117
3427
33120
14
31
3483
33424
6
5
3491
33450
—
—
19
25
3350
32486
39
86
2864
28154
Epilepsy and comparable convulsive disorders
111 [2001600111]
7.6e-01
9.2e-01
-1.0e+50
—
3.7e+00
1.9e+00
1.4e+00
cases:1.96%
controls:0.92%
cases:0.63%
controls:0.25%
cases:0.00%
controls:0.02%
—
—
cases:0.69%
controls:0.02%
cases:0.83%
controls:0.12%
cases:1.48%
controls:0.36%
68
307
3403
32930
22
84
3475
33371
0
6
3497
33449
—
24
6
3466
33397
28
39
3341
32472
43
103
2860
28137
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
1.1e+00
2.0e+00
—
—
2.6e+00
1.8e+00
1.3e+00
cases:0.86%
controls:0.30%
cases:0.92%
controls:0.13%
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.86%
controls:0.15%
cases:1.96%
controls:0.57%
30
100
3441
33137
32
43
3465
33412
—
—
10
7
3480
33396
29
48
3340
32463
57
161
2846
28079
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.0e+00
1.4e+00
2.3e+00
1.0e+50
2.5e+00
1.5e+00
6.4e-01
cases:0.78%
controls:0.29%
cases:0.83%
controls:0.20%
cases:0.29%
controls:0.03%
cases:0.49%
controls:0.00%
cases:0.29%
controls:0.02%
cases:0.65%
controls:0.15%
cases:0.83%
controls:0.44%
27
96
3444
33141
29
66
3468
33389
10
10
3487
33445
17
0
3480
33455
10
8
3480
33395
22
50
3347
32461
24
123
2879
28117
Other psychiatric treatment contact
IGY99 [2001304323]
9.7e-01
1.4e+00
1.7e+00
—
1.5e+00
1.6e+00
1.4e+00
cases:1.38%
controls:0.53%
cases:1.03%
controls:0.26%
cases:0.31%
controls:0.06%
—
—
cases:0.29%
controls:0.06%
cases:1.54%
controls:0.30%
cases:2.79%
controls:0.68%
48
175
3423
33062
36
86
3461
33369
11
20
3486
33435
—
10
21
3480
33382
52
99
3317
32412
81
193
2822
28047
olanzapine; oral, parenteral
N05AH03 [21604543]
1.3e+00
1.4e+00
1.4e+00
—
1.1e+00
1.6e+00
1.7e+00
cases:2.45%
controls:0.69%
cases:2.06%
controls:0.51%
cases:0.83%
controls:0.20%
—
—
cases:0.60%
controls:0.20%
cases:2.61%
controls:0.52%
cases:3.75%
controls:0.73%
85
230
3386
33007
72
170
3425
33285
29
67
3468
33388
—
21
67
3469
33336
88
168
3281
32343
109
207
2794
28033
Observation for suspected nervous system disorder
Z03.3 [45609903]
2.3e-01
1.4e+00
2.6e+00
—
2.3e+00
1.5e+00
6.4e-01
cases:1.24%
controls:0.99%
cases:1.17%
controls:0.28%
cases:0.43%
controls:0.03%
—
—
cases:0.34%
controls:0.03%
cases:1.01%
controls:0.22%
cases:1.31%
controls:0.70%
43
328
3428
32909
41
95
3456
33360
15
11
3482
33444
—
12
11
3478
33392
34
71
3335
32440
38
197
2865
28043
Migraine with aura [classical migraine]
G43.1 [45562086]
9.0e-01
1.3e+00
1.4e+00
—
2.6e+00
1.5e+00
8.5e-01
cases:2.05%
controls:0.85%
cases:1.34%
controls:0.38%
cases:0.31%
controls:0.08%
—
—
cases:0.69%
controls:0.05%
cases:1.66%
controls:0.38%
cases:2.58%
controls:1.12%
71
281
3400
32956
47
126
3450
33329
11
27
3486
33428
—
24
17
3466
33386
56
123
3313
32388
75
316
2828
27924
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.3e+00
1.4e+00
1.3e+00
—
1.5e+00
1.4e+00
1.5e+00
cases:1.84%
controls:0.50%
cases:1.40%
controls:0.34%
cases:0.51%
controls:0.13%
—
—
cases:0.52%
controls:0.11%
cases:1.37%
controls:0.35%
cases:2.62%
controls:0.61%
64
165
3407
33072
49
114
3448
33341
18
45
3479
33410
—
18
38
3472
33365
46
113
3323
32398
76
172
2827
28068
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
3.4e-01
4.0e-01
1.0e+00
4.5e+00
1.2e+00
5.0e-01
4.9e-01
cases:5.53%
controls:3.99%
cases:3.20%
controls:2.17%
cases:0.92%
controls:0.33%
cases:1.32%
controls:0.01%
cases:1.03%
controls:0.31%
cases:2.82%
controls:1.73%
cases:5.61%
controls:3.52%
192
1327
3279
31910
112
727
3385
32728
32
112
3465
33343
46
5
3451
33450
36
104
3454
33299
95
561
3274
31950
163
993
2740
27247
Epilepsy, unspecified
G40.9 [45562083]
1.0e+00
1.2e+00
1.7e+00
—
1.7e+00
1.4e+00
1.3e+00
cases:1.61%
controls:0.59%
cases:0.92%
controls:0.27%
cases:0.29%
controls:0.05%
—
—
cases:0.37%
controls:0.07%
cases:1.22%
controls:0.29%
cases:2.03%
controls:0.55%
56
196
3415
33041
32
89
3465
33366
10
18
3487
33437
—
13
22
3477
33381
41
95
3328
32416
59
156
2844
28084
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
3.7e-01
7.2e-01
8.9e-01
3.6e+00
2.1e+00
5.0e-01
2.7e-01
cases:16.28%
controls:11.89%
cases:10.35%
controls:5.34%
cases:1.74%
controls:0.73%
cases:0.97%
controls:0.03%
cases:5.79%
controls:0.76%
cases:8.34%
controls:5.21%
cases:16.22%
controls:12.84%
565
3951
2906
29286
362
1788
3135
31667
61
243
3436
33212
34
9
3463
33446
202
255
3288
33148
281
1694
3088
30817
471
3627
2432
24613
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.4e-01
6.8e-01
9.6e-01
3.7e+00
1.4e+00
6.9e-01
4.6e-01
cases:17.20%
controls:11.80%
cases:11.44%
controls:6.16%
cases:2.55%
controls:0.99%
cases:2.12%
controls:0.05%
cases:4.18%
controls:1.03%
cases:10.06%
controls:5.30%
cases:15.91%
controls:10.68%
597
3922
2874
29315
400
2062
3097
31393
89
332
3408
33123
74
18
3423
33437
146
345
3344
33058
339
1723
3030
30788
462
3015
2441
25225
Carotid artery syndrome (hemispheric)
G45.1 [45576586]
1.6e+00
2.1e+00
—
1.0e+50
—
2.8e+00
1.8e+00
cases:0.89%
controls:0.18%
cases:0.46%
controls:0.05%
—
—
cases:1.14%
controls:0.00%
—
—
cases:0.71%
controls:0.04%
cases:0.72%
controls:0.12%
31
61
3440
33176
16
18
3481
33437
—
40
0
3457
33455
—
24
14
3345
32497
21
34
2882
28206
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.9e-01
1.1e+00
2.0e+00
—
3.0e+00
1.0e+00
6.1e-01
cases:8.21%
controls:4.71%
cases:5.40%
controls:1.83%
cases:1.83%
controls:0.26%
—
—
cases:5.04%
controls:0.27%
cases:4.57%
controls:1.69%
cases:7.99%
controls:4.50%
285
1564
3186
31673
189
612
3308
32843
64
87
3433
33368
—
176
90
3314
33313
154
549
3215
31962
232
1271
2671
26969
Internal Medicine
11 [38004456]
2.9e-01
5.3e-01
9.5e-01
4.9e+00
1.1e+00
4.3e-01
1.8e-01
cases:15.01%
controls:11.66%
cases:7.81%
controls:4.73%
cases:2.14%
controls:0.84%
cases:4.35%
controls:0.03%
cases:2.41%
controls:0.78%
cases:7.21%
controls:4.83%
cases:14.23%
controls:12.16%
521
3877
2950
29360
273
1582
3224
31873
75
281
3422
33174
152
11
3345
33444
84
261
3406
33142
243
1570
3126
30941
413
3434
2490
24806
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
6.5e-01
1.2e+00
2.5e+00
1.0e+50
2.7e+00
1.2e+00
7.0e-01
cases:0.89%
controls:0.47%
cases:0.71%
controls:0.22%
cases:0.29%
controls:0.02%
cases:0.29%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.59%
controls:0.18%
cases:1.03%
controls:0.52%
31
156
3440
33081
25
72
3472
33383
10
8
3487
33447
10
0
3487
33455
12
8
3478
33395
20
58
3349
32453
30
146
2873
28094
Essential (primary) hypertension
I10 [45591453]
2.5e-01
4.7e-01
1.0e+00
4.5e+00
1.4e+00
5.6e-01
1.7e-01
cases:11.73%
controls:9.38%
cases:7.41%
controls:4.75%
cases:2.40%
controls:0.86%
cases:4.66%
controls:0.05%
cases:3.41%
controls:0.89%
cases:8.40%
controls:4.97%
cases:10.75%
controls:9.19%
407
3117
3064
30120
259
1589
3238
31866
84
289
3413
33166
163
18
3334
33437
119
297
3371
33106
283
1616
3086
30895
312
2594
2591
25646
bupropion; oral
N06AX12 [21604741]
1.2e+00
1.5e+00
1.6e+00
—
1.5e+00
1.3e+00
1.2e+00
cases:1.96%
controls:0.63%
cases:1.57%
controls:0.36%
cases:0.40%
controls:0.08%
—
—
cases:0.49%
controls:0.11%
cases:1.45%
controls:0.38%
cases:2.69%
controls:0.84%
68
208
3403
33029
55
120
3442
33335
14
28
3483
33427
—
17
38
3473
33365
49
124
3320
32387
78
238
2825
28002
Dysphasia and aphasia
R47.0 [45592421]
2.3e+00
3.5e+00
1.0e+50
1.0e+50
1.0e+50
—
2.3e+00
cases:0.35%
controls:0.03%
cases:0.49%
controls:0.01%
cases:0.26%
controls:0.00%
cases:0.29%
controls:0.00%
cases:0.17%
controls:0.00%
—
—
cases:0.45%
controls:0.05%
12
11
3459
33226
17
5
3480
33450
9
0
3488
33455
10
0
3487
33455
6
0
3484
33403
—
13
13
2890
28227
venlafaxine; oral
N06AX16 [21604745]
1.2e+00
1.2e+00
1.4e+00
—
1.6e+00
1.3e+00
1.3e+00
cases:4.29%
controls:1.32%
cases:2.69%
controls:0.79%
cases:0.94%
controls:0.24%
—
—
cases:1.20%
controls:0.24%
cases:3.00%
controls:0.81%
cases:5.13%
controls:1.46%
149
438
3322
32799
94
264
3403
33191
33
80
3464
33375
—
42
80
3448
33323
101
262
3268
32249
149
411
2754
27829
oxcarbazepine; oral
N03AF02 [21604418]
1.1e+00
1.2e+00
1.2e+00
—
1.8e+00
1.5e+00
1.3e+00
cases:2.10%
controls:0.71%
cases:1.60%
controls:0.50%
cases:0.46%
controls:0.13%
—
—
cases:0.80%
controls:0.13%
cases:1.96%
controls:0.46%
cases:2.38%
controls:0.66%
73
235
3398
33002
56
166
3441
33289
16
44
3481
33411
—
28
45
3462
33358
66
151
3303
32360
69
185
2834
28055
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.3e+00
1.4e+00
2.0e+00
—
1.5e+00
1.1e+00
7.8e-01
cases:2.94%
controls:0.82%
cases:1.86%
controls:0.45%
cases:0.66%
controls:0.09%
—
—
cases:0.46%
controls:0.10%
cases:1.48%
controls:0.49%
cases:3.13%
controls:1.46%
102
271
3369
32966
65
151
3432
33304
23
31
3474
33424
—
16
35
3474
33368
50
158
3319
32353
91
412
2812
27828
Outpatient Visit
OP [9202]
1.2e-01
2.7e-01
6.3e-01
4.8e+00
1.3e+00
7.0e-01
4.1e-01
cases:71.28%
controls:68.83%
cases:59.02%
controls:52.31%
cases:21.02%
controls:12.37%
cases:43.92%
controls:0.65%
cases:33.01%
controls:12.03%
cases:67.56%
controls:50.88%
cases:79.64%
controls:72.22%
2474
22878
997
10359
2064
17500
1433
15955
735
4139
2762
29316
1536
216
1961
33239
1152
4020
2338
29383
2276
16543
1093
15968
2312
20396
591
7844
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
3.0e+00
—
—
1.0e+50
1.0e+50
—
5.0e+00
cases:0.43%
controls:0.02%
—
—
—
—
cases:9.69%
controls:0.00%
cases:3.38%
controls:0.00%
—
—
cases:3.72%
controls:0.02%
15
7
3456
33230
—
—
339
0
3158
33455
118
0
3372
33403
—
108
7
2795
28233
buspirone; oral
N05BE01 [21604601]
1.8e+00
2.4e+00
—
—
—
2.4e+00
1.6e+00
cases:0.49%
controls:0.08%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.41%
controls:0.08%
17
28
3454
33209
11
10
3486
33445
—
—
—
13
12
3356
32499
12
24
2891
28216
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
9.8e-01
1.4e+00
1.5e+00
—
1.5e+00
1.6e+00
1.1e+00
cases:1.24%
controls:0.47%
cases:1.26%
controls:0.33%
cases:0.51%
controls:0.11%
—
—
cases:0.63%
controls:0.14%
cases:1.78%
controls:0.36%
cases:2.55%
controls:0.86%
43
156
3428
33081
44
110
3453
33345
18
38
3479
33417
—
22
48
3468
33355
60
117
3309
32394
74
242
2829
27998
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.0e-01
4.4e-01
9.3e-01
4.3e+00
1.5e+00
4.2e-01
2.5e-01
cases:32.58%
controls:28.28%
cases:27.39%
controls:19.55%
cases:8.98%
controls:3.73%
cases:15.53%
controls:0.26%
cases:14.87%
controls:3.60%
cases:25.79%
controls:18.61%
cases:34.21%
controls:28.80%
1131
9401
2340
23836
958
6542
2539
26913
314
1248
3183
32207
543
87
2954
33368
519
1203
2971
32200
869
6049
2500
26462
993
8133
1910
20107
Anxiety disorder, unspecified
F41.9 [45542849]
1.3e+00
1.3e+00
1.5e+00
—
1.6e+00
1.3e+00
1.0e+00
cases:3.54%
controls:1.00%
cases:2.29%
controls:0.61%
cases:0.80%
controls:0.18%
—
—
cases:0.83%
controls:0.18%
cases:2.34%
controls:0.66%
cases:4.75%
controls:1.75%
123
333
3348
32904
80
205
3417
33250
28
59
3469
33396
—
29
59
3461
33344
79
213
3290
32298
138
493
2765
27747
Child behaviour symptom/complaint
P22 [2002000817]
1.2e+00
1.6e+00
2.3e+00
—
1.9e+00
1.0e+00
4.9e-01
cases:2.13%
controls:0.67%
cases:1.89%
controls:0.39%
cases:0.60%
controls:0.06%
—
—
cases:0.43%
controls:0.06%
cases:1.04%
controls:0.37%
cases:1.24%
controls:0.76%
74
224
3397
33013
66
129
3431
33326
21
21
3476
33434
—
15
21
3475
33382
35
119
3334
32392
36
215
2867
28025
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.5e-01
3.8e-01
9.7e-01
4.4e+00
1.5e+00
4.2e-01
1.8e-01
cases:31.60%
controls:28.41%
cases:23.08%
controls:17.03%
cases:8.06%
controls:3.23%
cases:15.30%
controls:0.22%
cases:13.30%
controls:3.30%
cases:22.29%
controls:15.87%
cases:32.83%
controls:28.92%
1097
9441
2374
23796
807
5696
2690
27759
282
1079
3215
32376
535
74
2962
33381
464
1102
3026
32301
751
5158
2618
27353
953
8166
1950
20074
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.9e-01
6.7e-01
9.7e-01
3.5e+00
1.4e+00
6.9e-01
4.7e-01
cases:15.53%
controls:11.08%
cases:10.49%
controls:5.67%
cases:2.32%
controls:0.89%
cases:1.49%
controls:0.05%
cases:3.52%
controls:0.93%
cases:9.14%
controls:4.80%
cases:14.40%
controls:9.53%
539
3682
2932
29555
367
1896
3130
31559
81
298
3416
33157
52
16
3445
33439
123
309
3367
33094
308
1560
3061
30951
418
2690
2485
25550
Inpatient Hospital
21 [8717]
1.1e-01
2.7e-01
6.4e-01
4.7e+00
1.4e+00
6.4e-01
3.2e-01
cases:34.49%
controls:31.95%
cases:12.55%
controls:9.89%
cases:2.63%
controls:1.40%
cases:7.32%
controls:0.07%
cases:5.19%
controls:1.34%
cases:14.43%
controls:8.18%
cases:25.77%
controls:20.21%
1197
10620
2274
22617
439
3308
3058
30147
92
470
3405
32985
256
23
3241
33432
181
449
3309
32954
486
2659
2883
29852
748
5706
2155
22534
levetiracetam; oral, parenteral
N03AX14 [21604436]
1.1e+00
1.2e+00
1.4e+00
—
1.6e+00
1.4e+00
1.3e+00
cases:1.35%
controls:0.45%
cases:1.32%
controls:0.42%
cases:0.57%
controls:0.14%
—
—
cases:0.95%
controls:0.19%
cases:1.81%
controls:0.45%
cases:1.79%
controls:0.49%
47
150
3424
33087
46
140
3451
33315
20
47
3477
33408
—
33
65
3457
33338
61
145
3308
32366
52
138
2851
28102
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.0e-01
4.3e-01
9.4e-01
4.2e+00
1.5e+00
4.1e-01
2.4e-01
cases:32.67%
controls:28.38%
cases:27.48%
controls:19.73%
cases:9.01%
controls:3.74%
cases:15.07%
controls:0.25%
cases:14.73%
controls:3.65%
cases:25.65%
controls:18.63%
cases:34.14%
controls:28.89%
1134
9432
2337
23805
961
6602
2536
26853
315
1250
3182
32205
527
85
2970
33370
514
1219
2976
32184
864
6058
2505
26453
991
8159
1912
20081
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
4.3e-01
6.7e-01
1.0e+00
3.0e+00
1.5e+00
8.0e-01
5.9e-01
cases:4.84%
controls:3.20%
cases:3.09%
controls:1.60%
cases:0.89%
controls:0.33%
cases:0.34%
controls:0.02%
cases:1.46%
controls:0.32%
cases:2.88%
controls:1.31%
cases:5.03%
controls:2.84%
168
1065
3303
32172
108
535
3389
32920
31
109
3466
33346
12
6
3485
33449
51
108
3439
33295
97
426
3272
32085
146
803
2757
27437
Psychiatric monitoring contact
IGY02 [2001304322]
9.0e-01
1.3e+00
1.2e+00
—
1.6e+00
1.6e+00
1.3e+00
cases:1.44%
controls:0.59%
cases:1.37%
controls:0.36%
cases:0.34%
controls:0.10%
—
—
cases:0.43%
controls:0.09%
cases:1.99%
controls:0.41%
cases:3.07%
controls:0.88%
50
196
3421
33041
48
122
3449
33333
12
33
3485
33422
—
15
29
3475
33374
67
132
3302
32379
89
248
2814
27992
Mixed specific developmental disorders
F83 [45595922]
7.1e-01
1.2e+00
1.6e+00
—
1.4e+00
1.3e+00
1.6e+00
cases:2.68%
controls:1.34%
cases:2.12%
controls:0.62%
cases:0.54%
controls:0.11%
—
—
cases:0.49%
controls:0.12%
cases:2.37%
controls:0.63%
cases:4.41%
controls:0.91%
93
446
3378
32791
74
209
3423
33246
19
37
3478
33418
—
17
39
3473
33364
80
204
3289
32307
128
256
2775
27984
Bacteria [Presence] in Urine
87829-8 [36304419]
2.8e-01
4.8e-01
8.2e-01
3.9e+00
1.1e+00
7.0e-01
5.5e-01
cases:8.24%
controls:6.36%
cases:5.12%
controls:3.23%
cases:1.12%
controls:0.50%
cases:0.89%
controls:0.02%
cases:1.69%
controls:0.55%
cases:5.34%
controls:2.73%
cases:9.78%
controls:5.87%
286
2114
3185
31123
179
1082
3318
32373
39
166
3458
33289
31
6
3466
33449
59
185
3431
33218
180
887
3189
31624
284
1659
2619
26581
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
2.3e-01
4.2e-01
6.9e-01
4.3e+00
1.2e+00
6.5e-01
3.3e-01
cases:10.75%
controls:8.72%
cases:5.23%
controls:3.50%
cases:0.94%
controls:0.48%
cases:1.29%
controls:0.02%
cases:1.40%
controls:0.41%
cases:5.14%
controls:2.75%
cases:9.40%
controls:6.98%
373
2898
3098
30339
183
1172
3314
32283
33
159
3464
33296
45
6
3452
33449
49
136
3441
33267
173
894
3196
31617
273
1970
2630
26270
pH of Urine
2756-5 [3015736]
2.9e-01
6.8e-01
1.0e+00
3.9e+00
1.1e+00
5.5e-01
2.6e-01
cases:9.48%
controls:7.28%
cases:7.01%
controls:3.69%
cases:1.52%
controls:0.56%
cases:0.92%
controls:0.02%
cases:1.66%
controls:0.55%
cases:6.32%
controls:3.76%
cases:12.57%
controls:9.95%
329
2420
3142
30817
245
1235
3252
32220
53
186
3444
33269
32
6
3465
33449
58
185
3432
33218
213
1221
3156
31290
365
2810
2538
25430
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
1.6e+00
2.4e+00
—
1.0e+50
—
1.8e+00
2.0e+00
cases:0.37%
controls:0.08%
cases:0.37%
controls:0.03%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.27%
controls:0.04%
cases:0.48%
controls:0.07%
13
25
3458
33212
13
11
3484
33444
—
5
0
3492
33455
—
9
14
3360
32497
14
19
2889
28221
Other reactions to severe stress
F43.8 [45552483]
6.9e-01
1.6e+00
2.1e+00
1.0e+50
2.5e+00
1.6e+00
7.3e-01
cases:0.32%
controls:0.16%
cases:0.46%
controls:0.09%
cases:0.17%
controls:0.02%
cases:0.26%
controls:0.00%
cases:0.26%
controls:0.02%
cases:0.39%
controls:0.08%
cases:0.62%
controls:0.30%
11
53
3460
33184
16
31
3481
33424
6
7
3491
33448
9
0
3488
33455
9
7
3481
33396
13
25
3356
32486
18
85
2885
28155
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
2.9e-01
4.8e-01
7.3e-01
4.0e+00
1.1e+00
6.8e-01
5.8e-01
cases:8.47%
controls:6.46%
cases:5.29%
controls:3.35%
cases:1.09%
controls:0.53%
cases:0.97%
controls:0.02%
cases:1.72%
controls:0.60%
cases:5.55%
controls:2.89%
cases:10.37%
controls:6.07%
294
2148
3177
31089
185
1121
3312
32334
38
176
3459
33279
34
6
3463
33449
60
200
3430
33203
187
941
3182
31570
301
1715
2602
26525
Pervasive developmental disorder, unspecified
F84.9 [45600763]
1.0e-01
7.6e-01
2.5e+00
—
2.1e+00
1.6e+00
1.5e+00
cases:0.32%
controls:0.29%
cases:0.34%
controls:0.16%
cases:0.23%
controls:0.02%
—
—
cases:0.23%
controls:0.03%
cases:0.56%
controls:0.11%
cases:1.10%
controls:0.26%
11
95
3460
33142
12
54
3485
33401
8
6
3489
33449
—
8
9
3482
33394
19
36
3350
32475
32
73
2871
28167
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
331 [2001600292]
1.3e+00
2.6e+00
—
—
—
2.2e+00
1.7e+00
cases:0.52%
controls:0.14%
cases:0.46%
controls:0.04%
—
—
—
—
—
—
cases:0.65%
controls:0.07%
cases:1.65%
controls:0.31%
18
45
3453
33192
16
12
3481
33443
—
—
—
22
24
3347
32487
48
88
2855
28152
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
9.0e-01
1.5e+00
-1.0e+50
—
2.1e+00
1.9e+00
1.3e+00
cases:0.63%
controls:0.26%
cases:0.54%
controls:0.13%
cases:0.00%
controls:0.02%
—
—
cases:0.23%
controls:0.03%
cases:0.80%
controls:0.12%
cases:1.58%
controls:0.42%
22
86
3449
33151
19
42
3478
33413
0
8
3497
33447
—
8
9
3482
33394
27
39
3342
32472
46
118
2857
28122
Other specified anxiety disorders
F41.8 [45595908]
9.0e-01
1.5e+00
2.4e+00
1.0e+50
—
2.0e+00
9.1e-01
cases:0.52%
controls:0.21%
cases:0.40%
controls:0.09%
cases:0.17%
controls:0.01%
cases:0.26%
controls:0.00%
—
—
cases:0.56%
controls:0.08%
cases:0.86%
controls:0.35%
18
70
3453
33167
14
31
3483
33424
6
5
3491
33450
9
0
3488
33455
—
19
25
3350
32486
25
98
2878
28142
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
7.1e-01
1.1e+00
1.1e+00
—
1.5e+00
1.5e+00
1.8e+00
cases:3.60%
controls:1.81%
cases:1.77%
controls:0.61%
cases:0.43%
controls:0.14%
—
—
cases:0.46%
controls:0.10%
cases:1.81%
controls:0.40%
cases:2.72%
controls:0.47%
125
600
3346
32637
62
203
3435
33252
15
47
3482
33408
—
16
35
3474
33368
61
131
3308
32380
79
134
2824
28106
Neurosurgery
14 [38004459]
8.9e-01
8.9e-01
1.5e+00
—
2.2e+00
1.4e+00
7.1e-01
cases:3.69%
controls:1.55%
cases:1.66%
controls:0.68%
cases:0.49%
controls:0.10%
—
—
cases:1.03%
controls:0.12%
cases:2.20%
controls:0.55%
cases:2.58%
controls:1.29%
128
515
3343
32722
58
229
3439
33226
17
35
3480
33420
—
36
39
3454
33364
74
178
3295
32333
75
364
2828
27876
Medical assessment of need and possibilities to rehabilitation
R1210 [2001310174]
1.4e+00
1.9e+00
—
1.0e+50
—
2.3e+00
1.9e+00
cases:0.46%
controls:0.11%
cases:0.29%
controls:0.04%
—
—
cases:0.49%
controls:0.00%
—
—
cases:0.50%
controls:0.05%
cases:0.69%
controls:0.10%
16
38
3455
33199
10
14
3487
33441
—
17
0
3480
33455
—
17
16
3352
32495
20
28
2883
28212
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.9e-01
4.3e-01
7.5e-01
3.9e+00
1.0e+00
6.2e-01
5.3e-01
cases:9.36%
controls:7.14%
cases:5.60%
controls:3.71%
cases:1.23%
controls:0.59%
cases:1.06%
controls:0.02%
cases:1.81%
controls:0.66%
cases:5.88%
controls:3.25%
cases:11.23%
controls:6.94%
325
2374
3146
30863
196
1240
3301
32215
43
196
3454
33259
37
7
3460
33448
63
220
3427
33183
198
1055
3171
31456
326
1959
2577
26281
Medical doctor
Z2221 [2001311556]
8.2e-01
1.1e+00
1.3e+00
—
1.5e+00
1.5e+00
1.4e+00
cases:8.82%
controls:4.10%
cases:3.06%
controls:1.08%
cases:0.66%
controls:0.18%
—
—
cases:0.60%
controls:0.13%
cases:3.68%
controls:0.86%
cases:6.68%
controls:1.74%
306
1363
3165
31874
107
361
3390
33094
23
60
3474
33395
—
21
45
3469
33358
124
278
3245
32233
194
491
2709
27749
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.2e-01
5.6e-01
1.1e+00
3.6e+00
1.2e+00
5.8e-01
2.5e-01
cases:5.24%
controls:3.85%
cases:4.15%
controls:2.41%
cases:1.03%
controls:0.36%
cases:0.54%
controls:0.01%
cases:1.20%
controls:0.37%
cases:4.48%
controls:2.55%
cases:9.06%
controls:7.22%
182
1279
3289
31958
145
805
3352
32650
36
121
3461
33334
19
5
3478
33450
42
123
3448
33280
151
830
3218
31681
263
2039
2640
26201
Moderate panic disorder
F41.00 [2000501994]
1.4e+00
2.3e+00
—
—
—
2.3e+00
1.6e+00
cases:0.37%
controls:0.09%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.42%
controls:0.04%
cases:0.59%
controls:0.12%
13
31
3458
33206
11
11
3486
33444
—
—
—
14
13
3355
32498
17
35
2886
28205
Other rehabilitation service
R5599 [2001310270]
1.3e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:0.89%
controls:0.26%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
cases:0.47%
controls:0.05%
cases:1.45%
controls:0.17%
31
85
3440
33152
12
19
3485
33436
—
—
—
16
15
3353
32496
42
49
2861
28191
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
9.1e-01
1.2e+00
—
—
3.1e+00
2.4e+00
2.1e+00
cases:0.43%
controls:0.17%
cases:0.14%
controls:0.04%
—
—
—
—
cases:0.32%
controls:0.01%
cases:0.39%
controls:0.04%
cases:0.69%
controls:0.08%
15
58
3456
33179
5
15
3492
33440
—
—
11
5
3479
33398
13
12
3356
32499
20
24
2883
28216
EKG study
11524-6 [3013512]
2.1e-01
5.0e-01
9.6e-01
4.4e+00
1.6e+00
3.3e-01
1.4e-01
cases:5.96%
controls:4.89%
cases:4.03%
controls:2.48%
cases:0.86%
controls:0.33%
cases:1.43%
controls:0.02%
cases:1.60%
controls:0.32%
cases:3.44%
controls:2.50%
cases:6.20%
controls:5.42%
207
1624
3264
31613
141
831
3356
32624
30
111
3467
33344
50
6
3447
33449
56
106
3434
33297
116
814
3253
31697
180
1530
2723
26710
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.2e+00
1.3e+00
1.6e+00
—
2.5e+00
1.1e+00
1.4e+00
cases:1.30%
controls:0.41%
cases:0.60%
controls:0.16%
cases:0.17%
controls:0.04%
—
—
cases:0.29%
controls:0.02%
cases:0.53%
controls:0.17%
cases:1.62%
controls:0.42%
45
137
3426
33100
21
53
3476
33402
6
12
3491
33443
—
10
8
3480
33395
18
56
3351
32455
47
119
2856
28121
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.6e-01
3.6e-01
8.6e-01
4.2e+00
1.3e+00
3.4e-01
1.9e-01
cases:33.25%
controls:29.88%
cases:29.00%
controls:22.18%
cases:10.15%
controls:4.56%
cases:15.64%
controls:0.27%
cases:15.47%
controls:4.55%
cases:27.57%
controls:21.31%
cases:35.93%
controls:31.70%
1154
9931
2317
23306
1014
7421
2483
26034
355
1524
3142
31931
547
92
2950
33363
540
1521
2950
31882
929
6927
2440
25584
1043
8951
1860
19289
Psychiatric treatment plan, standard
ICB01 [2001304098]
9.6e-01
1.3e+00
1.5e+00
1.0e+50
2.2e+00
1.6e+00
1.4e+00
cases:1.35%
controls:0.52%
cases:1.29%
controls:0.34%
cases:0.17%
controls:0.04%
cases:0.66%
controls:0.00%
cases:0.37%
controls:0.04%
cases:1.84%
controls:0.39%
cases:3.51%
controls:0.90%
47
174
3424
33063
45
113
3452
33342
6
13
3491
33442
23
0
3474
33455
13
14
3477
33389
62
126
3307
32385
102
253
2801
27987
fluoxetine; oral
N06AB03 [21604711]
1.3e+00
1.5e+00
9.7e-01
—
2.0e+00
1.4e+00
1.2e+00
cases:2.59%
controls:0.74%
cases:1.77%
controls:0.41%
cases:0.31%
controls:0.12%
—
—
cases:0.83%
controls:0.11%
cases:1.81%
controls:0.45%
cases:3.34%
controls:1.00%
90
247
3381
32990
62
136
3435
33319
11
40
3486
33415
—
29
36
3461
33367
61
146
3308
32365
97
282
2806
27958
Traumatic subdural haemorrhage
S06.5 [45563422]
1.1e+00
1.6e+00
—
1.0e+50
2.8e+00
1.9e+00
4.8e-01
cases:0.40%
controls:0.14%
cases:0.29%
controls:0.06%
—
—
cases:0.14%
controls:0.00%
cases:0.29%
controls:0.02%
cases:0.39%
controls:0.06%
cases:0.28%
controls:0.17%
14
47
3457
33190
10
19
3487
33436
—
5
0
3492
33455
10
6
3480
33397
13
18
3356
32493
8
48
2895
28192
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.0e-01
4.8e-01
8.8e-01
3.8e+00
1.1e+00
5.3e-01
2.8e-01
cases:20.14%
controls:15.75%
cases:11.84%
controls:7.69%
cases:2.89%
controls:1.21%
cases:2.32%
controls:0.05%
cases:3.55%
controls:1.22%
cases:11.22%
controls:6.90%
cases:18.77%
controls:14.87%
699
5236
2772
28001
414
2574
3083
30881
101
406
3396
33049
81
18
3416
33437
124
406
3366
32997
378
2243
2991
30268
545
4199
2358
24041
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
1.0e+00
9.7e-01
—
—
2.3e+00
1.7e+00
1.4e+00
cases:1.58%
controls:0.57%
cases:0.54%
controls:0.21%
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.74%
controls:0.14%
cases:0.83%
controls:0.21%
55
191
3416
33046
19
69
3478
33386
—
—
7
7
3483
33396
25
44
3344
32467
24
59
2879
28181
CT of cerebral ischaemia
AA5BD [2001300158]
1.1e+00
2.7e+00
1.0e+50
1.0e+50
—
2.2e+00
1.4e+00
cases:0.40%
controls:0.14%
cases:0.40%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.92%
controls:0.00%
—
—
cases:0.24%
controls:0.03%
cases:0.41%
controls:0.10%
14
45
3457
33192
14
9
3483
33446
9
0
3488
33455
32
0
3465
33455
—
8
9
3361
32502
12
29
2891
28211
Remote contact by phone
ZYC01 [2001311579]
8.6e-01
1.1e+00
1.6e+00
—
1.8e+00
1.2e+00
9.1e-01
cases:1.41%
controls:0.60%
cases:0.80%
controls:0.28%
cases:0.29%
controls:0.06%
—
—
cases:0.32%
controls:0.05%
cases:0.92%
controls:0.28%
cases:1.62%
controls:0.66%
49
201
3422
33036
28
94
3469
33361
10
20
3487
33435
—
11
18
3479
33385
31
92
3338
32419
47
185
2856
28055
Kidney transplant status
Z94.0 [45566477]
9.1e-01
7.9e-01
7.8e-01
3.0e+00
1.1e+00
7.5e-01
8.2e-01
cases:0.81%
controls:0.32%
cases:0.74%
controls:0.34%
cases:0.51%
controls:0.24%
cases:0.29%
controls:0.01%
cases:0.60%
controls:0.20%
cases:0.74%
controls:0.35%
cases:0.86%
controls:0.38%
28
108
3443
33129
26
113
3471
33342
18
79
3479
33376
10
5
3487
33450
21
67
3469
33336
25
114
3344
32397
25
108
2878
28132
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.9e-01
4.3e-01
7.1e-01
3.9e+00
1.0e+00
5.7e-01
4.3e-01
cases:10.23%
controls:7.86%
cases:6.49%
controls:4.32%
cases:1.40%
controls:0.70%
cases:1.12%
controls:0.02%
cases:2.09%
controls:0.76%
cases:6.80%
controls:3.97%
cases:12.64%
controls:8.63%
355
2612
3116
30625
227
1446
3270
32009
49
233
3448
33222
39
8
3458
33447
73
255
3417
33148
229
1290
3140
31221
367
2437
2536
25803
Other specified intervertebral disc degeneration
M51.3 [45591865]
9.2e-01
1.3e+00
—
1.0e+50
2.7e+00
1.1e+00
1.2e+00
cases:1.04%
controls:0.42%
cases:0.49%
controls:0.13%
—
—
cases:0.46%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.47%
controls:0.16%
cases:1.24%
controls:0.36%
36
138
3435
33099
17
45
3480
33410
—
16
0
3481
33455
11
7
3479
33396
16
51
3353
32460
36
102
2867
28138
Visual field defects
H53.4 [45557469]
1.1e+00
2.2e+00
—
—
—
2.1e+00
1.9e+00
cases:0.37%
controls:0.13%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.48%
controls:0.07%
13
43
3458
33194
11
12
3486
33443
—
—
—
11
13
3358
32498
14
20
2889
28220
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
8.6e-01
1.6e+00
2.1e+00
—
1.5e+00
1.5e+00
1.2e+00
cases:1.24%
controls:0.53%
cases:0.92%
controls:0.19%
cases:0.23%
controls:0.03%
—
—
cases:0.17%
controls:0.04%
cases:0.71%
controls:0.16%
cases:1.24%
controls:0.38%
43
175
3428
33062
32
65
3465
33390
8
9
3489
33446
—
6
13
3484
33390
24
52
3345
32459
36
107
2867
28133
Unspecified nonorganic psychosis
F29 [45533099]
1.1e+00
1.3e+00
1.3e+00
—
1.4e+00
1.6e+00
1.8e+00
cases:1.21%
controls:0.40%
cases:0.74%
controls:0.20%
cases:0.29%
controls:0.07%
—
—
cases:0.32%
controls:0.07%
cases:0.98%
controls:0.20%
cases:2.03%
controls:0.36%
42
133
3429
33104
26
66
3471
33389
10
25
3487
33430
—
11
25
3479
33378
33
64
3336
32447
59
101
2844
28139
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.7e-01
4.7e-01
7.3e-01
3.6e+00
9.9e-01
6.4e-01
5.2e-01
cases:10.29%
controls:8.03%
cases:6.03%
controls:3.87%
cases:1.23%
controls:0.60%
cases:1.12%
controls:0.03%
cases:1.83%
controls:0.69%
cases:6.29%
controls:3.41%
cases:11.51%
controls:7.18%
357
2669
3114
30568
211
1296
3286
32159
43
200
3454
33255
39
10
3458
33445
64
231
3426
33172
212
1110
3157
31401
334
2028
2569
26212
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.2e-01
4.3e-01
8.8e-01
3.7e+00
1.1e+00
5.5e-01
3.6e-01
cases:18.21%
controls:15.18%
cases:10.75%
controls:7.24%
cases:2.77%
controls:1.17%
cases:2.63%
controls:0.07%
cases:3.30%
controls:1.13%
cases:10.86%
controls:6.57%
cases:18.67%
controls:13.83%
632
5046
2839
28191
376
2423
3121
31032
97
392
3400
33063
92
22
3405
33433
115
379
3375
33024
366
2137
3003
30374
542
3906
2361
24334
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
1.5e+00
1.9e+00
—
—
2.1e+00
2.3e+00
1.6e+00
cases:0.43%
controls:0.10%
cases:0.34%
controls:0.05%
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.27%
controls:0.03%
cases:0.59%
controls:0.12%
15
33
3456
33204
12
18
3485
33437
—
—
5
6
3485
33397
9
9
3360
32502
17
33
2886
28207
Cocaine [Presence] in Urine
3397-7 [3016879]
1.1e+00
1.9e+00
2.0e+00
—
2.3e+00
1.1e+00
6.9e-01
cases:2.13%
controls:0.71%
cases:2.40%
controls:0.35%
cases:0.17%
controls:0.02%
—
—
cases:0.49%
controls:0.05%
cases:1.07%
controls:0.34%
cases:2.41%
controls:1.23%
74
237
3397
33000
84
118
3413
33337
6
8
3491
33447
—
17
16
3473
33387
36
111
3333
32400
70
347
2833
27893
Other disorders of psychological development
F88 [45538087]
4.2e-01
1.3e+00
1.5e+00
—
2.3e+00
1.9e+00
1.7e+00
cases:0.20%
controls:0.13%
cases:0.34%
controls:0.09%
cases:0.17%
controls:0.04%
—
—
cases:0.34%
controls:0.04%
cases:0.62%
controls:0.10%
cases:0.76%
controls:0.13%
7
44
3464
33193
12
31
3485
33424
6
13
3491
33442
—
12
12
3478
33391
21
31
3348
32480
22
38
2881
28202
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.8e-01
3.2e-01
7.2e-01
4.1e+00
1.2e+00
3.7e-01
2.6e-01
cases:29.10%
controls:25.47%
cases:24.96%
controls:19.44%
cases:8.69%
controls:4.41%
cases:12.07%
controls:0.22%
cases:12.78%
controls:4.27%
cases:24.52%
controls:18.35%
cases:33.24%
controls:27.67%
1010
8466
2461
24771
873
6503
2624
26952
304
1476
3193
31979
422
75
3075
33380
446
1425
3044
31978
826
5966
2543
26545
965
7814
1938
20426
Accelerated psychiatric treatment contact
IGY01 [2001304321]
9.0e-01
1.4e+00
1.9e+00
—
1.7e+00
1.6e+00
1.4e+00
cases:0.72%
controls:0.29%
cases:0.83%
controls:0.21%
cases:0.20%
controls:0.03%
—
—
cases:0.17%
controls:0.03%
cases:1.07%
controls:0.22%
cases:2.24%
controls:0.57%
25
98
3446
33139
29
71
3468
33384
7
10
3490
33445
—
6
10
3484
33393
36
71
3333
32440
65
162
2838
28078
clopidogrel; oral
B01AC04 [21600989]
5.5e-01
9.1e-01
1.2e+00
—
2.1e+00
1.4e+00
9.6e-01
cases:2.59%
controls:1.51%
cases:2.43%
controls:0.99%
cases:0.86%
controls:0.27%
—
—
cases:2.55%
controls:0.31%
cases:4.13%
controls:1.03%
cases:3.20%
controls:1.25%
90
503
3381
32734
85
331
3412
33124
30
91
3467
33364
—
89
104
3401
33299
139
335
3230
32176
93
354
2810
27886
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
6.1e-01
8.9e-01
1.6e+00
—
2.2e+00
1.0e+00
7.3e-01
cases:6.25%
controls:3.49%
cases:3.72%
controls:1.56%
cases:1.14%
controls:0.24%
—
—
cases:1.58%
controls:0.17%
cases:3.18%
controls:1.14%
cases:4.99%
controls:2.46%
217
1161
3254
32076
130
522
3367
32933
40
79
3457
33376
—
55
57
3435
33346
107
369
3262
32142
145
696
2758
27544
Agoraphobia with concomitant panic disorder
F40.01 [2000501993]
2.5e+00
—
—
1.0e+50
1.0e+50
2.5e+00
2.1e+00
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.29%
controls:0.00%
cases:0.17%
controls:0.00%
cases:0.30%
controls:0.02%
cases:0.38%
controls:0.05%
10
8
3461
33229
—
—
10
0
3487
33455
6
0
3484
33403
10
8
3359
32503
11
13
2892
28227
Psychiatric evaluation of working capacity and rehabilitation
IBB02 [2001304049]
1.6e+00
3.6e+00
1.0e+50
1.0e+50
1.0e+50
3.4e+00
1.7e+00
cases:0.20%
controls:0.04%
cases:0.57%
controls:0.01%
cases:0.43%
controls:0.00%
cases:0.40%
controls:0.00%
cases:0.34%
controls:0.00%
cases:0.47%
controls:0.02%
cases:0.24%
controls:0.04%
7
13
3464
33224
20
5
3477
33450
15
0
3482
33455
14
0
3483
33455
12
0
3478
33403
16
5
3353
32506
7
12
2896
28228
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.8e-01
3.1e-01
8.7e-01
4.1e+00
1.3e+00
2.9e-01
1.2e-01
cases:20.54%
controls:17.75%
cases:18.36%
controls:14.16%
cases:6.55%
controls:2.85%
cases:10.69%
controls:0.20%
cases:10.32%
controls:2.96%
cases:18.17%
controls:14.26%
cases:24.15%
controls:22.03%
713
5900
2758
27337
642
4736
2855
28719
229
953
3268
32502
374
67
3123
33388
360
988
3130
32415
612
4635
2757
27876
701
6222
2202
22018
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
2.7e-01
3.6e-01
1.1e+00
4.3e+00
1.2e+00
4.5e-01
8.9e-02
cases:3.43%
controls:2.64%
cases:1.89%
controls:1.33%
cases:0.71%
controls:0.24%
cases:1.29%
controls:0.02%
cases:0.77%
controls:0.23%
cases:2.20%
controls:1.41%
cases:3.03%
controls:2.78%
119
876
3352
32361
66
444
3431
33011
25
81
3472
33374
45
6
3452
33449
27
76
3463
33327
74
460
3295
32051
88
785
2815
27455
Supine thorax X-ray examination
GD1QA [2001303648]
7.7e-01
1.3e+00
2.0e+00
—
1.4e+00
8.7e-01
6.4e-01
cases:2.79%
controls:1.32%
cases:1.54%
controls:0.42%
cases:0.46%
controls:0.06%
—
—
cases:0.32%
controls:0.07%
cases:1.34%
controls:0.57%
cases:3.03%
controls:1.63%
97
438
3374
32799
54
142
3443
33313
16
20
3481
33435
—
11
25
3479
33378
45
184
3324
32327
88
460
2815
27780
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
1.4e+00
1.9e+00
1.0e+50
1.0e+50
—
2.5e+00
1.2e+00
cases:0.92%
controls:0.22%
cases:0.43%
controls:0.06%
cases:0.20%
controls:0.00%
cases:0.37%
controls:0.00%
—
—
cases:0.83%
controls:0.07%
cases:1.17%
controls:0.36%
32
73
3439
33164
15
21
3482
33434
7
0
3490
33455
13
0
3484
33455
—
28
23
3341
32488
34
102
2869
28138
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
3.4e-01
5.5e-01
7.1e-01
3.7e+00
1.2e+00
7.0e-01
5.8e-01
cases:4.21%
controls:3.04%
cases:3.40%
controls:1.99%
cases:0.66%
controls:0.33%
cases:0.60%
controls:0.01%
cases:1.09%
controls:0.34%
cases:3.95%
controls:2.01%
cases:7.58%
controls:4.41%
146
1009
3325
32228
119
665
3378
32790
23
109
3474
33346
21
5
3476
33450
38
115
3452
33288
133
653
3236
31858
220
1244
2683
26996
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
1.0e+00
1.8e+00
1.9e+00
—
2.3e+00
1.1e+00
6.3e-01
cases:2.13%
controls:0.79%
cases:2.40%
controls:0.39%
cases:0.17%
controls:0.03%
—
—
cases:0.49%
controls:0.05%
cases:1.10%
controls:0.35%
cases:2.55%
controls:1.37%
74
264
3397
32973
84
131
3413
33324
6
9
3491
33446
—
17
16
3473
33387
37
115
3332
32396
74
388
2829
27852
Other specified special examinations
Z01.8 [45581003]
4.9e-01
1.1e+00
2.4e+00
—
1.7e+00
8.3e-01
4.3e-01
cases:4.75%
controls:2.96%
cases:3.09%
controls:1.10%
cases:1.20%
controls:0.11%
—
—
cases:0.63%
controls:0.11%
cases:2.17%
controls:0.96%
cases:4.58%
controls:3.03%
165
983
3306
32254
108
368
3389
33087
42
37
3455
33418
—
22
38
3468
33365
73
311
3296
32200
133
856
2770
27384
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.8e-01
5.2e-01
7.0e-01
3.1e+00
1.7e+00
3.9e-01
2.4e-01
cases:20.92%
controls:16.62%
cases:12.95%
controls:8.12%
cases:2.34%
controls:1.17%
cases:0.51%
controls:0.02%
cases:6.30%
controls:1.22%
cases:10.75%
controls:7.51%
cases:19.50%
controls:15.94%
726
5524
2745
27713
453
2715
3044
30740
82
393
3415
33062
18
8
3479
33447
220
409
3270
32994
362
2443
3007
30068
566
4501
2337
23739
Opiates [Presence] in Urine
3879-4 [3027008]
9.9e-01
1.8e+00
1.9e+00
—
2.3e+00
1.1e+00
6.4e-01
cases:2.13%
controls:0.80%
cases:2.40%
controls:0.39%
cases:0.17%
controls:0.03%
—
—
cases:0.49%
controls:0.05%
cases:1.07%
controls:0.35%
cases:2.55%
controls:1.36%
74
267
3397
32970
84
130
3413
33325
6
9
3491
33446
—
17
16
3473
33387
36
115
3333
32396
74
385
2829
27855
Cannabinoids [Presence] in Urine
3427-2 [3028300]
9.9e-01
1.8e+00
1.9e+00
—
2.3e+00
1.1e+00
6.3e-01
cases:2.13%
controls:0.80%
cases:2.40%
controls:0.39%
cases:0.17%
controls:0.03%
—
—
cases:0.49%
controls:0.05%
cases:1.07%
controls:0.36%
cases:2.55%
controls:1.38%
74
266
3397
32971
84
131
3413
33324
6
9
3491
33446
—
17
16
3473
33387
36
116
3333
32395
74
389
2829
27851
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
7.2e-01
1.2e+00
1.7e+00
—
3.0e+00
1.0e+00
9.8e-01
cases:1.33%
controls:0.65%
cases:0.66%
controls:0.21%
cases:0.17%
controls:0.03%
—
—
cases:0.46%
controls:0.02%
cases:0.53%
controls:0.19%
cases:0.86%
controls:0.33%
46
216
3425
33021
23
69
3474
33386
6
11
3491
33444
—
16
8
3474
33395
18
61
3351
32450
25
92
2878
28148
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
3.6e-01
5.9e-01
7.0e-01
3.6e+00
1.1e+00
7.2e-01
5.5e-01
cases:4.47%
controls:3.15%
cases:3.49%
controls:1.96%
cases:0.63%
controls:0.31%
cases:0.63%
controls:0.02%
cases:0.97%
controls:0.34%
cases:3.92%
controls:1.94%
cases:7.03%
controls:4.19%
155
1046
3316
32191
122
656
3375
32799
22
105
3475
33350
22
6
3475
33449
34
113
3456
33290
132
630
3237
31881
204
1184
2699
27056
Evaluation of communicative skills
R1260 [2001310179]
1.2e+00
1.8e+00
—
1.0e+50
—
2.2e+00
1.6e+00
cases:0.84%
controls:0.25%
cases:0.40%
controls:0.07%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.59%
controls:0.07%
cases:0.72%
controls:0.14%
29
82
3442
33155
14
22
3483
33433
—
11
0
3486
33455
—
20
22
3349
32489
21
40
2882
28200
Amphetamines [Presence] in Urine
3349-8 [3027944]
9.9e-01
1.8e+00
1.7e+00
—
2.3e+00
1.1e+00
6.4e-01
cases:2.05%
controls:0.77%
cases:2.26%
controls:0.37%
cases:0.14%
controls:0.03%
—
—
cases:0.43%
controls:0.04%
cases:1.04%
controls:0.35%
cases:2.55%
controls:1.36%
71
255
3400
32982
79
125
3418
33330
5
9
3492
33446
—
15
15
3475
33388
35
113
3334
32398
74
384
2829
27856
12 lead EKG panel
34534-8 [3044889]
2.6e-01
3.9e-01
6.1e-01
3.2e+00
1.7e+00
3.5e-01
3.1e-01
cases:16.94%
controls:13.57%
cases:9.24%
controls:6.42%
cases:1.49%
controls:0.82%
cases:0.66%
controls:0.03%
cases:3.61%
controls:0.69%
cases:8.31%
controls:5.99%
cases:17.02%
controls:13.08%
588
4510
2883
28727
323
2147
3174
31308
52
273
3445
33182
23
9
3474
33446
126
230
3364
33173
280
1948
3089
30563
494
3695
2409
24545
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
9.6e-01
1.2e+00
1.2e+00
—
3.3e+00
1.4e+00
4.9e-01
cases:1.47%
controls:0.57%
cases:0.69%
controls:0.22%
cases:0.23%
controls:0.07%
—
—
cases:0.77%
controls:0.03%
cases:0.62%
controls:0.15%
cases:0.65%
controls:0.40%
51
188
3420
33049
24
73
3473
33382
8
23
3489
33432
—
27
10
3463
33393
21
49
3348
32462
19
114
2884
28126
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.3e+00
1.5e+00
2.3e+00
—
—
2.4e+00
1.6e+00
cases:0.75%
controls:0.21%
cases:0.34%
controls:0.08%
cases:0.14%
controls:0.01%
—
—
—
—
cases:0.42%
controls:0.04%
cases:0.96%
controls:0.19%
26
70
3445
33167
12
27
3485
33428
5
5
3492
33450
—
—
14
12
3355
32499
28
53
2875
28187
Office Visit
OMOP4822458 [581477]
7.2e-02
1.1e-01
7.7e-01
4.4e+00
1.3e+00
2.6e-01
-3.4e-02
cases:12.76%
controls:11.98%
cases:5.83%
controls:5.23%
cases:1.60%
controls:0.74%
cases:2.09%
controls:0.03%
cases:2.84%
controls:0.75%
cases:6.35%
controls:4.99%
cases:10.75%
controls:11.08%
443
3983
3028
29254
204
1751
3293
31704
56
249
3441
33206
73
9
3424
33446
99
251
3391
33152
214
1621
3155
30890
312
3129
2591
25111
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.1e-01
3.1e-01
7.2e-01
4.0e+00
1.2e+00
3.7e-01
1.9e-01
cases:30.34%
controls:28.10%
cases:26.05%
controls:20.50%
cases:8.64%
controls:4.39%
cases:11.21%
controls:0.24%
cases:12.72%
controls:4.29%
cases:25.41%
controls:19.08%
cases:33.21%
controls:29.05%
1053
9338
2418
23899
911
6858
2586
26597
302
1468
3195
31987
392
79
3105
33376
444
1432
3046
31971
856
6202
2513
26309
964
8203
1939
20037
CBC panel - Blood by Automated count
58410-2 [40761511]
1.0e-01
2.5e-01
6.6e-01
4.2e+00
1.3e+00
2.6e-01
1.0e-01
cases:31.69%
controls:29.48%
cases:21.25%
controls:17.43%
cases:6.09%
controls:3.23%
cases:11.01%
controls:0.18%
cases:10.63%
controls:3.04%
cases:19.86%
controls:16.00%
cases:29.62%
controls:27.54%
1100
9797
2371
23440
743
5830
2754
27625
213
1082
3284
32373
385
61
3112
33394
371
1015
3119
32388
669
5201
2700
27310
860
7776
2043
20464
Partial epileptic seizure with cloudiness and automatism
G40.21 [2000502140]
2.4e+00
—
—
—
—
2.4e+00
1.9e+00
cases:0.20%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.28%
controls:0.04%
7
6
3464
33231
—
—
—
—
7
6
3362
32505
8
12
2895
28228
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
1.0e+00
1.1e+00
1.3e+00
—
3.1e+00
1.5e+00
6.0e-01
cases:1.41%
controls:0.52%
cases:0.63%
controls:0.20%
cases:0.23%
controls:0.06%
—
—
cases:0.63%
controls:0.03%
cases:0.62%
controls:0.14%
cases:0.65%
controls:0.36%
49
173
3422
33064
22
67
3475
33388
8
21
3489
33434
—
22
10
3468
33393
21
46
3348
32465
19
102
2884
28138
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.3e-01
6.6e-01
9.7e-01
2.1e+00
1.4e+00
6.8e-01
4.3e-01
cases:12.42%
controls:8.42%
cases:8.18%
controls:4.41%
cases:1.89%
controls:0.72%
cases:0.31%
controls:0.04%
cases:3.21%
controls:0.80%
cases:7.72%
controls:4.05%
cases:12.61%
controls:8.55%
431
2799
3040
30438
286
1474
3211
31981
66
242
3431
33213
11
13
3486
33442
112
266
3378
33137
260
1318
3109
31193
366
2415
2537
25825
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.8e-01
4.4e-01
8.7e-01
3.8e+00
9.7e-01
3.9e-01
1.9e-01
cases:10.40%
controls:8.87%
cases:7.43%
controls:4.93%
cases:1.80%
controls:0.76%
cases:1.09%
controls:0.02%
cases:2.06%
controls:0.79%
cases:7.39%
controls:5.11%
cases:14.92%
controls:12.66%
361
2949
3110
30288
260
1651
3237
31804
63
254
3434
33201
38
8
3459
33447
72
265
3418
33138
249
1662
3120
30849
433
3574
2470
24666
Outpatient Hospital
22 [8756]
1.7e-01
2.1e-01
5.3e-01
3.9e+00
1.2e+00
5.5e-01
4.2e-01
cases:26.51%
controls:23.35%
cases:7.81%
controls:6.45%
cases:1.60%
controls:0.95%
cases:2.49%
controls:0.05%
cases:2.75%
controls:0.88%
cases:8.34%
controls:4.98%
cases:17.29%
controls:12.03%
920
7761
2551
25476
273
2157
3224
31298
56
319
3441
33136
87
18
3410
33437
96
294
3394
33109
281
1619
3088
30892
502
3398
2401
24842
trazodone; oral
N06AX05 [21604734]
1.2e+00
1.7e+00
—
—
—
1.8e+00
1.9e+00
cases:0.49%
controls:0.15%
cases:0.40%
controls:0.07%
—
—
—
—
—
—
cases:0.39%
controls:0.06%
cases:1.00%
controls:0.15%
17
49
3454
33188
14
24
3483
33431
—
—
—
13
20
3356
32491
29
42
2874
28198
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41602-4 [3033386]
1.1e+00
1.6e+00
2.3e+00
—
—
1.7e+00
6.3e-01
cases:0.61%
controls:0.20%
cases:0.29%
controls:0.06%
cases:0.17%
controls:0.02%
—
—
—
—
cases:0.24%
controls:0.04%
cases:0.17%
controls:0.09%
21
65
3450
33172
10
20
3487
33435
6
6
3491
33449
—
—
8
14
3361
32497
5
26
2898
28214
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
1.2e-01
3.8e-01
9.6e-01
4.2e+00
8.2e-01
3.0e-01
6.9e-02
cases:8.30%
controls:7.40%
cases:5.00%
controls:3.48%
cases:1.37%
controls:0.53%
cases:0.97%
controls:0.01%
cases:1.26%
controls:0.56%
cases:4.48%
controls:3.36%
cases:9.06%
controls:8.51%
288
2461
3183
30776
175
1165
3322
32290
48
177
3449
33278
34
5
3463
33450
44
186
3446
33217
151
1093
3218
31418
263
2402
2640
25838
Counselling and guidance which enhance independent living
R2130 [2001310196]
6.2e-01
7.2e-01
1.4e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:3.28%
controls:1.80%
cases:1.37%
controls:0.67%
cases:0.54%
controls:0.13%
—
—
cases:0.57%
controls:0.13%
cases:2.26%
controls:0.66%
cases:4.27%
controls:1.36%
114
599
3357
32638
48
225
3449
33230
19
45
3478
33410
—
20
43
3470
33360
76
216
3293
32295
124
385
2779
27855
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.7e+00
1.3e+00
—
—
—
1.7e+00
1.9e+00
cases:0.92%
controls:0.17%
cases:0.37%
controls:0.10%
—
—
—
—
—
—
cases:0.53%
controls:0.10%
cases:1.27%
controls:0.20%
32
56
3439
33181
13
33
3484
33422
—
—
—
18
31
3351
32480
37
56
2866
28184
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.7e-01
5.2e-01
6.0e-01
2.9e+00
1.8e+00
3.4e-01
2.3e-01
cases:27.77%
controls:22.61%
cases:19.59%
controls:12.67%
cases:2.95%
controls:1.64%
cases:0.77%
controls:0.04%
cases:8.85%
controls:1.56%
cases:17.13%
controls:12.77%
cases:29.83%
controls:25.18%
964
7514
2507
25723
685
4240
2812
29215
103
550
3394
32905
27
15
3470
33440
309
522
3181
32881
577
4151
2792
28360
866
7112
2037
21128
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
2.6e-01
4.8e-01
9.1e-01
3.1e+00
1.1e+00
5.9e-01
3.9e-01
cases:5.47%
controls:4.28%
cases:4.09%
controls:2.56%
cases:1.00%
controls:0.40%
cases:0.34%
controls:0.01%
cases:1.12%
controls:0.37%
cases:4.54%
controls:2.57%
cases:9.34%
controls:6.54%
190
1421
3281
31816
143
857
3354
32598
35
135
3462
33320
12
5
3485
33450
39
123
3451
33280
153
835
3216
31676
271
1847
2632
26393
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
7.9e-01
9.8e-01
1.1e+00
—
1.5e+00
1.2e+00
1.0e+00
cases:4.47%
controls:2.07%
cases:2.23%
controls:0.85%
cases:0.51%
controls:0.18%
—
—
cases:0.77%
controls:0.17%
cases:2.58%
controls:0.78%
cases:4.24%
controls:1.53%
155
689
3316
32548
78
284
3419
33171
18
59
3479
33396
—
27
57
3463
33346
87
255
3282
32256
123
431
2780
27809
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
6.0e-01
1.2e+00
1.9e+00
1.0e+50
2.7e+00
8.3e-01
5.5e-01
cases:0.81%
controls:0.45%
cases:0.69%
controls:0.21%
cases:0.34%
controls:0.05%
cases:0.86%
controls:0.00%
cases:0.54%
controls:0.04%
cases:0.62%
controls:0.27%
cases:1.41%
controls:0.82%
28
148
3443
33089
24
69
3473
33386
12
18
3485
33437
30
0
3467
33455
19
12
3471
33391
21
89
3348
32422
41
232
2862
28008
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
1.9e-01
4.5e-01
8.8e-01
3.7e+00
9.4e-01
3.9e-01
2.0e-01
cases:10.69%
controls:9.04%
cases:7.69%
controls:5.02%
cases:1.86%
controls:0.78%
cases:1.12%
controls:0.03%
cases:2.03%
controls:0.81%
cases:7.45%
controls:5.15%
cases:15.23%
controls:12.84%
371
3004
3100
30233
269
1680
3228
31775
65
261
3432
33194
39
9
3458
33446
71
269
3419
33134
251
1673
3118
30838
442
3625
2461
24615
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
8.8e-01
1.6e+00
1.6e+00
—
2.1e+00
1.2e+00
8.3e-01
cases:4.35%
controls:1.85%
cases:2.86%
controls:0.62%
cases:0.23%
controls:0.05%
—
—
cases:0.69%
controls:0.08%
cases:2.02%
controls:0.60%
cases:4.44%
controls:1.99%
151
614
3320
32623
100
207
3397
33248
8
16
3489
33439
—
24
28
3466
33375
68
196
3301
32315
129
563
2774
27677
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.7e-01
4.4e-01
8.8e-01
3.7e+00
9.4e-01
3.8e-01
2.0e-01
cases:10.69%
controls:9.18%
cases:7.69%
controls:5.08%
cases:1.86%
controls:0.78%
cases:1.12%
controls:0.03%
cases:2.03%
controls:0.80%
cases:7.39%
controls:5.16%
cases:15.23%
controls:12.82%
371
3050
3100
30187
269
1700
3228
31755
65
261
3432
33194
39
9
3458
33446
71
268
3419
33135
249
1679
3120
30832
442
3619
2461
24621
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
9.3e-01
1.1e+00
1.2e+00
—
3.1e+00
1.4e+00
5.7e-01
cases:1.33%
controls:0.53%
cases:0.63%
controls:0.20%
cases:0.23%
controls:0.07%
—
—
cases:0.74%
controls:0.03%
cases:0.56%
controls:0.14%
cases:0.62%
controls:0.35%
46
176
3425
33061
22
67
3475
33388
8
23
3489
33432
—
26
11
3464
33392
19
47
3350
32464
18
99
2885
28141
duloxetine; oral
N06AX21 [21604749]
9.8e-01
1.1e+00
1.1e+00
—
1.1e+00
1.1e+00
1.1e+00
cases:2.30%
controls:0.88%
cases:1.63%
controls:0.53%
cases:0.54%
controls:0.19%
—
—
cases:0.52%
controls:0.17%
cases:1.54%
controls:0.51%
cases:2.93%
controls:0.95%
80
291
3391
32946
57
178
3440
33277
19
63
3478
33392
—
18
56
3472
33347
52
166
3317
32345
85
269
2818
27971
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
9.1e-01
9.9e-01
—
—
2.3e+00
1.2e+00
1.2e+00
cases:1.12%
controls:0.45%
cases:0.77%
controls:0.29%
—
—
—
—
cases:0.46%
controls:0.04%
cases:0.83%
controls:0.26%
cases:1.48%
controls:0.47%
39
151
3432
33086
27
96
3470
33359
—
—
16
15
3474
33388
28
86
3341
32425
43
132
2860
28108
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
4.5e-01
7.5e-01
1.7e+00
—
2.2e+00
8.7e-01
5.7e-01
cases:5.36%
controls:3.49%
cases:3.20%
controls:1.55%
cases:1.26%
controls:0.23%
—
—
cases:1.69%
controls:0.19%
cases:3.32%
controls:1.42%
cases:5.72%
controls:3.33%
186
1159
3285
32078
112
517
3385
32938
44
77
3453
33378
—
59
63
3431
33340
112
463
3257
32048
166
941
2737
27299
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
1.3e+00
1.6e+00
1.6e+00
1.0e+50
1.4e+00
2.1e+00
1.5e+00
cases:0.61%
controls:0.16%
cases:0.37%
controls:0.07%
cases:0.14%
controls:0.03%
cases:0.14%
controls:0.00%
cases:0.14%
controls:0.04%
cases:0.62%
controls:0.08%
cases:0.86%
controls:0.19%
21
53
3450
33184
13
24
3484
33431
5
10
3492
33445
5
0
3492
33455
5
12
3485
33391
21
26
3348
32485
25
55
2878
28185
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.0e-01
6.7e-01
9.5e-01
2.5e+00
1.0e+00
6.0e-01
3.9e-01
cases:13.17%
controls:9.23%
cases:8.26%
controls:4.42%
cases:2.20%
controls:0.86%
cases:0.57%
controls:0.05%
cases:2.49%
controls:0.92%
cases:7.63%
controls:4.33%
cases:12.92%
controls:9.14%
457
3069
3014
30168
289
1480
3208
31975
77
288
3420
33167
20
16
3477
33439
87
307
3403
33096
257
1408
3112
31103
375
2581
2528
25659
vortioxetine; oral
N06AX26 [44819158]
1.0e+00
1.2e+00
1.1e+00
—
1.5e+00
8.3e-01
8.4e-01
cases:1.56%
controls:0.57%
cases:1.40%
controls:0.44%
cases:0.51%
controls:0.17%
—
—
cases:0.74%
controls:0.17%
cases:1.10%
controls:0.48%
cases:2.38%
controls:1.04%
54
188
3417
33049
49
147
3448
33308
18
56
3479
33399
—
26
56
3464
33347
37
156
3332
32355
69
293
2834
27947
General Surgery
2 [38004447]
3.1e-01
5.2e-01
8.6e-01
3.1e+00
8.4e-01
4.3e-01
3.6e-01
cases:12.19%
controls:9.28%
cases:4.52%
controls:2.73%
cases:0.74%
controls:0.32%
cases:0.40%
controls:0.02%
cases:0.83%
controls:0.36%
cases:4.24%
controls:2.81%
cases:11.51%
controls:8.35%
423
3083
3048
30154
158
914
3339
32541
26
106
3471
33349
14
6
3483
33449
29
120
3461
33283
143
912
3226
31599
334
2357
2569
25883
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
1.2e+00
1.1e+00
1.4e+00
—
3.5e+00
1.7e+00
7.4e-01
cases:0.89%
controls:0.28%
cases:0.34%
controls:0.12%
cases:0.14%
controls:0.04%
—
—
cases:0.52%
controls:0.01%
cases:0.50%
controls:0.10%
cases:0.52%
controls:0.25%
31
92
3440
33145
12
39
3485
33416
5
12
3492
33443
—
18
5
3472
33398
17
31
3352
32480
15
70
2888
28170
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
1.1e+00
1.5e+00
—
—
1.5e+00
1.5e+00
2.3e+00
cases:1.24%
controls:0.42%
cases:0.66%
controls:0.15%
—
—
—
—
cases:0.14%
controls:0.03%
cases:0.62%
controls:0.14%
cases:1.14%
controls:0.12%
43
139
3428
33098
23
50
3474
33405
—
—
5
11
3485
33392
21
44
3348
32467
33
34
2870
28206
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
6.8e-02
2.5e-01
6.8e-01
4.0e+00
1.2e+00
2.7e-01
7.7e-02
cases:37.11%
controls:35.54%
cases:33.06%
controls:27.87%
cases:11.44%
controls:6.14%
cases:16.04%
controls:0.36%
cases:17.51%
controls:6.04%
cases:32.24%
controls:26.72%
cases:40.23%
controls:38.39%
1288
11811
2183
21426
1156
9323
2341
24132
400
2055
3097
31400
561
119
2936
33336
611
2017
2879
31386
1086
8688
2283
23823
1168
10842
1735
17398
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.1e-01
4.0e-01
7.0e-01
3.2e+00
1.3e+00
3.6e-01
1.9e-01
cases:32.41%
controls:28.07%
cases:26.65%
controls:19.56%
cases:7.03%
controls:3.60%
cases:3.06%
controls:0.13%
cases:12.26%
controls:3.58%
cases:25.23%
controls:19.02%
cases:34.76%
controls:30.65%
1125
9331
2346
23906
932
6545
2565
26910
246
1206
3251
32249
107
44
3390
33411
428
1195
3062
32208
850
6182
2519
26329
1009
8656
1894
19584
Platelets [#/volume] in Blood
26515-7 [3007461]
7.1e-02
2.5e-01
6.8e-01
4.0e+00
1.2e+00
2.7e-01
8.1e-02
cases:37.08%
controls:35.45%
cases:33.03%
controls:27.83%
cases:11.44%
controls:6.14%
cases:16.04%
controls:0.36%
cases:17.39%
controls:6.02%
cases:32.18%
controls:26.67%
cases:40.23%
controls:38.30%
1287
11781
2184
21456
1155
9310
2342
24145
400
2054
3097
31401
561
119
2936
33336
607
2012
2883
31391
1084
8672
2285
23839
1168
10816
1735
17424
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
6.7e-02
2.5e-01
6.8e-01
4.0e+00
1.2e+00
2.7e-01
7.9e-02
cases:37.08%
controls:35.54%
cases:33.06%
controls:27.86%
cases:11.44%
controls:6.14%
cases:16.04%
controls:0.36%
cases:17.39%
controls:6.03%
cases:32.21%
controls:26.69%
cases:40.23%
controls:38.35%
1287
11811
2184
21426
1156
9321
2341
24134
400
2054
3097
31401
561
119
2936
33336
607
2013
2883
31390
1085
8678
2284
23833
1168
10830
1735
17410
MCH [Entitic mass]
28539-5 [3035941]
6.7e-02
2.5e-01
6.8e-01
4.0e+00
1.2e+00
2.7e-01
7.8e-02
cases:37.05%
controls:35.50%
cases:33.06%
controls:27.86%
cases:11.44%
controls:6.15%
cases:16.04%
controls:0.36%
cases:17.39%
controls:6.03%
cases:32.21%
controls:26.69%
cases:40.23%
controls:38.38%
1286
11799
2185
21438
1156
9322
2341
24133
400
2056
3097
31399
561
119
2936
33336
607
2013
2883
31390
1085
8678
2284
23833
1168
10839
1735
17401
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
6.7e-02
2.4e-01
6.8e-01
4.0e+00
1.2e+00
2.6e-01
7.7e-02
cases:37.08%
controls:35.53%
cases:33.06%
controls:27.89%
cases:11.44%
controls:6.14%
cases:16.04%
controls:0.36%
cases:17.42%
controls:6.03%
cases:32.21%
controls:26.74%
cases:40.23%
controls:38.39%
1287
11809
2184
21428
1156
9329
2341
24126
400
2055
3097
31400
561
119
2936
33336
608
2014
2882
31389
1085
8693
2284
23818
1168
10842
1735
17398
Bipolar affective disorder, currently in remission
F31.7 [45581457]
1.4e+00
1.5e+00
1.6e+00
—
1.7e+00
1.6e+00
1.9e+00
cases:0.58%
controls:0.14%
cases:0.29%
controls:0.07%
cases:0.14%
controls:0.03%
—
—
cases:0.14%
controls:0.03%
cases:0.39%
controls:0.08%
cases:0.76%
controls:0.12%
20
46
3451
33191
10
22
3487
33433
5
10
3492
33445
—
5
9
3485
33394
13
26
3356
32485
22
33
2881
28207
Leukocytes [#/volume] in Blood
26464-8 [3010813]
6.5e-02
2.4e-01
6.7e-01
4.0e+00
1.2e+00
2.7e-01
7.4e-02
cases:37.11%
controls:35.60%
cases:33.09%
controls:27.91%
cases:11.41%
controls:6.17%
cases:16.04%
controls:0.36%
cases:17.42%
controls:6.05%
cases:32.26%
controls:26.76%
cases:40.23%
controls:38.46%
1288
11834
2183
21403
1157
9338
2340
24117
399
2063
3098
31392
561
119
2936
33336
608
2021
2882
31382
1087
8700
2282
23811
1168
10862
1735
17378
Dizziness and giddiness
R42 [45568132]
6.5e-01
1.1e+00
1.5e+00
—
1.6e+00
8.8e-01
6.6e-01
cases:3.72%
controls:1.98%
cases:1.97%
controls:0.69%
cases:0.37%
controls:0.08%
—
—
cases:0.46%
controls:0.09%
cases:1.57%
controls:0.66%
cases:4.10%
controls:2.16%
129
659
3342
32578
69
231
3428
33224
13
28
3484
33427
—
16
31
3474
33372
53
215
3316
32296
119
610
2784
27630
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
6.5e-02
2.4e-01
6.8e-01
4.0e+00
1.2e+00
2.6e-01
7.5e-02
cases:37.08%
controls:35.57%
cases:33.03%
controls:27.95%
cases:11.47%
controls:6.17%
cases:16.07%
controls:0.36%
cases:17.42%
controls:6.06%
cases:32.21%
controls:26.77%
cases:40.23%
controls:38.45%
1287
11824
2184
21413
1155
9349
2342
24106
401
2064
3096
31391
562
120
2935
33335
608
2025
2882
31378
1085
8704
2284
23807
1168
10857
1735
17383
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
6.5e-01
5.8e-01
1.6e+00
—
2.2e+00
1.2e+00
6.7e-01
cases:3.14%
controls:1.66%
cases:1.09%
controls:0.61%
cases:0.29%
controls:0.06%
—
—
cases:0.54%
controls:0.06%
cases:1.22%
controls:0.38%
cases:1.86%
controls:0.96%
109
552
3362
32685
38
204
3459
33251
10
19
3487
33436
—
19
20
3471
33383
41
123
3328
32388
54
270
2849
27970
Tension-type headache
G44.2 [45581495]
6.6e-01
2.0e-01
2.0e+00
1.0e+50
1.9e+00
8.1e-01
9.1e-01
cases:2.19%
controls:1.15%
cases:0.43%
controls:0.35%
cases:0.20%
controls:0.03%
cases:0.14%
controls:0.00%
cases:0.20%
controls:0.03%
cases:0.83%
controls:0.37%
cases:2.69%
controls:1.09%
76
381
3395
32856
15
118
3482
33337
7
9
3490
33446
5
0
3492
33455
7
10
3483
33393
28
121
3341
32390
78
309
2825
27931
Syncope and collapse
R55 [45568141]
8.0e-01
1.2e+00
2.4e+00
—
1.2e+00
1.0e+00
8.7e-01
cases:1.79%
controls:0.81%
cases:0.97%
controls:0.30%
cases:0.20%
controls:0.02%
—
—
cases:0.14%
controls:0.04%
cases:0.77%
controls:0.28%
cases:1.96%
controls:0.83%
62
269
3409
32968
34
100
3463
33355
7
6
3490
33449
—
5
15
3485
33388
26
92
3343
32419
57
234
2846
28006
Supplier / Service Provider
OMOP5117446 [33004]
-4.6e-01
-4.6e-01
-5.7e-01
—
2.7e+00
2.3e+00
2.2e+00
cases:15.01%
controls:21.80%
cases:5.06%
controls:7.77%
cases:0.51%
controls:0.91%
—
—
cases:1.12%
controls:0.08%
cases:4.87%
controls:0.53%
cases:11.44%
controls:1.39%
521
7247
2950
25990
177
2599
3320
30856
18
303
3479
33152
—
39
26
3451
33377
164
173
3205
32338
332
393
2571
27847
Physical Medicine And Rehabilitation
25 [38004468]
5.9e-01
1.0e+00
1.4e+00
—
1.6e+00
1.0e+00
6.3e-01
cases:8.12%
controls:4.67%
cases:4.58%
controls:1.69%
cases:1.00%
controls:0.26%
—
—
cases:1.43%
controls:0.30%
cases:4.75%
controls:1.78%
cases:8.68%
controls:4.81%
282
1553
3189
31684
160
565
3337
32890
35
87
3462
33368
—
50
99
3440
33304
160
579
3209
31932
252
1358
2651
26882
Migraine, unspecified
G43.9 [45595943]
1.0e+00
1.2e+00
2.0e+00
1.0e+50
1.7e+00
1.2e+00
7.3e-01
cases:1.73%
controls:0.63%
cases:0.86%
controls:0.25%
cases:0.31%
controls:0.04%
cases:0.57%
controls:0.00%
cases:0.17%
controls:0.03%
cases:0.74%
controls:0.22%
cases:1.83%
controls:0.89%
60
209
3411
33028
30
85
3467
33370
11
14
3486
33441
20
0
3477
33455
6
10
3484
33393
25
73
3344
32438
53
251
2850
27989
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
8.5e-01
1.1e+00
9.6e-01
—
2.9e+00
1.3e+00
6.2e-01
cases:1.27%
controls:0.54%
cases:0.63%
controls:0.22%
cases:0.17%
controls:0.07%
—
—
cases:0.60%
controls:0.03%
cases:0.56%
controls:0.15%
cases:0.72%
controls:0.39%
44
181
3427
33056
22
72
3475
33383
6
22
3491
33433
—
21
11
3469
33392
19
48
3350
32463
21
110
2882
28130
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
1.7e+00
—
—
—
—
2.1e+00
2.4e+00
cases:0.35%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.41%
controls:0.04%
12
22
3459
33215
—
—
—
—
7
8
3362
32503
12
11
2891
28229
Headache
R51.80 [2000503603]
6.1e-01
9.4e-01
1.5e+00
—
1.6e+00
9.1e-01
6.0e-01
cases:3.98%
controls:2.21%
cases:1.83%
controls:0.72%
cases:0.37%
controls:0.09%
—
—
cases:0.52%
controls:0.10%
cases:1.84%
controls:0.75%
cases:4.72%
controls:2.65%
138
734
3333
32503
64
241
3433
33214
13
29
3484
33426
—
18
34
3472
33369
62
244
3307
32267
137
747
2766
27493
Other obesity
E66.8 [45533036]
9.0e-01
1.0e+00
—
1.0e+50
1.7e+00
1.4e+00
1.2e+00
cases:0.86%
controls:0.35%
cases:0.60%
controls:0.22%
—
—
cases:0.20%
controls:0.00%
cases:0.26%
controls:0.05%
cases:0.68%
controls:0.18%
cases:1.31%
controls:0.42%
30
117
3441
33120
21
73
3476
33382
—
7
0
3490
33455
9
16
3481
33387
23
57
3346
32454
38
118
2865
28122
Obesity, unspecified
E66.9 [45576460]
7.1e-01
1.1e+00
—
1.0e+50
2.3e+00
2.1e+00
1.7e+00
cases:0.61%
controls:0.30%
cases:0.31%
controls:0.10%
—
—
cases:0.17%
controls:0.00%
cases:0.20%
controls:0.02%
cases:0.53%
controls:0.06%
cases:1.24%
controls:0.22%
21
99
3450
33138
11
34
3486
33421
—
6
0
3491
33455
7
7
3483
33396
18
21
3351
32490
36
62
2867
28178
Education problem
Z07 [2002001463]
1.1e+00
1.8e+00
—
—
—
1.7e+00
1.6e+00
cases:0.37%
controls:0.13%
cases:0.20%
controls:0.03%
—
—
—
—
—
—
cases:0.30%
controls:0.06%
cases:0.65%
controls:0.14%
13
43
3458
33194
7
11
3490
33444
—
—
—
10
18
3359
32493
19
39
2884
28201
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.9e-01
4.7e-01
7.3e-01
2.4e+00
1.1e+00
6.2e-01
4.8e-01
cases:5.70%
controls:4.34%
cases:3.77%
controls:2.39%
cases:1.00%
controls:0.49%
cases:0.26%
controls:0.02%
cases:1.40%
controls:0.45%
cases:3.68%
controls:2.01%
cases:5.51%
controls:3.49%
198
1442
3273
31795
132
799
3365
32656
35
163
3462
33292
9
8
3488
33447
49
150
3441
33253
124
655
3245
31856
160
986
2743
27254
Spastic hemiplegic cerebral palsy
G80.2 [45571826]
1.2e+00
1.5e+00
—
1.0e+50
—
1.7e+00
1.7e+00
cases:0.37%
controls:0.11%
cases:0.34%
controls:0.08%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.45%
controls:0.08%
cases:0.55%
controls:0.10%
13
37
3458
33200
12
26
3485
33429
—
11
0
3486
33455
—
15
27
3354
32484
16
28
2887
28212
pregabalin; oral
N02BF02 [955152]
8.0e-01
1.1e+00
1.2e+00
—
1.1e+00
1.0e+00
8.7e-01
cases:4.49%
controls:2.07%
cases:3.00%
controls:1.05%
cases:1.23%
controls:0.36%
—
—
cases:1.17%
controls:0.40%
cases:2.85%
controls:1.04%
cases:4.13%
controls:1.78%
156
687
3315
32550
105
351
3392
33104
43
121
3454
33334
—
41
132
3449
33271
96
338
3273
32173
120
502
2783
27738
Rheumatism, unspecified
M79.0 [45567658]
2.1e+00
2.5e+00
—
—
—
—
1.5e+00
cases:0.66%
controls:0.08%
cases:0.23%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.10%
23
28
3448
33209
8
6
3489
33449
—
—
—
—
12
27
2891
28213
Monitored bed care
WX892 [2001310850]
4.7e-01
7.7e-01
2.3e+00
1.0e+50
2.1e+00
1.2e+00
7.0e-01
cases:1.99%
controls:1.25%
cases:0.66%
controls:0.30%
cases:0.26%
controls:0.03%
cases:0.17%
controls:0.00%
cases:0.23%
controls:0.03%
cases:0.56%
controls:0.17%
cases:0.93%
controls:0.46%
69
416
3402
32821
23
102
3474
33353
9
9
3488
33446
6
0
3491
33455
8
9
3482
33394
19
55
3350
32456
27
131
2876
28109
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.2e-01
2.0e-01
6.1e-01
3.3e+00
2.0e+00
1.3e-01
5.4e-02
cases:21.41%
controls:19.45%
cases:11.50%
controls:9.59%
cases:1.89%
controls:1.04%
cases:0.77%
controls:0.03%
cases:6.73%
controls:0.98%
cases:10.36%
controls:9.18%
cases:19.57%
controls:18.73%
743
6464
2728
26773
402
3208
3095
30247
66
347
3431
33108
27
10
3470
33445
235
328
3255
33075
349
2986
3020
29525
568
5288
2335
22952
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.3e-01
2.5e-01
6.9e-01
3.0e+00
1.9e+00
1.9e-01
3.0e-02
cases:22.27%
controls:20.16%
cases:14.13%
controls:11.39%
cases:2.49%
controls:1.26%
cases:0.83%
controls:0.04%
cases:7.85%
controls:1.23%
cases:13.51%
controls:11.49%
cases:23.39%
controls:22.85%
773
6700
2698
26537
494
3810
3003
29645
87
422
3410
33033
29
14
3468
33441
274
411
3216
32992
455
3734
2914
28777
679
6453
2224
21787
General evaluation of the need for rehabilitation
R1100 [2001310172]
9.1e-01
1.6e+00
—
1.0e+50
—
1.7e+00
1.8e+00
cases:1.30%
controls:0.53%
cases:0.63%
controls:0.13%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.62%
controls:0.12%
cases:1.65%
controls:0.27%
45
175
3426
33062
22
42
3475
33413
—
5
0
3492
33455
—
21
38
3348
32473
48
76
2855
28164
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.2e-01
2.6e-01
6.9e-01
3.0e+00
1.9e+00
1.8e-01
2.0e-02
cases:22.73%
controls:20.68%
cases:14.70%
controls:11.71%
cases:2.57%
controls:1.30%
cases:0.80%
controls:0.04%
cases:8.05%
controls:1.25%
cases:13.92%
controls:11.86%
cases:23.63%
controls:23.26%
789
6873
2682
26364
514
3919
2983
29536
90
436
3407
33019
28
14
3469
33441
281
418
3209
32985
469
3857
2900
28654
686
6570
2217
21670
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
8.6e-01
1.0e+00
1.0e+00
—
2.8e+00
1.3e+00
6.4e-01
cases:1.27%
controls:0.54%
cases:0.60%
controls:0.22%
cases:0.17%
controls:0.06%
—
—
cases:0.54%
controls:0.03%
cases:0.56%
controls:0.15%
cases:0.72%
controls:0.38%
44
179
3427
33058
21
72
3476
33383
6
21
3491
33434
—
19
11
3471
33392
19
49
3350
32462
21
108
2882
28132
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
1.0e+00
7.0e-01
1.2e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:0.66%
controls:0.23%
cases:0.37%
controls:0.19%
cases:0.17%
controls:0.05%
—
—
cases:0.32%
controls:0.04%
cases:0.92%
controls:0.16%
cases:1.14%
controls:0.40%
23
78
3448
33159
13
62
3484
33393
6
17
3491
33438
—
11
12
3479
33391
31
53
3338
32458
33
113
2870
28127
agomelatine; oral
N06AX22 [21604750]
1.6e+00
1.4e+00
—
—
—
1.7e+00
1.4e+00
cases:0.95%
controls:0.20%
cases:0.49%
controls:0.12%
—
—
—
—
—
—
cases:0.53%
controls:0.10%
cases:0.83%
controls:0.21%
33
67
3438
33170
17
40
3480
33415
—
—
—
18
33
3351
32478
24
60
2879
28180
citalopram; oral, parenteral
N06AB04 [21604712]
9.7e-01
9.7e-01
1.0e+00
—
9.0e-01
1.1e+00
1.0e+00
cases:3.63%
controls:1.41%
cases:1.97%
controls:0.76%
cases:0.63%
controls:0.22%
—
—
cases:0.54%
controls:0.22%
cases:2.29%
controls:0.78%
cases:3.75%
controls:1.38%
126
468
3345
32769
69
254
3428
33201
22
75
3475
33380
—
19
74
3471
33329
77
254
3292
32257
109
390
2794
27850
Emotionally unstable personality disorder
F60.3 [45566852]
1.9e+00
1.6e+00
—
—
—
2.0e+00
2.0e+00
cases:0.26%
controls:0.04%
cases:0.17%
controls:0.04%
—
—
—
—
—
—
cases:0.24%
controls:0.03%
cases:0.52%
controls:0.07%
9
13
3462
33224
6
12
3491
33443
—
—
—
8
10
3361
32501
15
19
2888
28221
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
7.8e-01
1.1e+00
1.7e+00
—
1.0e+00
1.2e+00
1.2e+00
cases:1.07%
controls:0.49%
cases:0.94%
controls:0.33%
cases:0.43%
controls:0.08%
—
—
cases:0.23%
controls:0.08%
cases:1.13%
controls:0.34%
cases:1.72%
controls:0.55%
37
164
3434
33073
33
109
3464
33346
15
26
3482
33429
—
8
28
3482
33375
38
110
3331
32401
50
155
2853
28085
Rehabilitation Hospital
283X00000X [38004285]
1.6e+00
—
—
1.0e+50
1.0e+50
2.3e+00
2.1e+00
cases:0.66%
controls:0.14%
—
—
—
—
cases:0.31%
controls:0.00%
cases:0.37%
controls:0.00%
cases:0.24%
controls:0.02%
cases:0.55%
controls:0.07%
23
45
3448
33192
—
—
11
0
3486
33455
13
0
3477
33403
8
8
3361
32503
16
20
2887
28220
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
5.3e-01
9.9e-01
1.0e+00
—
2.2e+00
8.7e-01
3.4e-01
cases:4.18%
controls:2.50%
cases:4.12%
controls:1.57%
cases:0.43%
controls:0.16%
—
—
cases:1.58%
controls:0.18%
cases:4.10%
controls:1.76%
cases:7.51%
controls:5.44%
145
832
3326
32405
144
525
3353
32930
15
53
3482
33402
—
55
60
3435
33343
138
572
3231
31939
218
1536
2685
26704
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
8.9e-01
7.8e-01
7.0e-01
2.1e+00
1.1e+00
1.0e+00
1.4e+00
cases:3.08%
controls:1.29%
cases:2.49%
controls:1.15%
cases:0.89%
controls:0.44%
cases:0.14%
controls:0.02%
cases:1.38%
controls:0.44%
cases:3.06%
controls:1.14%
cases:4.65%
controls:1.20%
107
429
3364
32808
87
386
3410
33069
31
148
3466
33307
5
6
3492
33449
48
148
3442
33255
103
370
3266
32141
135
338
2768
27902
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
7.3e-01
8.0e-01
1.0e+00
—
1.9e+00
1.2e+00
1.3e+00
cases:1.04%
controls:0.50%
cases:0.71%
controls:0.32%
cases:0.29%
controls:0.10%
—
—
cases:0.46%
controls:0.07%
cases:1.01%
controls:0.29%
cases:1.03%
controls:0.30%
36
167
3435
33070
25
108
3472
33347
10
35
3487
33420
—
16
24
3474
33379
34
95
3335
32416
30
84
2873
28156
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
7.3e-01
8.0e-01
1.0e+00
—
1.9e+00
1.2e+00
1.3e+00
cases:1.04%
controls:0.50%
cases:0.71%
controls:0.32%
cases:0.29%
controls:0.10%
—
—
cases:0.46%
controls:0.07%
cases:1.01%
controls:0.29%
cases:1.03%
controls:0.30%
36
167
3435
33070
25
108
3472
33347
10
35
3487
33420
—
16
24
3474
33379
34
95
3335
32416
30
84
2873
28156
Physiotherapy
R4110 [2001310233]
5.9e-01
8.4e-01
9.5e-01
—
1.7e+00
9.6e-01
8.6e-01
cases:8.61%
controls:4.99%
cases:4.40%
controls:1.95%
cases:0.71%
controls:0.28%
—
—
cases:1.32%
controls:0.25%
cases:4.13%
controls:1.63%
cases:7.89%
controls:3.49%
299
1658
3172
31579
154
654
3343
32801
25
93
3472
33362
—
46
84
3444
33319
139
529
3230
31982
229
985
2674
27255
Predominantly allergic asthma
J45.0 [45557624]
4.8e-01
5.6e-01
7.9e-01
3.5e+00
6.7e-01
3.8e-01
4.7e-01
cases:3.51%
controls:2.20%
cases:2.52%
controls:1.46%
cases:0.74%
controls:0.34%
cases:0.60%
controls:0.02%
cases:0.66%
controls:0.34%
cases:2.32%
controls:1.60%
cases:4.20%
controls:2.67%
122
732
3349
32505
88
488
3409
32967
26
113
3471
33342
21
6
3476
33449
23
113
3467
33290
78
521
3291
31990
122
753
2781
27487
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.5e-01
2.8e-01
6.7e-01
2.7e+00
1.8e+00
1.8e-01
6.6e-02
cases:24.14%
controls:21.46%
cases:16.59%
controls:13.09%
cases:2.89%
controls:1.49%
cases:0.80%
controls:0.05%
cases:8.08%
controls:1.42%
cases:15.49%
controls:13.23%
cases:25.66%
controls:24.42%
838
7134
2633
26103
580
4378
2917
29077
101
500
3396
32955
28
18
3469
33437
282
475
3208
32928
522
4302
2847
28209
745
6895
2158
21345
Speech disorder
N19 [2002000730]
7.0e-01
1.4e+00
9.2e-01
1.0e+50
2.3e+00
1.5e+00
3.5e-01
cases:1.24%
controls:0.62%
cases:1.03%
controls:0.26%
cases:0.14%
controls:0.06%
cases:0.37%
controls:0.00%
cases:0.52%
controls:0.05%
cases:1.16%
controls:0.27%
cases:0.86%
controls:0.61%
43
205
3428
33032
36
88
3461
33367
5
19
3492
33436
13
0
3484
33455
18
18
3472
33385
39
88
3330
32423
25
171
2878
28069
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
6.1e-01
1.2e+00
1.8e+00
—
2.7e+00
8.0e-01
5.4e-01
cases:0.84%
controls:0.46%
cases:0.71%
controls:0.22%
cases:0.34%
controls:0.06%
—
—
cases:0.60%
controls:0.04%
cases:0.62%
controls:0.28%
cases:1.48%
controls:0.87%
29
152
3442
33085
25
73
3472
33382
12
19
3485
33436
—
21
13
3469
33390
21
91
3348
32420
43
245
2860
27995
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.2e-01
5.5e-01
7.7e-01
2.3e+00
1.0e+00
4.7e-01
3.4e-01
cases:20.80%
controls:16.05%
cases:14.76%
controls:9.08%
cases:3.40%
controls:1.60%
cases:0.69%
controls:0.07%
cases:4.47%
controls:1.66%
cases:13.15%
controls:8.67%
cases:21.46%
controls:16.31%
722
5335
2749
27902
516
3037
2981
30418
119
536
3378
32919
24
24
3473
33431
156
556
3334
32847
443
2818
2926
29693
623
4605
2280
23635
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
4.8e-01
9.3e-01
1.8e+00
1.0e+50
2.1e+00
9.6e-01
1.2e-01
cases:0.78%
controls:0.48%
cases:0.57%
controls:0.23%
cases:0.23%
controls:0.04%
cases:0.37%
controls:0.00%
cases:0.26%
controls:0.03%
cases:0.50%
controls:0.19%
cases:0.65%
controls:0.58%
27
161
3444
33076
20
76
3477
33379
8
13
3489
33442
13
0
3484
33455
9
11
3481
33392
17
63
3352
32448
19
164
2884
28076
sertraline; oral
N06AB06 [21604714]
1.0e+00
9.8e-01
1.0e+00
—
9.3e-01
9.6e-01
7.8e-01
cases:2.94%
controls:1.10%
cases:1.72%
controls:0.65%
cases:0.57%
controls:0.21%
—
—
cases:0.52%
controls:0.20%
cases:1.96%
controls:0.76%
cases:3.38%
controls:1.58%
102
366
3369
32871
60
218
3437
33237
20
69
3477
33386
—
18
68
3472
33335
66
246
3303
32265
98
446
2805
27794
temazepam; oral
N05CD07 [21604642]
6.4e-01
9.3e-01
1.0e+00
—
1.1e+00
1.1e+00
9.2e-01
cases:2.91%
controls:1.56%
cases:2.12%
controls:0.84%
cases:0.69%
controls:0.25%
—
—
cases:0.72%
controls:0.24%
cases:2.20%
controls:0.77%
cases:2.96%
controls:1.21%
101
517
3370
32720
74
282
3423
33173
24
85
3473
33370
—
25
81
3465
33322
74
249
3295
32262
86
341
2817
27899
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
5.0e-01
7.5e-01
1.2e+00
—
2.0e+00
8.2e-01
3.4e-01
cases:10.40%
controls:6.57%
cases:6.32%
controls:3.09%
cases:1.06%
controls:0.32%
—
—
cases:2.15%
controls:0.29%
cases:6.50%
controls:2.98%
cases:10.58%
controls:7.77%
361
2185
3110
31052
221
1034
3276
32421
37
107
3460
33348
—
75
97
3415
33306
219
969
3150
31542
307
2194
2596
26046
risperidone; oral, parenteral
N05AX08 [21604559]
1.0e+00
1.1e+00
1.2e+00
—
8.1e-01
1.3e+00
9.8e-01
cases:2.10%
controls:0.77%
cases:1.54%
controls:0.51%
cases:0.63%
controls:0.19%
—
—
cases:0.52%
controls:0.23%
cases:1.99%
controls:0.57%
cases:3.31%
controls:1.27%
73
257
3398
32980
54
172
3443
33283
22
62
3475
33393
—
18
77
3472
33326
67
184
3302
32327
96
359
2807
27881
lamotrigine; oral
N03AX09 [21604431]
9.1e-01
9.7e-01
6.2e-01
—
1.1e+00
1.4e+00
1.2e+00
cases:2.02%
controls:0.82%
cases:1.32%
controls:0.51%
cases:0.37%
controls:0.20%
—
—
cases:0.57%
controls:0.19%
cases:1.90%
controls:0.48%
cases:2.62%
controls:0.78%
70
274
3401
32963
46
169
3451
33286
13
67
3484
33388
—
20
64
3470
33339
64
156
3305
32355
76
220
2827
28020
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
1.1e+00
1.9e+00
—
1.0e+50
—
1.9e+00
1.8e+00
cases:0.23%
controls:0.08%
cases:0.34%
controls:0.05%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.36%
controls:0.06%
cases:0.65%
controls:0.11%
8
25
3463
33212
12
17
3485
33438
—
5
0
3492
33455
—
12
18
3357
32493
19
31
2884
28209
alprazolam; oral
N05BA12 [21604577]
9.6e-01
9.5e-01
1.5e+00
—
1.6e+00
1.1e+00
1.0e+00
cases:1.21%
controls:0.47%
cases:0.57%
controls:0.22%
cases:0.23%
controls:0.05%
—
—
cases:0.26%
controls:0.05%
cases:0.68%
controls:0.23%
cases:1.14%
controls:0.42%
42
155
3429
33082
20
74
3477
33381
8
17
3489
33438
—
9
18
3481
33385
23
76
3346
32435
33
118
2870
28122
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
4.4e-01
7.3e-01
1.4e+00
—
1.6e+00
8.1e-01
5.3e-01
cases:2.71%
controls:1.76%
cases:1.63%
controls:0.79%
cases:0.37%
controls:0.09%
—
—
cases:0.49%
controls:0.10%
cases:1.87%
controls:0.84%
cases:4.00%
controls:2.40%
94
584
3377
32653
57
264
3440
33191
13
30
3484
33425
—
17
32
3473
33371
63
274
3306
32237
116
678
2787
27562
Other therapy enhancing rehabilitation
R4160 [2001310240]
1.1e+00
1.5e+00
—
—
2.3e+00
1.8e+00
1.1e+00
cases:1.18%
controls:0.40%
cases:0.43%
controls:0.09%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.59%
controls:0.10%
cases:1.17%
controls:0.40%
41
133
3430
33104
15
31
3482
33424
—
—
5
5
3485
33398
20
32
3349
32479
34
112
2869
28128
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
2.3e-01
4.1e-01
6.4e-01
2.3e+00
1.5e+00
2.3e-01
2.3e-01
cases:24.92%
controls:20.91%
cases:15.78%
controls:11.09%
cases:2.23%
controls:1.18%
cases:0.43%
controls:0.04%
cases:5.39%
controls:1.25%
cases:13.59%
controls:11.09%
cases:25.56%
controls:21.41%
865
6949
2606
26288
552
3709
2945
29746
78
396
3419
33059
15
15
3482
33440
188
416
3302
32987
458
3605
2911
28906
742
6046
2161
22194
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
2.2e-01
3.2e-01
6.1e-01
2.7e+00
1.6e+00
1.5e-01
1.0e-01
cases:21.58%
controls:18.09%
cases:15.47%
controls:11.72%
cases:2.75%
controls:1.51%
cases:0.71%
controls:0.05%
cases:6.93%
controls:1.41%
cases:13.77%
controls:12.12%
cases:23.77%
controls:22.01%
749
6014
2722
27223
541
3922
2956
29533
96
504
3401
32951
25
16
3472
33439
242
472
3248
32931
464
3939
2905
28572
690
6215
2213
22025
Pain general/multiple sites
A01 [2002000142]
9.0e-01
1.0e+00
—
—
2.1e+00
9.1e-01
5.8e-01
cases:1.79%
controls:0.73%
cases:0.74%
controls:0.27%
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.74%
controls:0.30%
cases:1.83%
controls:1.03%
62
243
3409
32994
26
91
3471
33364
—
—
6
7
3484
33396
25
98
3344
32413
53
290
2850
27950
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.5e-01
1.5e-01
5.7e-01
3.4e+00
8.6e-01
3.1e-01
3.4e-01
cases:12.68%
controls:11.06%
cases:9.15%
controls:8.00%
cases:3.29%
controls:1.89%
cases:2.43%
controls:0.08%
cases:4.24%
controls:1.84%
cases:10.12%
controls:7.63%
cases:16.47%
controls:12.27%
440
3677
3031
29560
320
2676
3177
30779
115
633
3382
32822
85
27
3412
33428
148
615
3342
32788
341
2479
3028
30032
478
3466
2425
24774
clonazepam; oral, parenteral
N03AE01 [21604415]
9.4e-01
8.3e-01
1.1e+00
—
1.4e+00
1.1e+00
1.3e+00
cases:1.24%
controls:0.49%
cases:0.74%
controls:0.33%
cases:0.26%
controls:0.08%
—
—
cases:0.34%
controls:0.09%
cases:0.92%
controls:0.32%
cases:1.31%
controls:0.36%
43
162
3428
33075
26
109
3471
33346
9
28
3488
33427
—
12
29
3478
33374
31
103
3338
32408
38
103
2865
28137
Psychiatric network contact
IGV01 [2001304319]
1.1e+00
1.4e+00
—
—
—
1.8e+00
1.2e+00
cases:0.63%
controls:0.20%
cases:0.49%
controls:0.12%
—
—
—
—
—
—
cases:0.86%
controls:0.14%
cases:1.45%
controls:0.46%
22
67
3449
33170
17
41
3480
33414
—
—
—
29
46
3340
32465
42
129
2861
28111
CT of neck arteries
PA6AD [2001308692]
1.4e+00
2.1e+00
—
1.0e+50
2.3e+00
2.0e+00
7.5e-01
cases:0.37%
controls:0.09%
cases:0.40%
controls:0.05%
—
—
cases:1.49%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.27%
controls:0.04%
cases:0.62%
controls:0.29%
13
31
3458
33206
14
16
3483
33439
—
52
0
3445
33455
5
5
3485
33398
9
12
3360
32499
18
83
2885
28157
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
5.1e-01
7.0e-01
1.3e+00
—
1.7e+00
8.5e-01
4.9e-01
cases:2.79%
controls:1.70%
cases:1.60%
controls:0.80%
cases:0.34%
controls:0.10%
—
—
cases:0.52%
controls:0.10%
cases:2.05%
controls:0.88%
cases:4.03%
controls:2.51%
97
565
3374
32672
56
267
3441
33188
12
32
3485
33423
—
18
33
3472
33370
69
287
3300
32224
117
709
2786
27531
disulfiram; oral
N07BB01 [21604821]
1.1e+00
1.4e+00
—
—
—
1.3e+00
1.7e+00
cases:0.66%
controls:0.22%
cases:0.37%
controls:0.09%
—
—
—
—
—
—
cases:0.36%
controls:0.10%
cases:0.86%
controls:0.17%
23
72
3448
33165
13
31
3484
33424
—
—
—
12
31
3357
32480
25
47
2878
28193
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
6.7e-01
1.1e+00
2.2e+00
1.0e+50
2.2e+00
8.1e-01
1.4e-01
cases:0.63%
controls:0.32%
cases:0.57%
controls:0.19%
cases:0.29%
controls:0.03%
cases:0.94%
controls:0.00%
cases:0.34%
controls:0.04%
cases:0.39%
controls:0.17%
cases:0.65%
controls:0.57%
22
108
3449
33129
20
62
3477
33393
10
11
3487
33444
33
0
3464
33455
12
13
3478
33390
13
56
3356
32455
19
161
2884
28079
lithium; oral
N05AN01 [21604556]
1.1e+00
1.1e+00
1.1e+00
—
1.6e+00
1.7e+00
1.5e+00
cases:0.58%
controls:0.19%
cases:0.37%
controls:0.12%
cases:0.17%
controls:0.06%
—
—
cases:0.17%
controls:0.04%
cases:0.62%
controls:0.11%
cases:0.72%
controls:0.16%
20
64
3451
33173
13
41
3484
33414
6
19
3491
33436
—
6
12
3484
33391
21
36
3348
32475
21
45
2882
28195
More than one and less than three hours
ZXE10 [2001311401]
3.2e-01
6.6e-01
1.1e+00
—
1.3e+00
1.2e+00
8.9e-01
cases:8.15%
controls:6.03%
cases:2.60%
controls:1.36%
cases:0.46%
controls:0.16%
—
—
cases:0.34%
controls:0.10%
cases:2.52%
controls:0.77%
cases:5.30%
controls:2.25%
283
2005
3188
31232
91
456
3406
32999
16
52
3481
33403
—
12
32
3478
33371
85
249
3284
32262
154
635
2749
27605
Presence of electronic cardiac devices
Z95.0 [45571406]
7.8e-01
8.5e-01
5.9e-01
1.0e+50
1.9e+00
9.3e-01
9.7e-01
cases:1.15%
controls:0.53%
cases:0.74%
controls:0.32%
cases:0.17%
controls:0.10%
cases:0.17%
controls:0.00%
cases:0.34%
controls:0.05%
cases:0.80%
controls:0.32%
cases:1.31%
controls:0.50%
40
177
3431
33060
26
107
3471
33348
6
32
3491
33423
6
0
3491
33455
12
17
3478
33386
27
103
3342
32408
38
141
2865
28099
Drawing up a rehabilitation plan
R1410 [2001310189]
1.1e+00
—
—
1.0e+50
—
2.5e+00
1.9e+00
cases:0.43%
controls:0.15%
—
—
—
—
cases:0.20%
controls:0.00%
—
—
cases:0.33%
controls:0.03%
cases:0.59%
controls:0.09%
15
49
3456
33188
—
—
7
0
3490
33455
—
11
9
3358
32502
17
25
2886
28215
Personal history of certain conditions arising in the perinatal period
Z87.6 [45581084]
7.8e-01
1.3e+00
—
—
—
2.1e+00
2.6e+00
cases:1.09%
controls:0.51%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.28%
controls:0.02%
38
168
3433
33069
7
18
3490
33437
—
—
—
9
11
3360
32500
8
6
2895
28234
Childhood emotional disorder, unspecified
F93.9 [45538091]
9.1e-01
2.1e+00
—
—
—
1.8e+00
1.5e+00
cases:0.20%
controls:0.08%
cases:0.23%
controls:0.03%
—
—
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.83%
controls:0.19%
7
27
3464
33210
8
9
3489
33446
—
—
—
12
19
3357
32492
24
55
2879
28185
Pure hypercholesterolaemia
E78.01 [2000501514]
4.6e-01
8.1e-01
1.1e+00
—
1.6e+00
8.4e-01
5.3e-01
cases:2.65%
controls:1.69%
cases:1.92%
controls:0.86%
cases:0.51%
controls:0.17%
—
—
cases:1.03%
controls:0.20%
cases:2.29%
controls:1.00%
cases:3.89%
controls:2.34%
92
562
3379
32675
67
288
3430
33167
18
58
3479
33397
—
36
67
3454
33336
77
324
3292
32187
113
660
2790
27580
Acute alcohol abuse
P16 [2002000812]
1.7e+00
2.1e+00
—
—
—
—
1.5e+00
cases:0.35%
controls:0.06%
cases:0.20%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.07%
12
21
3459
33216
7
8
3490
33447
—
—
—
—
10
21
2893
28219
Nursing episode
950 [44777714]
4.5e-01
6.8e-01
8.4e-01
1.5e+00
1.1e+00
8.2e-01
2.2e-01
cases:1.96%
controls:1.25%
cases:1.40%
controls:0.72%
cases:0.69%
controls:0.30%
cases:0.34%
controls:0.08%
cases:0.89%
controls:0.29%
cases:1.96%
controls:0.87%
cases:1.62%
controls:1.31%
68
417
3403
32820
49
240
3448
33215
24
100
3473
33355
12
27
3485
33428
31
97
3459
33306
66
284
3303
32227
47
369
2856
27871
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
7.8e-01
1.1e+00
1.1e+00
—
1.4e+00
1.5e+00
2.0e+00
cases:2.07%
controls:0.97%
cases:1.03%
controls:0.33%
cases:0.20%
controls:0.07%
—
—
cases:0.17%
controls:0.04%
cases:1.07%
controls:0.25%
cases:1.79%
controls:0.25%
72
321
3399
32916
36
111
3461
33344
7
22
3490
33433
—
6
14
3484
33389
36
82
3333
32429
52
71
2851
28169
Personality disorder, unspecified
F60.9 [45538076]
2.1e+00
—
—
1.0e+50
—
—
3.2e+00
cases:0.46%
controls:0.05%
—
—
—
—
cases:0.14%
controls:0.00%
—
—
—
—
cases:0.52%
controls:0.02%
16
18
3455
33219
—
—
5
0
3492
33455
—
—
15
6
2888
28234
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 [3035999]
1.4e+00
1.8e+00
—
—
—
2.1e+00
—
cases:0.55%
controls:0.13%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
cases:0.18%
controls:0.02%
—
—
19
43
3452
33194
8
13
3489
33442
—
—
—
6
7
3363
32504
—
Unspecified disorder of psychological development
F89 [45557220]
2.1e+00
2.0e+00
—
—
—
1.8e+00
1.2e+00
cases:0.32%
controls:0.04%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
cases:0.18%
controls:0.03%
cases:0.52%
controls:0.15%
11
13
3460
33224
12
16
3485
33439
—
—
—
6
10
3363
32501
15
42
2888
28198
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
4.9e-01
7.4e-01
1.3e+00
—
1.6e+00
7.5e-01
4.7e-01
cases:3.66%
controls:2.27%
cases:2.23%
controls:1.07%
cases:0.49%
controls:0.14%
—
—
cases:0.60%
controls:0.12%
cases:2.37%
controls:1.14%
cases:4.99%
controls:3.18%
127
755
3344
32482
78
359
3419
33096
17
46
3480
33409
—
21
41
3469
33362
80
370
3289
32141
145
898
2758
27342
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
4.2e-01
5.4e-01
7.3e-01
2.4e+00
7.2e-01
5.9e-01
6.5e-01
cases:4.15%
controls:2.78%
cases:3.00%
controls:1.78%
cases:0.89%
controls:0.43%
cases:0.23%
controls:0.02%
cases:0.74%
controls:0.37%
cases:2.52%
controls:1.41%
cases:4.41%
controls:2.36%
144
923
3327
32314
105
594
3392
32861
31
144
3466
33311
8
7
3489
33448
26
122
3464
33281
85
459
3284
32052
128
666
2775
27574
chlorprothixene; oral, parenteral
N05AF03 [21604533]
1.6e+00
1.1e+00
1.7e+00
—
2.3e+00
2.0e+00
1.7e+00
cases:0.49%
controls:0.10%
cases:0.34%
controls:0.11%
cases:0.14%
controls:0.03%
—
—
cases:0.14%
controls:0.01%
cases:0.47%
controls:0.06%
cases:0.76%
controls:0.14%
17
33
3454
33204
12
37
3485
33418
5
9
3492
33446
—
5
5
3485
33398
16
21
3353
32490
22
39
2881
28201
Inpatient Visit
IP [9201]
3.3e-01
4.3e-01
9.8e-01
—
2.3e+00
8.1e-01
4.5e-01
cases:9.33%
controls:6.92%
cases:4.52%
controls:2.99%
cases:0.94%
controls:0.36%
—
—
cases:2.92%
controls:0.30%
cases:5.88%
controls:2.71%
cases:10.06%
controls:6.67%
324
2301
3147
30936
158
1001
3339
32454
33
119
3464
33336
—
102
99
3388
33304
198
880
3171
31631
292
1883
2611
26357
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.0e-01
3.3e-01
6.4e-01
2.1e+00
9.8e-01
5.5e-01
4.2e-01
cases:11.32%
controls:8.62%
cases:7.18%
controls:5.26%
cases:2.20%
controls:1.17%
cases:0.29%
controls:0.04%
cases:3.07%
controls:1.17%
cases:8.31%
controls:4.99%
cases:12.85%
controls:8.83%
393
2866
3078
30371
251
1760
3246
31695
77
391
3420
33064
10
12
3487
33443
107
391
3383
33012
280
1621
3089
30890
373
2495
2530
25745
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
1.1e+00
1.6e+00
—
—
—
2.6e+00
6.3e-01
cases:0.40%
controls:0.13%
cases:0.29%
controls:0.06%
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.21%
controls:0.11%
14
44
3457
33193
10
20
3487
33435
—
—
—
7
5
3362
32506
6
31
2897
28209
Mental disorder, not otherwise specified
F99 [45605525]
1.9e+00
2.1e+00
—
—
—
—
1.3e+00
cases:0.55%
controls:0.08%
cases:0.34%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.16%
19
28
3452
33209
12
14
3485
33441
—
—
—
—
17
45
2886
28195
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
3.0e-01
5.2e-01
5.2e-01
1.9e+00
1.4e+00
3.9e-01
2.4e-01
cases:22.47%
controls:17.74%
cases:14.78%
controls:9.39%
cases:2.00%
controls:1.20%
cases:0.20%
controls:0.03%
cases:4.61%
controls:1.17%
cases:13.45%
controls:9.48%
cases:24.08%
controls:19.93%
780
5895
2691
27342
517
3141
2980
30314
70
403
3427
33052
7
10
3490
33445
161
391
3329
33012
453
3081
2916
29430
699
5628
2204
22612

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1468
7353
2.38
144.78
3.1
2.3
198.83
275.22
u/l
2.26
1430
7025
2091
12566
2.15
128.37
11.8
8.0
1.22
1.22
mmol/l
1.08
1999
11752
2247
13974
2.13
125.05
11.5
7.9
1.21
1.22
mmol/l
1.78
2058
12315
976
4403
2.45
118.16
4.0
3.4
29.61
29.73
s
0.26
960
4290
1781
10992
1.94
92.11
4.5
3.5
31.10
31.23
u/l
0.05
1718
10460
1356
7739
1.99
87.10
4.6
4.0
7.39
7.39
ph
0.16
965
5306
1871
11908
1.89
86.60
6.9
5.7
37.16
37.33
g/l
0.65
1771
11201
2992
22253
1.94
83.95
8.8
7.1
88.15
81.74
u/l
7.34
2852
21111
256
657
3.91
82.59
5.9
6.0
381.09
393.71
umol/l
0.61
236
601
2503
17789
1.83
78.39
8.2
5.5
6.27
6.31
mmol/l
0.35
2382
16372
511
2035
2.59
78.25
3.4
3.1
—
—
—
0
0
777
3736
2.21
77.80
8.8
6.6
5.76
5.85
kpa
1.85
757
3635
764
3655
2.22
77.42
8.9
6.6
1.12
1.43
mmol/l
1.46
645
3103
1602
9976
1.86
76.95
8.9
6.5
—
—
—
0
0
772
3732
2.20
76.13
8.9
6.6
7.37
7.37
ph
0.50
518
2311
704
3316
2.24
73.83
9.1
6.4
4.96
4.89
kpa
0.33
686
3232
1735
11193
1.81
73.35
2.2
1.9
96.59
97.20
pmol/l
0.24
952
6183
2121
14524
1.79
73.28
7.7
6.0
12.94
12.59
umol/l
0.29
2012
13645
1316
7834
1.88
71.83
6.8
4.9
90.34
90.25
%
0.04
1291
7686
998
5451
1.98
70.34
4.0
3.0
0.80
1.11
e6/l
1.80
537
2689
823
4247
2.06
67.71
10.7
8.1
1.15
1.15
mmol/l
0.03
784
3997
1464
9159
1.80
67.09
3.3
3.0
2.36
2.36
mmol/l
0.53
1356
8450
1205
7142
1.86
65.61
1.8
1.6
18.69
19.37
nmol/l
0.99
1095
6310
2662
19864
1.74
64.46
14.6
9.7
3.97
3.91
e9/l
0.71
2286
17177
2464
18002
1.73
64.33
9.9
7.2
0.57
0.56
e9/l
2.46
2114
15606
2463
18009
1.72
63.95
10.0
7.3
0.04
0.04
e9/l
0.14
2109
15609
3807
31844
2.25
63.63
22.2
13.0
3.92
3.92
mmol/l
0.26
3741
30947
3803
31808
2.24
63.39
22.3
13.0
139.55
139.56
mmol/l
0.03
3746
31005
1550
10007
1.76
62.81
4.8
3.4
82.22
62.50
e6/l
0.15
1169
7401
2518
18600
1.71
62.21
10.9
7.6
0.19
0.19
e9/l
0.18
2201
16354
940
5231
1.92
61.68
4.1
3.1
4.26
2.99
e6/l
1.71
472
2460
1396
8807
1.77
60.89
4.7
3.3
0.27
0.31
e6/l
0.28
1020
6243
670
3322
2.10
60.80
13.5
10.4
—
—
—
0
0
3315
26573
1.85
60.41
4.9
4.0
14.58
14.58
pmol/l
0.04
3131
24405
2053
14453
1.69
59.75
3.6
2.7
67.58
70.57
nmol/l
5.50
1935
13590
1620
10736
1.71
58.79
13.0
9.7
1.18
1.16
inr
0.73
1371
8983
2297
16719
1.68
58.36
10.0
7.4
8.55
8.51
%
0.33
2190
15880
1484
9620
1.73
58.22
4.5
3.9
8.39
8.65
mmol/l
0.94
1366
8630
2284
16640
1.67
57.46
10.1
7.4
0.66
0.66
%
0.14
2174
15782
2285
16678
1.67
56.81
9.9
7.4
2.88
2.86
%
0.11
2179
15819
3669
30630
1.99
55.68
6.1
4.8
1.85
1.81
mu/l
1.29
3516
29062
855
4758
1.90
55.42
4.9
3.5
373.89
515.46
ng/l
0.79
572
2895
2490
18654
1.66
55.27
10.0
7.2
2.06
2.06
e9/l
0.09
2192
16588
680
3539
2.00
53.53
1.8
1.7
997.50
1172.25
nmol/l
6.86
560
2722
549
2656
2.12
52.65
12.5
10.3
1.35
1.35
mmol/l
0.01
537
2604
813
4520
1.89
52.56
8.9
5.5
0.81
0.82
mmol/l
2.38
776
4298
527
2539
2.13
51.00
11.3
9.9
0.79
0.52
mmol/l
0.76
414
2053
1761
12297
1.63
49.94
5.9
4.0
51.93
72.15
e6/l
0.97
1221
7994
854
4908
1.83
49.38
3.2
2.6
13.14
14.22
umol/l
3.63
808
4617
2305
17220
1.61
49.19
9.7
7.1
54.47
54.51
%
0.05
2229
16626
2337
17529
1.61
48.94
9.9
7.2
30.98
30.96
%
0.03
2245
16824
214
686
3.09
48.72
3.2
3.1
34.28
32.89
umol/l
0.28
198
633
524
2569
2.09
48.30
11.7
9.9
7.42
7.41
ph
1.08
289
1312
1310
8562
1.67
47.76
3.7
2.7
—
—
—
0
0
523
2574
2.08
47.68
11.5
9.8
5.07
5.09
kpa
0.21
498
2474
523
2575
2.08
47.63
11.5
9.8
12.78
13.45
kpa
1.98
498
2475
1256
8130
1.68
47.47
4.4
3.4
0.71
0.21
—
7
47
539
2725
2.02
45.55
14.1
10.2
6.93
7.20
mmol/l
0.50
522
2635
1288
8469
1.65
45.42
2.9
2.5
2.69
2.59
mg/l
0.72
1137
7434
1127
7186
1.68
44.61
4.7
4.0
—
—
—
0
0
786
4529
1.81
44.58
3.2
2.6
2.47
2.45
g/l
0.28
728
4230
448
2143
2.12
43.87
2.0
1.8
0.23
0.23
mg/l
0.01
186
972
726
4131
1.82
42.75
3.4
2.7
21.00
23.36
%
5.23
685
3889
104
227
4.47
41.51
2.8
3.0
63.23
52.19
umol/l
2.94
88
212
548
2884
1.94
41.04
9.5
7.1
5.10
5.08
kpa
0.46
523
2796
543
2849
1.95
41.03
9.6
7.1
7.41
7.41
ph
0.04
461
2344
3356
28043
1.66
40.27
4.8
3.5
5.76
5.60
mmol/l
8.01
3179
26234
314
1345
2.33
40.20
14.5
13.1
16.22
16.18
%
0.08
305
1297
445
2200
2.05
39.76
10.3
7.5
—
—
—
0
0
1959
14539
1.53
39.64
4.4
3.2
6.34
6.28
ph
1.65
1022
7944
588
3203
1.88
39.58
5.1
4.1
1.62
1.62
%
0.00
535
2954
456
2290
2.02
38.98
12.5
10.5
95.51
95.85
%
0.37
435
2215
349
1583
2.21
38.97
5.0
3.9
21.19
21.20
s
0.01
326
1428
428
2110
2.05
38.49
12.4
10.4
122.97
123.40
g/l
0.15
417
2066
3983
35134
2.14
38.39
13.8
9.5
29.09
27.47
u/l
2.10
3898
34275
1306
8954
1.57
37.20
3.3
2.7
54.39
67.15
u/l
0.80
1229
8306
2118
16135
1.51
36.90
13.4
10.4
0.00
0.00
e9/l
0.21
1675
13019
640
3654
1.80
36.83
5.2
3.7
8.07
6.83
umol/l
0.82
544
3118
227
872
2.58
36.79
2.0
2.1
—
—
—
0
0
250
1018
2.44
35.81
2.0
2.0
538.74
425.22
mg/l
1.26
244
971
1019
6640
1.62
35.77
3.7
2.8
7.93
6.98
e6/l
0.99
932
6002
933
5950
1.64
35.72
3.7
2.8
558.37
557.38
mosm/kgh2o
0.04
833
5234
623
3568
1.79
35.37
3.9
3.0
—
—
—
0
0
354
1683
2.11
34.99
7.8
5.9
130.52
131.44
g/l
0.33
344
1640
2652
21306
1.50
34.65
6.2
4.2
1491.44
1601.89
e6/l
0.05
45
271
3975
35231
2.04
34.60
21.5
13.3
70.35
71.77
umol/l
2.12
3936
34761
621
3600
1.76
33.71
2.7
2.2
346.13
375.63
nmol/l
3.37
585
3371
229
925
2.45
33.37
1.8
2.0
3.57
3.54
mmol/l
0.13
214
874
229
928
2.44
33.13
2.0
2.1
988.02
5007.53
e6/l
0.46
176
699
1230
8496
1.54
33.11
4.4
3.3
1.02
1.59
kg/l
1.08
801
5298
396
2015
1.97
32.40
10.8
8.0
9.54
9.46
kpa
0.30
377
1970
1024
6816
1.58
32.38
3.2
2.3
1.51
1.13
mg/l
1.23
761
4852
224
910
2.43
32.23
6.3
5.4
1.84
1.64
%
1.36
211
851
225
922
2.41
31.76
2.0
2.1
18.78
20.31
e6/l
0.08
166
663
535
3021
1.80
31.64
2.6
2.5
28.79
50.77
u/l
0.77
462
2542
406
2101
1.94
31.60
10.6
7.6
24.18
24.21
mmol/l
0.10
399
2043
666
4010
1.70
31.39
1.9
1.7
—
—
—
0
0
187
709
2.60
31.12
5.1
3.5
24.64
24.55
nmol/l
0.03
182
690
226
944
2.37
30.56
3.0
2.7
449.04
377.10
ug/l
0.17
207
879
434
2321
1.88
30.55
4.2
3.5
67.81
68.39
e9/l
0.11
311
1564
207
833
2.45
30.40
6.6
5.6
0.90
0.89
%
0.05
197
778
3586
31090
1.63
30.18
25.4
15.0
13.36
13.21
%
11.35
3548
30653
2732
22434
1.46
29.20
6.0
4.2
—
23.71
—
0
24
313
1528
2.04
28.71
5.3
3.6
175.70
181.78
ng/l
0.10
293
1346
656
4032
1.66
28.37
3.0
2.3
—
—
—
0
0
2904
24204
1.46
28.06
4.9
3.2
40.69
35.55
u/l
3.12
2815
23236
390
2075
1.88
27.81
8.2
5.4
70.77
73.49
ng/l
0.30
365
1898
714
4517
1.62
27.45
2.8
2.5
2.43
2.42
mmol/l
0.49
612
4016
267
1250
2.12
27.37
7.0
6.6
24.39
24.16
mmol/l
0.39
249
1191
1378
10057
1.46
27.22
1.7
1.5
2.01
2.03
g/l
0.17
790
6324
811
5299
1.57
27.18
4.7
3.8
1342.18
1137.38
ng/l
0.52
683
4283
456
2588
1.77
26.29
1.2
1.2
3.36
18.31
u/ml
—
5
22
292
1444
2.01
25.80
6.2
4.7
3.22
3.27
g/l
0.25
281
1401
3860
34395
1.72
25.63
19.4
12.1
21.66
22.33
mg/l
0.67
3170
26820
122
415
2.87
25.06
7.5
7.5
12.23
11.65
mmol/l
0.87
111
371
122
416
2.86
24.95
7.5
7.5
105.12
105.08
mmol/l
0.02
111
372
3146
26893
1.45
24.36
5.8
4.4
37.30
36.87
mmol/mol
1.55
3015
25671
483
2855
1.70
23.99
3.9
3.2
0.22
0.22
g/l
0.67
456
2688
151
586
2.52
23.99
3.6
3.0
20.79
22.27
mu/l
0.29
146
549
722
4719
1.56
23.86
2.9
2.3
—
—
—
0
0
137
510
2.63
23.70
2.5
2.8
—
—
—
0
0
284
1438
1.96
23.44
15.8
13.1
24.11
24.05
mmol/l
0.13
278
1408
191
836
2.24
23.17
2.9
3.2
5.91
2.96
index
1.38
111
463
165
679
2.38
23.10
6.4
5.7
1.47
1.25
mmol/l
0.97
150
590
1206
8869
1.42
21.83
4.3
3.1
33.65
87.64
ng/l
1.22
711
4597
130
495
2.56
21.51
3.6
3.0
—
—
—
0
0
3627
32110
1.52
21.43
26.4
14.8
334.03
334.56
g/l
2.87
3608
31866
225
1086
2.04
21.25
5.1
4.5
24.76
24.94
mmol/l
0.41
220
1032
293
1565
1.85
20.53
19.2
11.4
1.21
1.17
mg/l
0.67
281
1497
1485
11416
1.38
20.37
2.0
1.8
1.44
1.34
mmol/l
3.67
1367
10202
1486
11433
1.37
20.25
1.6
1.5
2.51
2.09
u/ml
0.35
335
2926
302
1638
1.82
20.14
2.4
2.6
65.87
66.83
g/l
1.33
276
1533
1332
10082
1.38
20.02
3.1
2.4
—
—
—
0
0
1081
13211
0.71
19.82
2.6
2.3
—
—
—
0
0
282
1511
1.84
19.56
16.3
13.1
0.65
0.66
%
0.14
277
1502
2172
17791
1.34
19.40
4.8
3.5
0.02
5.36
estimate
3.43
386
3684
740
5062
1.48
19.37
2.9
2.2
—
—
—
0
0
735
5027
1.48
19.25
3.0
2.3
—
—
—
0
0
740
5074
1.48
19.12
3.0
2.3
—
—
—
0
0
286
1553
1.82
19.00
16.1
12.7
1.35
1.27
%
0.69
280
1543
101
364
2.70
18.69
11.8
12.7
0.55
0.59
mmol/l
1.35
92
336
2146
17623
1.33
18.45
4.8
3.5
0.00
0.00
estimate
0.80
392
3694
4184
38675
2.25
18.42
29.9
18.0
262.16
258.26
e9/l
3.63
4097
37764
4186
38704
2.26
18.36
31.1
18.5
40.71
41.44
%
2.35
4160
38335
4186
38704
2.26
18.36
29.7
17.9
29.65
29.82
pg
7.25
4160
38349
4186
38707
2.26
18.30
29.8
18.0
4.63
4.64
e12/l
0.12
4081
37735
878
6266
1.43
18.29
4.5
4.5
9.68
13.77
mg/mmol
0.74
617
4309
4185
38695
2.25
18.28
29.8
17.9
88.56
88.90
fl
4.60
4159
38341
2168
17852
1.33
18.19
4.9
3.6
0.01
0.09
estimate
0.46
375
3576
725
5000
1.47
18.10
2.9
2.2
—
—
—
0
0
606
4031
1.51
18.09
2.2
1.9
—
—
—
0
0
4186
38721
2.24
18.03
30.1
18.2
136.54
137.55
g/l
4.47
4162
38373
4186
38726
2.24
17.94
29.9
18.0
6.90
6.77
e9/l
3.51
4089
37734
1822
14664
1.33
17.77
3.4
2.9
—
—
estimate
—
0
0
623
4195
1.49
17.49
1.3
1.2
—
—
—
0
0
485
3105
1.56
17.22
4.2
2.9
9.82
10.32
g/l
2.16
457
2901
102
387
2.56
17.07
1.9
1.5
1.23
1.26
promille
0.06
83
299
857
6158
1.42
17.04
4.0
3.9
59.38
73.94
mg/l
1.02
627
4322
68
207
3.18
17.03
2.9
4.2
202.97
169.13
umol/l
0.29
35
117
1336
10325
1.35
16.96
3.7
2.7
0.10
0.04
0.38
21
131
74
238
3.01
16.90
2.4
2.4
149.62
148.18
nmol/l
0.04
65
207
278
1554
1.76
16.75
2.3
2.5
7.30
7.03
ug/l
0.08
242
1354
276
1547
1.76
16.47
16.6
12.9
93.72
94.46
%
0.88
276
1539
2256
18849
1.31
16.25
4.0
3.3
85.94
82.38
ug/l
0.40
2146
17916
236
1270
1.83
16.15
3.9
2.9
1.02
1.02
ratio
0.45
209
1117
93
347
2.60
16.12
7.6
7.6
10.71
10.15
mg/l
0.45
85
324
173
848
1.99
15.70
10.3
7.1
66.71
64.83
%
0.54
163
828
309
4657
0.61
15.67
1.3
1.2
—
—
—
0
0
703
4959
1.43
15.35
1.7
1.6
14262728.67
26366392.51
pmol/l
0.48
610
4301
227
1227
1.82
15.32
5.5
5.2
227.45
427.86
mg/l
2.85
148
712
3392
30178
1.36
14.71
5.1
3.9
2.68
2.73
mmol/l
3.49
3262
28705
39
92
4.09
14.25
1.8
3.2
—
—
—
0
0
41
101
3.92
14.14
9.0
7.5
1.96
2.54
mg/l
1.19
34
86
29
54
5.17
14.06
1.1
1.2
—
—
—
0
0
80
298
2.60
13.96
3.3
4.1
15.80
16.44
index
0.16
60
227
122
550
2.16
13.88
2.3
1.7
—
—
—
0
0
122
550
2.16
13.88
2.3
1.7
—
—
—
0
0
57
177
3.11
13.88
2.0
2.2
16.46
15.83
umol/l
0.15
57
177
122
551
2.15
13.82
2.3
1.7
—
—
—
0
0
122
551
2.15
13.82
2.3
1.7
—
—
—
0
0
99
410
2.34
13.79
4.0
2.7
567.36
571.40
e6/l
0.02
74
294
380
2426
1.55
13.58
2.2
1.8
1.08
1.20
g/l
1.46
356
2275
83
320
2.51
13.52
4.6
2.8
0.33
0.31
e9/l
0.11
52
176
67
232
2.79
13.48
55.1
46.7
6.82
7.05
ug/l
0.41
61
214
303
1838
1.62
13.46
1.7
1.4
—
—
—
0
0
153
761
1.96
13.37
2.4
1.9
3.50
1.95
ug/l
0.82
128
676
99
419
2.29
13.14
4.1
2.8
190.25
207.31
e6/l
0.38
75
308
77
293
2.55
12.90
1.4
1.3
1.94
1.74
mmol/l
1.08
70
269
544
3783
1.43
12.70
1.7
1.5
—
—
—
0
0
3140
27830
1.30
12.50
4.1
3.2
1.32
1.21
mmol/l
10.16
2998
26388
366
5050
0.67
12.20
1.5
1.6
3.67
3.53
ratio
1.09
263
3561
341
2176
1.54
12.20
3.0
3.4
4.86
4.77
pmol/l
0.50
316
1990
664
4812
1.38
12.18
1.5
1.5
418.05
466.60
titre
0.49
113
857
106
477
2.16
12.16
4.1
2.8
1552.65
1428.10
e6/l
0.43
84
366
3356
30060
1.31
12.02
4.7
3.7
4.42
4.55
mmol/l
13.64
3241
28752
93
400
2.25
11.92
1.2
1.1
43.53
36.59
mg/l
0.53
79
332
103
462
2.16
11.92
2.9
2.3
73.76
72.91
mmol/l
0.06
86
390
272
3976
0.63
11.92
1.4
1.4
3.44
3.37
mmol/l
0.43
171
2511
3335
29859
1.31
11.89
4.6
3.6
1.33
1.41
mmol/l
29.74
3205
28416
131
651
1.96
11.52
2.1
2.0
3.55
3.71
g/l
0.74
122
603
193
1085
1.74
11.45
1.9
2.1
1.52
1.30
g/l
2.16
170
957
126
620
1.98
11.41
2.1
2.0
2.88
3.00
g/l
0.66
117
570
60
215
2.70
11.37
34.7
32.2
139.10
126.32
ug/l
0.52
52
192
796
5994
1.33
11.33
3.8
2.8
333.96
331.90
umol/l
0.21
725
5488
357
2343
1.50
11.20
2.2
1.7
7.11
7.05
u/l
0.04
256
1763
130
653
1.94
11.10
2.1
2.0
7.36
7.32
g/l
0.08
120
603
89
388
2.22
11.08
1.1
1.1
250.48
214.20
mg/l
0.64
82
340
129
652
1.92
10.82
2.1
2.0
4.21
4.22
g/l
0.05
120
602
145
762
1.85
10.80
11.8
7.4
65.16
64.40
%
0.17
145
757
320
2085
1.51
10.40
3.0
2.5
0.27
0.39
e6/l
0.60
304
1977
60
227
2.55
10.25
3.2
4.5
0.70
0.76
index
0.22
60
227
141
756
1.81
9.88
1.2
1.2
30.79
38.80
u/ml
—
9
49
362
2444
1.46
9.85
2.1
1.7
11.07
13.28
iu/l
1.00
261
1887
60
233
2.49
9.73
6.5
7.4
43.65
279.65
mg/mmol
0.62
51
218
480
3421
1.39
9.64
1.3
1.2
—
—
—
0
0
374
2552
1.44
9.62
2.6
2.0
—
—
—
0
0
538
3915
1.36
9.50
3.8
2.8
4.22
4.57
e9/l
1.03
487
3492
113
573
1.91
9.44
2.3
2.0
9.80
10.44
g/l
0.89
101
521
393
2716
1.43
9.43
2.2
2.0
0.00
0.02
estimate
1.79
83
677
188
1111
1.65
9.33
1.9
2.1
—
—
—
0
0
182
1072
1.65
9.15
2.3
2.3
—
—
—
0
0
58
232
2.41
8.87
2.1
2.3
129.12
127.98
ng/l
0.03
53
211
78
355
2.13
8.81
4.2
3.1
1.73
1.73
umol/l
0.01
78
339
60
245
2.37
8.77
3.4
2.4
10.91
10.56
mmol/l
0.29
60
240
394
2760
1.40
8.76
1.9
1.7
389.05
308.46
mu/l
3.51
360
2502
72
320
2.18
8.64
1.2
1.2
—
—
—
0
0
86
411
2.03
8.55
1.4
1.5
362.15
387.87
pmol/l
0.19
71
360
433
3096
1.38
8.52
1.5
1.4
376.38
304.95
u/ml
0.21
399
2894
74
338
2.12
8.30
1.2
1.2
—
—
—
0
0
142
807
1.71
8.20
1.9
1.6
487.81
364.82
mu/l
1.18
129
661
385
4911
0.73
8.04
1.6
1.6
975.33
984.97
mu/l
0.05
328
4335
158
933
1.65
7.91
1.3
1.3
59.17
32.76
u/ml
—
7
40
18
37
4.68
7.85
1.1
1.2
—
—
—
0
0
44
164
2.59
7.83
4.5
4.3
—
—
—
0
0
206
1300
1.54
7.82
2.1
1.8
—
—
—
0
0
818
6464
1.26
7.79
3.1
3.1
106.88
122.26
ug/g
0.83
669
5181
71
330
2.08
7.64
1.2
1.2
0.70
0.67
ratio
0.11
41
187
692
5377
1.28
7.56
1.3
1.3
25.03
23.35
iu/ml
0.08
154
1366
86
431
1.93
7.52
1.7
1.6
45.53
92.78
mu/l
1.30
78
393
186
1158
1.56
7.51
2.4
1.7
120.86
122.24
au/ml
0.05
64
348
214
1378
1.51
7.41
1.6
2.0
5.26
7.27
iu/ml
0.54
38
318
54
229
2.28
7.31
2.0
2.5
1.17
0.46
mmol/l
0.77
47
205
39
142
2.65
7.29
1.4
1.3
156.39
140.15
nmol/l
0.84
39
142
148
883
1.63
7.15
1.3
1.3
1.68
14.33
u/ml
—
10
114
148
886
1.62
7.06
1.3
1.3
1.40
7.71
u/ml
—
9
75
114
1807
0.59
7.04
1.0
1.1
0.61
0.63
ratio
—
7
128
126
1948
0.61
7.03
1.6
1.6
58.52
59.83
ug/l
0.13
126
1948
139
820
1.64
7.03
1.4
1.4
317.30
307.69
ug/g
0.20
74
425
190
1209
1.53
6.98
2.4
1.7
—
—
—
0
0
30
97
2.98
6.97
2.3
1.3
0.86
1.33
iu/ml
1.38
16
50
623
4844
1.27
6.73
1.3
1.3
10.15
9.09
u/ml
0.13
207
1860
88
462
1.84
6.72
4.7
2.8
36.90
38.39
%
0.42
88
457
228
1521
1.46
6.66
2.0
1.5
197.34
198.98
u/ml
0.04
133
873
375
2726
1.35
6.65
1.3
1.2
159.62
235.13
titre
0.28
13
90
300
2106
1.39
6.61
1.3
1.3
37.17
44.42
au/ml
0.22
18
104
45
186
2.33
6.49
1.2
1.1
3.80
3.08
nmol/l
0.06
13
29
26
82
3.05
6.32
3.7
2.8
35.06
30.74
umol/l
0.63
18
59
26
82
3.05
6.32
2.5
1.3
0.21
0.35
iu/ml
1.43
14
46
88
474
1.79
6.22
2.6
3.3
36.73
58.01
mg/l
0.95
76
403
88
475
1.79
6.18
2.6
3.3
31.95
46.79
mg/l
0.95
76
405
100
562
1.72
6.11
2.0
2.4
—
—
—
0
0
298
2125
1.37
5.99
1.2
1.2
—
—
—
0
0
182
1190
1.49
5.92
1.6
1.8
1.20
1.17
g/l
0.85
177
1140
178
1161
1.49
5.87
1.6
1.9
0.23
0.22
g/l
0.53
173
1111
479
3671
1.28
5.80
2.8
2.3
11.06
12.88
nmol/l
4.54
445
3384
10
9
10.67
5.63
1.0
1.1
—
—
—
0
0
208
1411
1.43
5.61
1.2
1.2
—
—
—
0
0
76
406
1.81
5.56
1.9
2.0
284.48
286.19
mosm/kgh2o
0.23
50
305
345
2547
1.32
5.53
2.9
2.3
6.24
6.23
ph
0.10
257
1611
51
239
2.06
5.48
1.5
1.3
1.58
1.39
nmol/l
0.49
46
211
236
1645
1.40
5.47
1.4
1.4
—
—
—
0
0
78
423
1.78
5.44
2.6
3.1
1.42
3.12
ratio
1.19
43
241
114
687
1.61
5.39
4.5
3.8
1.56
1.38
mmol/l
0.96
109
673
311
2271
1.34
5.38
2.5
2.3
23.61
17.29
au/ml
0.47
27
276
81
446
1.75
5.37
1.4
1.3
0.35
0.37
g/l
0.14
67
333
81
446
1.75
5.37
1.4
1.3
2.41
2.72
g/l
1.18
69
335
81
446
1.75
5.37
1.4
1.3
6.32
6.35
g/l
0.02
69
335
117
716
1.58
5.20
2.3
2.3
133.69
133.95
g/l
0.04
99
605
138
1949
0.67
5.17
1.4
1.5
—
—
—
0
0
113
687
1.59
5.16
4.0
3.9
—
—
—
0
0
27
612
0.42
5.13
1.8
1.5
0.47
0.52
e9/l
0.57
27
612
909
9971
0.84
5.09
2.1
2.0
—
—
—
0
0
94
548
1.66
5.09
4.2
3.9
3.84
3.86
mmol/l
0.15
89
541
14
26
5.17
5.02
1.2
1.0
—
—
—
0
0
869
7205
1.19
5.01
2.0
1.7
—
—
—
0
0
79
442
1.73
4.98
1.4
1.4
—
—
—
0
0
18
53
3.26
4.93
1.1
1.6
39.82
41.81
g/l
0.53
18
53
10
12
8.00
4.90
1.0
1.0
—
—
—
0
0
35
148
2.28
4.88
1.2
1.1
61.70
230.83
ng/l
—
10
30
183
1248
1.42
4.84
1.8
1.7
8.75
8.31
iu/ml
—
6
59
31
126
2.37
4.73
1.7
1.8
—
—
—
0
0
59
308
1.85
4.70
1.4
1.6
—
—
—
0
0
164
1103
1.44
4.69
1.5
1.5
69.44
77.84
titre
0.21
18
125
26
99
2.53
4.55
2.2
1.9
—
—
—
0
0
67
369
1.75
4.50
7.1
5.8
7.84
6.57
mmol/l
1.29
55
309
83
485
1.65
4.50
5.9
3.6
—
—
—
0
0
410
3184
1.26
4.48
1.4
1.3
82.13
145.85
u/ml
3.94
115
1141
149
994
1.45
4.47
1.2
1.2
—
—
—
0
0
176
1217
1.40
4.34
1.3
1.2
0.39
0.72
u/ml
—
9
73
262
1931
1.32
4.31
1.6
1.4
—
—
—
0
0
43
209
1.98
4.26
1.3
1.3
—
—
—
0
0
114
729
1.51
4.23
2.1
2.6
1.02
0.70
nmol/l
1.60
96
630
40
192
2.01
4.11
2.6
1.7
—
—
—
0
0
1091
9351
1.16
4.10
4.9
3.5
0.00
0.00
estimate
2.22
363
3486
23
88
2.51
4.02
1.0
1.1
—
—
—
0
0
148
1008
1.42
4.01
2.0
2.2
3.50
8.53
iu/l
0.47
65
449
41
201
1.96
3.99
2.3
2.1
—
—
—
0
0
59
326
1.74
3.96
1.3
1.3
0.18
0.22
nmol/l
0.36
46
252
101
641
1.52
3.92
1.6
1.3
5.03
4.43
u/ml
0.16
62
317
14
41
3.28
3.89
1.5
1.3
—
—
—
0
0
275
2072
1.29
3.87
5.8
3.7
7.33
7.35
ph
0.32
218
1495
113
737
1.48
3.85
11.3
8.4
—
—
—
0
0
30
133
2.17
3.81
1.3
1.3
—
—
—
0
0
49
261
1.81
3.74
1.3
1.2
104.90
115.98
pmol/l
0.64
49
261
29
129
2.16
3.66
1.3
2.3
1.17
1.31
nmol/l
0.19
22
99
110
724
1.47
3.61
1.3
1.8
0.55
0.79
g/l
3.44
93
588
37
182
1.96
3.60
1.5
1.4
54.33
77.14
%
—
6
22
77
471
1.58
3.55
2.8
2.4
—
—
—
0
0
121
814
1.44
3.55
1.2
1.1
—
—
—
0
0
17
60
2.72
3.49
1.3
1.6
6.81
366672.09
nmol/l
0.49
12
51
25
107
2.25
3.47
1.5
1.4
115.42
105.17
nmol/l
0.13
17
75
122
828
1.42
3.42
1.2
1.1
—
—
—
0
0
344
2708
1.24
3.38
5.5
5.1
0.88
0.74
%
0.40
121
772
158
1125
1.36
3.35
1.4
1.4
—
—
—
0
0
28
128
2.10
3.33
3.8
2.7
—
—
—
0
0
129
892
1.40
3.27
1.4
1.5
15.16
9.48
iu/ml
—
5
13
17
63
2.59
3.20
1.9
2.8
—
—
—
0
0
38
198
1.85
3.16
1.9
1.6
1.61
2.80
nmol/l
0.53
32
150
20
81
2.37
3.15
2.9
2.8
0.59
0.61
mmol/l
0.60
20
81
329
2602
1.23
3.11
4.9
4.7
0.68
0.52
%
0.48
114
733
329
2604
1.23
3.09
5.5
5.2
0.05
0.09
%
0.93
103
672
45
249
1.74
3.08
3.3
4.1
—
—
—
0
0
16
59
2.60
3.05
3.7
4.6
—
—
—
0
0
561
4678
1.17
2.98
1.7
1.5
—
—
—
0
0
32
161
1.91
2.97
1.1
1.1
—
—
—
0
0
23
103
2.15
2.91
6.0
7.8
1.21
1.21
mmol/l
0.13
23
96
22
97
2.18
2.89
2.5
3.0
20.49
34.25
mg/l
0.54
15
35
14
50
2.69
2.84
3.0
4.7
51.36
43.87
umol/l
0.63
14
39
37
201
1.77
2.73
2.9
2.6
1.51
1.93
mmol/l
0.53
21
160
331
2664
1.21
2.66
6.0
5.4
0.04
0.09
%
0.84
93
643
51
305
1.61
2.66
3.3
2.2
23.68
27.83
mg/l
0.40
41
197
31
162
1.84
2.60
1.0
1.0
—
—
—
0
0
53
323
1.58
2.57
1.3
1.1
—
—
—
0
0
103
718
1.38
2.57
1.3
1.1
163.17
752.63
iu/ml
0.50
20
212
144
1058
1.31
2.55
1.2
1.1
23.11
20.00
au/ml
0.11
11
252
64
410
1.50
2.50
2.0
2.0
4.34
4.89
mmol/24h
0.80
58
373
34
187
1.75
2.44
1.4
1.4
15843.63
1891.49
e6/l
0.63
24
117
83
564
1.42
2.41
1.2
1.2
—
—
—
0
0
25
125
1.92
2.41
4.4
3.9
2.98
3.20
%
0.04
11
46
32
174
1.77
2.39
1.1
1.1
25.27
37.06
iu/ml
1.02
32
174
30
160
1.80
2.38
1.3
1.5
—
—
—
0
0
12
44
2.62
2.34
1.3
1.3
58.50
66.52
ug/l
0.50
12
44
1478
13280
1.10
2.33
4.6
3.3
0.11
0.03
estimate
0.44
314
3104
90
625
1.39
2.33
4.8
4.1
1.76
2.11
mmol/l
0.86
60
378
16
68
2.26
2.32
1.1
1.2
—
—
—
0
0
80
545
1.41
2.31
1.6
1.7
11070.86
15215.09
e6/l
0.53
58
388
212
2473
0.81
2.30
1.5
1.5
1.17
1.15
ratio
0.13
113
1465
5
8
5.99
2.30
1.2
1.4
133.40
248.38
nmol/l
—
5
8
205
1599
1.24
2.28
1.1
1.1
—
—
—
0
0
230
2654
0.82
2.25
1.5
1.6
62.32
60.93
ug/l
0.18
190
2307
125
920
1.31
2.23
1.3
1.2
—
—
—
0
0
237
1883
1.22
2.22
4.4
3.8
1.23
1.23
mmol/l
0.18
215
1617
29
157
1.77
2.22
1.6
1.4
154.29
167.93
mmol/24h
0.39
29
157
21
102
1.98
2.21
3.0
2.6
111.63
102.39
ng/l
0.16
21
102
16
70
2.19
2.19
1.7
1.4
4.88
6.82
pmol/l
—
6
30
88
617
1.37
2.17
1.7
1.4
12.68
12.61
u/l
0.01
75
539
268
2161
1.20
2.16
1.3
1.2
—
—
—
0
0
375
3116
1.17
2.14
1.4
1.5
—
—
—
0
0
33
188
1.69
2.13
1.1
1.1
240.24
222.90
iu/ml
0.13
33
188
17
317
0.51
2.08
2.4
1.7
—
—
—
0
0
25
132
1.82
2.08
1.5
1.4
169.20
94.45
nmol/24h
0.51
25
132
35
205
1.64
2.05
1.8
2.5
40.10
42.41
%
0.24
21
94
29
162
1.72
2.02
1.3
1.4
—
—
—
0
0
29
162
1.72
2.02
1.3
1.4
53168.13
71844.52
e6/l
0.17
16
86
70
479
1.41
2.01
1.2
1.2
—
—
—
0
0
33
192
1.65
1.99
1.5
1.4
194073.09
123502.02
e6/l
0.24
22
132
17
80
2.04
1.96
3.3
2.4
—
—
—
0
0
559
4808
1.13
1.96
4.0
4.1
2.30
2.01
ug/l
0.24
496
4341
8
26
2.95
1.91
1.0
1.6
628.14
475.62
nmol/l
—
8
26
24
129
1.79
1.91
1.9
1.7
—
1400.00
—
0
16
60
404
1.43
1.90
1.2
1.3
24.54
27.71
u/l
0.16
55
356
29
166
1.68
1.87
3.4
3.2
64.00
110.07
umol/l
—
7
52
17
82
1.99
1.85
1.3
1.5
—
—
—
0
0
70
487
1.38
1.85
1.2
1.1
5.98
7.01
iu/ml
0.22
16
114
8
27
2.84
1.84
1.5
1.1
—
—
—
0
0
167
1311
1.23
1.81
1.1
1.1
4.17
6.49
eliau/ml
0.42
17
186
363
3052
1.15
1.81
1.8
1.4
—
—
—
0
0
51
338
1.45
1.77
1.4
1.3
5.38
6.60
u/ml
0.24
32
212
44
283
1.49
1.77
1.6
1.5
—
—
—
0
0
27
155
1.67
1.74
1.2
1.1
—
—
—
0
0
36
224
1.54
1.70
2.0
2.8
1.79
1.62
g/24h
0.15
19
146
10
38
2.52
1.67
1.2
1.3
—
—
—
0
0
6
18
3.20
1.67
1.0
1.0
291.83
294.17
u/ml
—
6
18
155
1226
1.22
1.60
4.2
2.9
8.00
7.18
umol/l
0.35
123
948
6
19
3.03
1.58
3.3
2.2
—
—
—
0
0
168
1342
1.21
1.58
1.6
1.7
15.03
8.84
u/ml
0.70
36
391
7
25
2.69
1.56
1.6
1.2
38.29
29.40
%
—
7
15
55
380
1.39
1.56
1.1
1.0
—
—
—
0
0
48
324
1.42
1.55
2.7
4.3
21.45
102.19
u/ml
—
6
103
263
2893
0.86
1.55
4.9
3.5
—
—
—
0
0
50
343
1.40
1.49
1.1
1.1
—
—
—
0
0
38
248
1.47
1.47
1.8
1.7
6.76
6.05
mmol/l
0.68
27
204
40
264
1.46
1.47
1.8
1.6
—
—
—
0
0
85
637
1.28
1.43
1.9
1.8
—
—
—
0
0
951
8547
1.08
1.43
6.3
4.6
—
—
—
0
0
54
381
1.36
1.38
1.1
1.4
350.00
235.00
titre
—
5
72
54
381
1.36
1.38
1.1
1.4
—
138.13
—
0
16
10
190
0.50
1.38
1.4
1.2
—
—
—
0
0
5
16
3.00
1.37
2.2
1.7
—
—
—
0
0
26
379
0.66
1.35
3.1
3.1
44.35
44.43
%
0.01
26
379
26
379
0.66
1.35
6.2
6.2
10.12
8.94
%
0.55
26
379
27
167
1.55
1.35
2.3
3.0
23.64
48.00
mg/l
0.89
22
126
29
183
1.52
1.33
1.3
1.2
10.13
22.18
u/ml
—
8
22
388
3356
1.12
1.30
1.2
1.2
—
—
—
0
0
5
17
2.82
1.29
3.4
2.8
649.40
243.65
umol/l
—
5
17
17
94
1.74
1.29
1.4
1.3
—
—
—
0
0
65
478
1.31
1.29
2.1
2.6
156.38
95.99
ug/min
0.37
46
311
29
185
1.51
1.28
1.2
1.1
346.71
395.54
nmol/l
0.54
21
172
83
633
1.26
1.25
1.5
1.3
—
—
—
0
0
8
35
2.19
1.22
1.3
1.2
—
—
—
0
0
35
235
1.43
1.22
1.2
1.1
—
—
—
0
0
11
54
1.95
1.19
1.7
1.3
38.54
81.49
ng/l
—
5
26
51
367
1.34
1.19
1.0
1.0
9.21
8.82
mu/l
0.18
42
317
18
105
1.65
1.16
2.3
1.8
22.83
18.63
nmol/l
—
6
27
48
344
1.34
1.16
1.2
1.2
45.01
14.60
u/ml
0.34
34
264
5
19
2.52
1.15
1.8
1.2
544.60
19.09
u/l
—
5
11
17
98
1.66
1.14
1.2
1.3
—
—
—
0
0
12
62
1.86
1.14
1.2
1.2
42.17
40.39
g/l
—
6
35
7
29
2.31
1.11
2.4
1.8
280.43
264.62
ug/l
—
7
29
7
30
2.24
1.09
2.1
1.4
21.77
25.23
g/l
—
7
22
224
1898
1.14
1.09
1.2
1.2
2.84
2.74
u/ml
0.05
151
1158
424
3728
1.10
1.08
3.1
2.7
8092.54
7071.75
u/l
0.17
124
1444
42
299
1.35
1.07
1.3
1.3
—
—
—
0
0
197
1660
1.14
1.05
1.2
1.1
1.56
1.23
u/ml
0.27
117
946
17
101
1.62
1.04
6.2
6.2
22.79
23.33
mg/l
0.06
17
96
18
109
1.58
1.02
2.6
2.3
32.61
29.21
%
0.44
18
109
13
206
0.60
1.02
1.2
1.3
57.62
72.11
ug/l
0.53
13
206
38
269
1.36
1.01
3.4
3.5
0.82
0.83
nmol/l
0.08
29
216
19
117
1.56
1.01
2.8
2.4
8.38
7.99
mmol/l
0.21
19
117
0
27
0.00
0.98
0.0
1.0
—
—
—
0
0
9
48
1.80
0.96
1.0
1.6
—
—
—
0
0
37
264
1.35
0.95
1.3
1.3
845.45
1054.55
titre
0.45
11
44
186
2011
0.88
0.94
1.6
1.5
—
—
—
0
0
202
1721
1.13
0.94
1.2
1.2
5.58
7.40
u/ml
0.79
133
1136
25
167
1.44
0.93
1.1
1.1
—
—
—
0
0
85
678
1.21
0.91
3.0
2.6
14.08
19.61
iu/ml
—
5
26
180
1945
0.88
0.91
1.5
1.5
1.26
1.27
mm
0.14
131
1458
41
300
1.31
0.91
1.2
1.3
39.21
11.42
u/ml
0.62
29
230
38
476
0.76
0.90
1.6
1.5
26.27
37.61
nmol/l
1.86
33
439
8
41
1.87
0.87
1.4
1.5
1.95
3.75
mmol/l
—
8
34
10
54
1.78
0.85
2.0
4.0
3.10
5.48
ug/l
—
10
54
8
43
1.78
0.84
2.9
3.2
0.24
0.21
%
—
8
43
37
271
1.31
0.83
2.4
2.2
0.91
0.88
%
0.11
28
155
36
263
1.31
0.82
1.3
1.7
53.37
52.25
%
0.06
27
189
191
2035
0.89
0.79
1.6
1.6
—
—
—
0
0
0
23
0.00
0.79
0.0
8.2
—
—
—
0
0
29
207
1.34
0.78
1.5
1.3
—
—
—
0
0
6
32
1.80
0.78
6.5
2.7
4.83
4.52
mmol/l
—
6
32
180
1549
1.12
0.75
3.6
4.3
54.25
17.67
ug/l
0.33
131
1177
15
95
1.51
0.74
5.3
5.4
5.19
5.13
kpa
0.09
15
95
12
72
1.60
0.74
6.7
5.6
—
—
—
0
0
121
1017
1.14
0.74
1.9
1.6
0.32
0.40
nmol/l
0.64
104
824
9
53
1.63
0.73
2.6
2.0
18.71
20.49
pmol/l
—
9
47
16
221
0.69
0.72
1.1
1.2
8.81
7.54
mm/h
0.28
16
221
18
120
1.44
0.71
1.1
1.2
430.25
302.37
u/ml
—
8
30
31
229
1.30
0.68
1.3
1.3
—
—
—
0
0
56
445
1.21
0.68
1.0
1.0
—
—
—
0
0
24
171
1.35
0.67
3.0
2.9
—
—
—
0
0
1026
10185
0.95
0.66
4.1
2.9
0.17
0.06
estimate
0.32
311
3045
110
1191
0.88
0.64
1.2
1.1
—
—
—
0
0
1470
14466
0.96
0.64
2.7
2.4
—
—
—
0
0
8
47
1.63
0.62
1.0
1.1
85.16
70.21
ug/l
—
8
41
73
602
1.16
0.60
1.3
1.3
10.26
3.26
u/ml
0.58
39
319
0
19
0.00
0.60
0.0
1.2
—
7.12
—
0
10
111
1193
0.89
0.59
1.2
1.1
—
—
—
0
0
193
1696
1.09
0.58
1.2
1.1
3.52
2.82
u/ml
0.30
134
1070
12
77
1.49
0.58
1.0
1.1
—
—
—
0
0
145
1257
1.11
0.58
1.1
1.1
8.04
8.67
u/ml
0.12
82
701
29
219
1.27
0.57
4.7
3.1
—
—
—
0
0
25
306
0.78
0.56
1.2
1.5
—
—
—
0
0
12
78
1.48
0.55
1.1
1.0
0.67
0.64
u/ml
—
7
48
136
1180
1.11
0.54
1.1
1.2
—
—
—
0
0
15
103
1.40
0.54
1.0
1.3
—
—
—
0
0
92
781
1.13
0.53
1.1
1.1
3.35
2.98
eliau/ml
0.15
34
346
80
673
1.14
0.53
3.6
3.9
704.99
2260.31
u/ml
0.51
70
580
6
38
1.51
0.52
1.7
1.1
0.02
0.03
u/ml
—
6
38
26
197
1.27
0.51
1.5
1.3
64.85
76.50
umol/l
2.78
26
197
404
3674
1.06
0.51
1.5
1.4
—
—
—
0
0
10
64
1.50
0.50
4.3
2.6
102.50
99.27
g/l
—
10
64
44
355
1.19
0.50
4.9
5.1
8.21
9.55
mg/l
0.67
39
294
43
348
1.19
0.47
1.5
1.2
—
—
—
0
0
7
45
1.49
0.47
2.1
2.1
3.43
3.00
%
—
7
45
1325
12402
1.03
0.46
1.6
1.7
—
—
—
0
0
7
47
1.43
0.46
1.7
2.0
—
—
—
0
0
76
646
1.13
0.45
3.0
3.7
3.96
3.79
e9/l
0.30
76
646
13
168
0.74
0.45
1.1
1.1
—
—
—
0
0
23
274
0.80
0.44
1.1
1.0
12.89
15.59
u/ml
0.29
15
186
152
1346
1.08
0.43
1.2
1.1
6.48
5.23
u/ml
0.33
96
814
242
2461
0.94
0.42
1.4
1.3
223.99
228.73
miu/ml
0.06
86
1176
14
100
1.34
0.42
2.3
2.6
15.50
16.84
%
0.77
14
100
30
239
1.20
0.40
1.5
1.2
—
—
—
0
0
8
57
1.35
0.40
1.1
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
190.71
—
0
7
0
18
0.00
0.39
0.0
1.0
—
20.17
—
0
6
17
127
1.28
0.39
1.0
1.1
1.01
0.39
u/ml
—
6
70
144
1280
1.08
0.39
1.6
1.4
4.35
4.36
ug/l
0.01
138
1218
33
372
0.85
0.38
2.3
2.2
14.58
2.95
u/ml
—
7
146
405
3721
1.05
0.38
1.9
2.0
—
—
—
0
0
129
1145
1.08
0.36
1.1
1.1
0.22
0.60
u/ml
1.13
64
435
18
137
1.26
0.36
1.3
1.2
—
—
—
0
0
18
137
1.26
0.36
1.3
1.2
—
—
—
0
0
18
137
1.26
0.36
1.3
1.2
—
—
—
0
0
9
117
0.74
0.35
1.2
1.1
—
—
—
0
0
20
156
1.23
0.34
2.3
2.0
—
—
—
0
0
196
1777
1.06
0.32
1.1
1.1
—
—
—
0
0
12
88
1.31
0.32
1.1
1.0
—
—
—
0
0
20
158
1.21
0.31
2.4
2.3
242.54
141.36
au/ml
—
5
24
36
301
1.15
0.31
1.0
1.0
7.08
7.22
kpa
0.13
30
256
36
301
1.15
0.31
1.0
1.0
—
—
—
0
0
36
301
1.15
0.31
1.0
1.0
-1.10
-2.12
mmol/l
—
7
69
19
150
1.21
0.30
1.5
1.5
—
—
—
0
0
17
133
1.23
0.29
1.9
1.3
32.12
28.57
s
1.33
17
133
8
105
0.73
0.29
1.1
1.1
—
—
—
0
0
5
68
0.70
0.26
1.0
1.1
—
—
—
0
0
5
68
0.70
0.26
1.0
1.1
—
—
—
0
0
298
2758
1.04
0.24
2.4
2.6
0.64
0.71
ug/l
0.66
179
1409
33
355
0.89
0.24
1.2
1.1
—
—
—
0
0
14
110
1.22
0.23
1.0
1.2
4.23
9.96
u/ml
—
7
64
71
631
1.08
0.23
3.5
2.9
22.36
26.80
mg/l
0.59
49
406
51
534
0.91
0.23
1.3
1.3
—
—
—
0
0
5
37
1.30
0.23
10.2
5.8
5.86
6.16
mmol/l
—
5
37
12
93
1.24
0.22
2.2
1.9
—
—
—
0
0
23
252
0.87
0.22
3.1
2.9
—
—
—
0
0
58
513
1.08
0.21
1.1
1.1
5.72
1.39
u/ml
0.40
29
237
0
10
0.00
0.21
0.0
1.5
—
374.40
—
0
10
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
122
1230
0.95
0.21
2.7
2.4
29.87
53.47
u/ml
1.30
115
1184
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
158
1449
1.05
0.20
2.2
1.9
0.02
0.49
estimate
0.51
64
537
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
11
127
0.83
0.19
1.2
1.5
0.00
0.02
estimate
0.50
11
127
30
318
0.90
0.18
2.6
3.9
17.72
1230.72
u/ml
0.88
24
296
5
64
0.75
0.17
1.0
1.0
—
—
—
0
0
8
65
1.18
0.16
2.8
2.1
5.02
3.54
ug/l
—
8
59
34
298
1.09
0.16
1.0
1.0
3.32
3.26
kpa
0.05
28
254
78
787
0.95
0.15
1.9
1.8
672.00
3546.67
titre
—
5
27
30
314
0.91
0.15
1.2
1.1
1651.70
1374.05
miu/ml
0.70
30
314
1170
11102
1.01
0.14
2.0
1.8
—
—
—
0
0
17
144
1.13
0.14
1.0
1.1
1.03
4.68
u/ml
—
7
74
17
145
1.12
0.13
1.0
1.1
3.55
1.50
u/ml
—
7
77
21
183
1.10
0.11
2.0
1.6
35.37
40.98
%
0.32
16
126
21
183
1.10
0.11
2.0
2.4
1.69
1.72
u/field
0.01
13
121
104
962
1.04
0.11
3.2
3.2
55.53
55.43
%
0.02
104
962
15
128
1.12
0.11
1.5
2.4
—
—
—
0
0
63
578
1.04
0.10
1.5
1.3
8.14
11.49
u/ml
0.25
29
270
51
512
0.95
0.09
1.0
1.1
5.58
16.01
u/ml
—
5
182
7
65
1.03
0.08
3.1
1.8
—
—
—
0
0
6
72
0.80
0.07
1.3
1.6
6.52
10.20
mmol/l
—
6
72
285
2766
0.99
0.07
4.8
3.5
32.15
31.73
%
0.27
226
2014
84
783
1.03
0.07
2.0
2.1
12.65
10.59
mg/l
2.61
78
747
9
81
1.06
0.07
1.7
1.6
—
—
—
0
0
16
141
1.09
0.07
1.2
1.2
1.82
0.82
u/ml
0.23
16
141
35
351
0.95
0.06
1.2
1.3
198.35
207.97
pmol/l
0.22
35
351
12
104
1.11
0.06
1.2
1.3
—
—
—
0
0
35
322
1.04
0.05
1.3
1.3
—
—
—
0
0
67
653
0.98
0.03
1.3
1.1
—
—
—
0
0
15
136
1.06
0.02
4.8
7.7
2.85
123.55
ug/l
—
8
102
16
146
1.05
0.02
2.2
2.4
547.55
597.61
ml
0.25
11
107
85
805
1.01
0.02
1.2
1.2
—
—
—
0
0
19
175
1.04
0.01
1.2
1.2
—
49.54
—
0
17
14
133
1.01
0.00
1.3
1.2
—
—
—
0
0
15
141
1.02
0.00
1.5
2.4
—
—
—
0
0
8
78
0.98
0.00
1.4
1.1
—
—
—
0
0
5
51
0.94
-0.00
1.4
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
15.87
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
2600.00
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
13.40
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
47
1.02
-0.00
1.2
1.9
1.88
2.01
ug/l
—
5
22
0
5
0.00
-0.00
0.0
1.2
—
0.02
—
0
5
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
35.20
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_SPEELING – Speech and linguistic disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).